ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification Number) |
Title of Each Class | Trading Symbols(s) | Name of Each Exchange on Which Registered | ||||||
Page | |||||||||||
PART I | Item 1. | ||||||||||
Item 1A. | |||||||||||
Item 1B. | |||||||||||
Item 2. | |||||||||||
Item 3. | |||||||||||
Item 4. | |||||||||||
PART II | Item 5. | ||||||||||
Item 6. | |||||||||||
Item 7. | |||||||||||
Item 7A. | |||||||||||
Item 8. | |||||||||||
Item 9. | |||||||||||
Item 9A. | |||||||||||
Item 9B. | |||||||||||
Item 9C. | |||||||||||
PART III | Item 10. | ||||||||||
Item 11. | |||||||||||
Item 12. | |||||||||||
Item 13. | |||||||||||
Item 14. | |||||||||||
PART IV | Item 15. | ||||||||||
Item 16. | |||||||||||
ITEM 1. | BUSINESS |
Page | |||||
Products Our products and services are offered through the following businesses: •PGIM Fixed Income—provides global active asset management services across public fixed income markets. •Jennison Associates—provides active fundamental public equity and fixed income asset management services across an array of growth, value, global and specialty equity strategies, as well as fixed income strategies. •PGIM Quantitative Solutions—provides a range of systematic, customized solutions across equity, multi-asset, and liquid alternative platforms. •PGIM Private Capital—provides private credit solutions across the risk spectrum including investment grade, high yield, direct lending and mezzanine financing. •PGIM Real Estate—provides a broad range of public and private real estate debt and equity strategies as well as private equity investments with a focus on secondary transactions in the small and mid-cap market. •PGIM Investments—offers actively managed investment solutions, including mutual funds, exchange-traded funds (“ETFs”) and separately managed accounts to individual investors and financial intermediaries in the U.S., as well as Undertakings for the Collective Investment in Transferable Securities (“UCITS”) and other investment solutions to financial intermediaries in select countries across Europe, Asia and Latin America. Additionally, operates local asset management businesses in Taiwan and India and has interests in an operating joint venture in China. We hold seed and co-investments in some of our investment products to either (i) seed new products or investment strategies in order to develop a track record prior to obtaining third-party investments, or (ii) co-invest alongside clients in PGIM-managed funds to demonstrate that our interests are aligned with theirs. | Marketing and Distribution We primarily distribute products through the following channels: •Institutional ◦Proprietary sales force for each PGIM business with independent marketing and client service teams. ◦PGIM’s Institutional Relationship Group, which develops relationships with, and introduces PGIM’s broad capabilities to, large institutions globally. •Retail ◦Third-party intermediaries and product manufacturers/distributors globally who include our investment options in their products and platforms. ◦Distribution channels associated with other Prudential business segments. ◦Licensed sales professionals within Prudential Advisors, Prudential’s proprietary nationwide sales organization. •General Account ◦Provide investment management services across a broad array of asset classes for our general account. |
Revenues and Profitability Our revenues primarily come from: •Asset management fees, which are typically calculated based upon a percentage of assets under management. In certain asset management arrangements, we also receive performance-based incentive fees when the return on the managed assets exceeds certain benchmark returns or other performance targets. •Revenues from commercial mortgage origination and servicing. •Transaction fees earned in connection with the structuring, sale or purchase of assets, primarily related to real estate and private fixed income. •Investment returns from seed and co-investments. Our profitability is substantially impacted by: •Macro market movements (e.g., interest rates, credit spreads and equity market performance). •Our ability to achieve investment returns above the target benchmarks. •Our ability to attract and retain client investments. | Competition We compete with numerous asset managers and other financial institutions. For our investment management products, we compete based on a number of factors, including investment performance, strategy and process, talent, organizational stability and client relationships. We offer products across multiple asset classes, with specialized investment teams that employ approaches designed to add value in each product area or asset class. Our organizational stability and robust institutional and retail businesses have helped attract and retain talent critical to delivering investment results for clients. Our private credit and commercial real estate lending businesses compete based on price, terms, execution and the strength of our relationship with the borrower. |
Products | |||||
We offer a variety of products and solutions to serve different retirement needs and goals: Institutional Retirement Strategies Payout Annuities: products that provide a predictable source of monthly income, generally for the life of the annuitant. •Pension risk transfer—non-participating group annuity insurance and reinsurance contracts issued to pension plan sponsors and intermediaries, under which we assume all investment and actuarial risk associated with a group of specified participants within a plan in return for a premium typically paid as a lump-sum at inception. •Pension risk transfer—longevity reinsurance contracts with counterparties from which we earn a fee for assuming the longevity risk of pension plans that have been insured by third-parties. Premiums for these products are typically paid over the duration of the contract as opposed to a lump-sum at inception. Stable Value: products where our obligations are backed by our general account, and where we bear some or all of the investment and asset-liability management risk, depending on the product. •Investment-only products—for use in institutional capital markets and qualified plans primarily including fee-based wraps through which customers’ funds are held in a client-owned trust and investment results pass through to the customer. We earn fee revenue for providing a guaranteed minimum interest rate backed by the general account. •Guaranteed Investment Contracts and Funding Agreements—contain an obligation to pay interest at a specified rate and to repay principal at maturity or following contract termination. Other products: includes structured settlements and other group annuities. Individual Retirement Strategies Indexed Variable Annuities •The Prudential FlexGuard® indexed variable annuity, offers the contractholder an opportunity to allocate funds to variable subaccounts and index-based strategies. The strategies provide an interest component linked to, but not an investment in, the selected index, and its performance over the elected term, subject to certain contractual minimums and maximums, and also provides varying levels of downside protection at pre-determined levels and durations. The product also allows for additional deposits and provides a Return of Purchase Payment (“ROP”) death benefit at no additional charge. | •The Prudential FlexGuard® Income indexed variable annuity offers similar investment and crediting features as The Prudential FlexGuard® product, with a focus on income protection by providing a protected income benefit for an additional fee. Crediting strategies are limited during the income phase. Traditional Variable Annuities •The Prudential Premier® Investment Variable Annuity (“PPI”) offers tax-deferred asset accumulation, annuitization options and an optional death benefit that guarantees the contractholder’s beneficiary a return of total purchase payments made to the contract, adjusted for any partial withdrawals, upon death. •The Prudential MyRock® Advisor Variable Annuity, a fee-based product that offers an optional Dynamic Income Benefit (“IB”) rider that provides longevity protection through a preset withdrawal percentage applied to a variable income base. In addition, the product offers either a basic death benefit or an ROP death benefit. Both the IB and the ROP are available for an additional fee. Fixed Annuities •PruSecure®, SurePath® and SurePath® Income, all single premium fixed indexed annuities, offer flexibility to allocate account balances between an index-based strategy and a fixed rate strategy. The index-based strategy provides interest or an interest component linked to, but not an investment in, the selected index, and its performance over the elected term (i.e., 1, 3 or 5 years for PruSecure® and 1 or 3 years for SurePath® and SurePath® Income), subject to certain contractual minimums and maximums. The fixed rate strategy, not associated with an index, offers a guaranteed growth at a set interest rate for one year and can be renewed annually. Additionally, SurePath® Income offers a benefit that provides for guaranteed lifetime withdrawal payments. •The Prudential Fixed Annuity with Daily Advantage Income Benefit® (“DAI”), a single premium fixed annuity, provides principal protection as well as a guaranteed lifetime withdrawal income payment for an additional fee. The lifetime income amount increases daily without exposure to the equity market until the contractholder begins taking withdrawals. •The Prudential Immediate Income Annuity (“PIIA”), a single premium immediate annuity, provides a regular stream of benefit payments. The payments are guaranteed, cannot be changed and are higher than those guaranteed on products that provide liquidity. |
Revenues and Profitability Our revenues primarily come in the form of: Institutional Retirement Strategies •Premiums associated with insurance and reinsurance contracts and our payout annuities. •Policy charges and fee income based on account values of our fee-based stable value and longevity reinsurance products. •Investment income (which contributes to the net spread over interest credited on our products and related expenses). Our profitability is substantially impacted by our ability to appropriately price our products. We price our products based on pricing models that consider the investment environment and our risk, fees, expenses, profitability targets, and assumptions for mortality and potential for early retirement. These assumptions may be less predictable in certain markets. Individual Retirement Strategies •Fee income from asset management fees and service fees, which represent administrative service and distribution fees from many of our proprietary and non-proprietary mutual funds. The asset management fees are determined as a percentage of the average assets of our proprietary mutual funds in our variable annuity products (net of sub-advisory expenses related to non-proprietary sub-advisors). •Policy charges and fee income representing mortality, expense and other fees for various insurance-related options and features based on the average daily net asset value of the annuity separate accounts, account value, premium, or guaranteed value, as applicable. •Investment income (which contributes to the net spread over interest credited on certain products and related expenses). Our profitability is substantially impacted by our ability to appropriately price our products. We price our products based on: •An evaluation of the risks assumed and consideration of applicable risk management strategies, including hedging and reinsurance costs. •Assumptions regarding investment returns and contractholder behavior, including persistency, benefit utilization and the timing and efficiency of withdrawals for contracts with living benefit features, as well as other assumptions. | Marketing and Distribution Institutional Retirement Strategies We primarily distribute products through the following channels: •Pension risk transfer through actuarial consultants and third-party brokers. •Structured settlements through third-party specialized brokers. •Voluntary income products and other group annuities directly to plan sponsors. •Stable value products through our proprietary sales force and third-party intermediaries. Individual Retirement Strategies Our distribution efforts, which are supported by a network of internal and external wholesalers, are executed through a diverse group of distributors, including: •Third-party distribution through: ◦Broker-dealers; ◦Banks and wirehouses; ◦Independent financial planners; and ◦Independent Marketing Organizations (“IMO”) (specifically for SurePath® and SurePath® Income). •Financial professionals associated with Prudential Advisors, Prudential’s proprietary nationwide sales organization. Competition Institutional Retirement Strategies We compete with other large, well-established insurance companies, asset managers and diversified financial institutions primarily based on: •Pricing. •Structuring capabilities. •Our ability to offer innovative product solutions and successfully execute large-scale transactions. We are a leader in providing innovative pension risk management solutions to plan sponsors and in the stable value market. We believe the pension risk transfer market continues to offer attractive opportunities that are aligned with our expertise. Individual Retirement Strategies We are among the industry’s largest providers of individual annuities and we compete with other providers of retirement savings and accumulation products, including large, well-established insurance and financial services companies, and private equity firms. We believe our competitive advantage lies primarily in our innovative product features and our risk management strategies as well as brand recognition, financial strength, the breadth of our distribution platform and our customer service capabilities. We periodically adjust product offerings, prices and features based on the market and our strategy, with a goal of achieving customer and enterprise value. |
Products We offer a variety of products, through both non-experience rated contracts (where we assume all mortality/morbidity risk) and experience rated contracts (where mortality/morbidity experience is shared between us and the clients), and services through the following businesses: Group Life Insurance •Employer-paid, employee-paid and member-paid coverages for term life, group universal life and group variable universal life insurance, as well as accidental death and dismemberment insurance. Certain coverages allow employees to retain their coverage when they change employers or retire, and we offer waiver of premium coverage in the event the insured suffers a qualifying disability. •Group corporate-, bank- and trust-owned life insurance in the form of group variable life insurance contracts utilizing separate accounts. These products are typically used by large corporations to fund deferred compensation plans and benefit plans for retired employees. Group Disability Insurance •Short-term and long-term group disability insurance, which protect against loss of wages due to illness or injury. Short-term disability generally provides weekly benefits for three to six months while long-term disability benefits are typically paid monthly, following a waiting period, and generally continue until the insured either returns to work or reaches normal retirement age. •Other supplemental health solutions, including accident and critical illness insurance. •Plan administration and absence management services. | Marketing and Distribution We primarily distribute products through a proprietary sales force organized around market segments in conjunction with employee benefit brokers and consultants. We define our market segments as follows: •National—large corporations and other organizations having over 5,000 individuals. •Premier—corporations and other organizations that have between 100 and 5,000 individuals. •Association—affinity groups, regardless of size. |
Revenues and Profitability Our revenues primarily come in the form of: •Premiums and policy charges for our group life and group disability products. •Investment income (which contributes to the net spread over interest credited on our products and related expenses). Our profitability is substantially impacted by our ability to appropriately price our products, many of which include multiple year premium rate guarantees. We price our products based on: •Underwriting practices and rating systems that consider company, industry and/or other experience. •The expected pay-out of benefits and other costs that we calculate using assumptions for mortality and morbidity rates, interest rates and expenses, depending upon the specific product features. | Competition We compete with other large, well-established life and health insurance providers in mature markets. We compete primarily based on brand recognition, service capabilities, customer relationships, financial strength, our range of product offerings and price. Our pricing of group insurance products is reflective of the large number of competitors in the marketplace. While the majority of our premiums are derived from the National segment, we are actively seeking to grow our Premier and Association segments. Employee-paid coverage is important as employers attempt to control costs and shift benefit decisions and funding to employees who continue to value workplace benefits. Our profitability is dependent, in part, on the voluntary coverage marketplace, which will be affected by future employment and compensation rates. |
Products We offer a variety of products, consisting of base contracts and riders, that serve different protection needs and goals, including: Variable Life—permanent coverage for life with potential to accumulate policy cash value based on underlying investment options. •Our variable life policies offer flexibility in payment options and the potential to accumulate cash value through a suite of underlying investment options or a fixed rate option. •Indexed variable life policies provide index-linked investment options (index strategies) in addition to a suite of underlying investment options or a fixed rate option. Index strategies credit interest to the cash value that is linked to, but not an investment in, the performance of an external index, subject to certain parameters such as cap, step, participation, and buffer rates, and contractual minimums/maximums. Universal Life—permanent coverage for life with the potential to accumulate policy cash value. ◦Our universal life policies offer flexibility in payment options and the potential to accumulate cash value in an account that earns interest based on a crediting rate determined by the Company, subject to contractual minimums. ◦Indexed universal life policies provide interest credited to the cash value that is linked to, but not an investment in, the performance of an external index subject to certain cap and participation rates and contractual minimums/maximums. Term Life—coverage for a specified number of years with a guaranteed tax-advantaged death benefit. •Most of our term life policies offer an income tax-free death benefit and guaranteed premiums that will stay the same during the level-premium period. •Most of our term life policies also offer a conversion option that allows the policyholder to convert the policy into a permanent policy that can potentially cover the insured for life. Other •Final Expense Insurance—a whole life product that provides coverage in smaller face amounts, typically used for funeral expenses. | Marketing and Distribution Our distribution efforts, which are supported by a network of internal and external wholesalers, are executed through a diverse group of distributors, including: •Third-party distribution through: ◦Independent brokers; ◦Banks and wirehouses; and ◦General agencies and producer groups. •Prudential Advisors (Prudential’s proprietary nationwide sales organization), which: ◦Distributes Prudential life insurance, annuities and investment products with proprietary and non-proprietary investment options as well as select insurance, annuities and investment products from other financial services firms. ◦Offers certain retail brokerage and retail investment advisory services (through our dually-registered broker-dealer and investment advisor, Pruco Securities, LLC) including brokerage accounts, discretionary and non-discretionary investment advisory programs and financial planning services. ◦Executes a solutions-oriented business model centered around client relationships while strengthening and driving Prudential’s brand promise. ◦Receives a market-based allowance from other Prudential business segments for distributing their products, which is eliminated between the segments in consolidation. •Assurance IQ: ◦A wholly-owned consumer solutions platform that leverages data science and technology to distribute proprietary simplified products consisting of term life and final expense insurance (as well as other third-party life, health and financial wellness solutions) directly to retail shoppers primarily through its digital and agent channels. •Direct-to-Consumer through: ◦The digital platform, Prudential.com, provides distribution of our simplified products online. ◦Personal Advisory Group is Prudential’s sales desk where customers can speak to an agent via phone to fulfill their insurance or investment needs. |
Revenues and Profitability Our revenues primarily come in the form of: •Premiums that are fixed in accordance with the terms of the policies. •Policy charges and fee income consisting of in-force policy- and/or asset-based fees. •Investment income (which contributes to the net spread over interest credited on our products and related expenses). Our profitability is substantially impacted by our ability to appropriately price our products. We price our products based on our assumptions of future: •Mortality and morbidity; •Policyholder behavior; •Interest rates; •Expenses; •Premium payment patterns; •Performance of ceded reinsurance; •Separate account fund performance; and •Product-generated tax deductions. | Competition We compete with other large, well-established life insurance companies in a mature market. We compete primarily based on price, service (including the speed and ease of underwriting), distribution channel relationships, brand recognition and financial strength. Due to the large number of competitors, pricing is competitive. We periodically adjust product offerings, prices and features based on the market and our strategy, with a goal of achieving customer and enterprise value. |
Products Assurance IQ distributes the following products: •Medicare—third-party Medicare Supplement and Medicare Advantage for qualifying Medicare beneficiaries. •Life—third-party life insurance products, including term life, final expense, and whole life protection, as well as simplified products consisting of proprietary term life and final expense insurance. Most carriers’ products allow for simplified underwriting to enable faster policy placement. •Health Under 65—third-party primary and supplemental health insurance that help cover an individual’s medical and prescription expenses, including product coverage provided under the Affordable Care Act. •Property and Casualty—primarily third-party auto and home insurance coverage that indemnifies customers for loss caused by accidents, theft, natural disasters and other events where property damage or financial loss may occur. | Marketing and Distribution The Assurance IQ business model relies primarily on digital marketing and data science to reach prospective customers (“shoppers”) to, in turn, drive traffic to its distribution platform. Digital marketing includes traffic from various sources such as search, email, and social media. To a lesser extent, we also use traditional forms of marketing such as direct mail and television. We primarily distribute products through the following channels: •Hub Agents—Licensed agents employed by Assurance IQ who work in certain strategic locations across the U.S. or via remote arrangements. Agents are compensated through a combination of base and incentive pay. •On Demand Agents—Commission-based, independent agents that are located across the United States. They work remotely, and collectively are licensed to sell various products in all 50 states. •Third-Party Agent Call Centers—Assurance IQ may contract with licensed agent call centers as a means of serving shoppers, especially during periods of peak shopper demand (e.g., Medicare annual election period in the fourth quarter). •Digital—Shoppers can price and purchase many of Assurance IQ’s offerings completely online, without the involvement of an agent. •Third-Party Case Referrals—Assurance IQ transfers shoppers in the form of calls, clicks and leads to selected marketing partners who may be able to alternatively serve a shopper’s specific needs for Medicare, property and casualty insurance, and various personal finance, life and health products. |
Revenues and Profitability Our revenues primarily come in the form of: •Commissions received from product manufacturers. •Case referral revenues earned from marketing partners related to the transfer of calls, clicks or leads. Our profitability will be substantially impacted by (i) our ability to achieve scale in the long-term and (ii) the impact of our customer retention experience and assumptions on our revenue valuation. | Competition We compete with large and small Medicare, life, health and property and casualty retail distributors, third-party brokers, and other fintech and insurtech companies. We compete based on several factors, including: marketing reach and effectiveness; the ability to effectively match shoppers to products and solutions using data science; our capacity to meet shoppers’ demands; and the quality of our technology platform, which optimizes the customer experience and enables agents to efficiently service shoppers. |
Products Our products are classified into the following four categories: Life Insurance Protection Products—include various traditional whole life products that provide either level or increasing coverage, and that offer limited or lifetime premium payment options. •We also offer increasing, decreasing and level benefit term insurance products that provide coverage for a specified time period, as well as protection-oriented variable life products. •Some of these protection products are denominated in U.S. dollars and some are sold as bundled products that, in addition to death protection, include health benefits or savings elements. Retirement Products—include retirement income products that combine insurance protection similar to term life with: •A lifetime income stream that commences at a predefined age; •A savings-oriented variable life product that provides a non-guaranteed return linked to an underlying investment portfolio of equity and fixed income funds selected by the customer; and •Endowments that provide payment of the face amount on the earlier of death or policy maturity. Investment Products—primarily represented by U.S. dollar-denominated investment contracts sold by our Gibraltar Life operations in Japan. •Represents single-pay whole life products where credited interest rates are reset periodically for certain products. •Most of our investment contracts impose a market value adjustment if the contract is not held to maturity. Accident and Health Products—that provide the following: •Benefits to cover accidental death and dismemberment, hospitalization, surgeries, as well as costs of cancer and other dread diseases often sold as supplementary riders and not as stand-alone products; and •Waiver of premium coverage where required premiums are waived in the event the customer suffers a qualifying disability. | Marketing and Distribution Our marketing and distribution efforts are conducted through the following proprietary agent models and third-party channels: •Proprietary agent models: ◦Life Planners—focus on selling protection-oriented life insurance products on a needs basis to mass affluent and affluent customers, as well as retirement-oriented products to small businesses. We believe that our recruiting and selection process, training programs and compensation packages are key to the Life Planner model and have helped our Life Planner operations achieve higher levels of agent retention, agent productivity and policy persistency. ◦Life Consultants—a proprietary distribution force for products offered by our Gibraltar Life operations. Their focus is to provide individual protection products to the broad middle income market, primarily in Japan, particularly through relationships with affinity groups. Our Life Consultant operation is based on a variable compensation plan designed to improve productivity and persistency that is similar to compensation plans in our Life Planner operations. •Third-party channels: ◦Bank Distribution Channel—sells primarily life insurance products intended to provide savings features, premature death protection and estate planning benefits as well as investment products primarily denominated in U.S. dollars. We view this channel as an adjunct to our core Life Planner and Life Consultant distribution channels. We have relationships with each of Japan’s four largest banks, as well as many regional banks, and we continue to explore opportunities to expand our distribution capabilities through this channel, as appropriate. ◦Independent Agency Distribution Channel—sells protection products and high cash value products for retirement benefits through the corporate market, and a variety of other products including protection and investment products through the individual market. Our focus is to maintain a diverse mix of independent agency relationships, including corporate agencies and other independent agencies, with a balanced focus on individual and corporate markets. |
Revenues and Profitability Our revenues primarily come in the form of: •Premiums that are fixed or flexible in accordance with the terms of the policies. •Policy charges and fee income consisting of in-force policy- and/or asset-based fees. •Investment income (which contributes to the net spread over interest credited on our products and related expenses). Our profitability is substantially impacted by our ability to appropriately price our products. Sales and surrenders of non-yen denominated products in Japan can be sensitive to foreign currency relationships which are impacted by, among other things, the comparative interest rates in their respective countries. We price our products based on: •Local regulation, which is generally more restrictive for product offerings, pricing and structure than U.S. insurance regulation. Each international insurance operation has its own underwriting department that employs variations of U.S. practices in underwriting individual policy risks. To the extent permitted by local regulation, we base premiums and policy charges for our products on expected death and morbidity benefits, surrender benefits, expenses, required reserves, interest rates, policy persistency and premium payment patterns. In setting underwriting limits, we also consider local industry standards to prevent adverse selection and to stay abreast of industry trends. In addition, we set underwriting limits together with each operation’s reinsurers. •Achieving a targeted rate of return for each operation, taking into account the country-specific costs of capital, risks, and competitive environment. The profitability of our products is impacted by differences between actual mortality, morbidity, expense, and investment experience and the related assumptions used in pricing these policies. As a result, the profitability of our products can fluctuate from period to period. Changes in local tax laws may also affect profitability. | Competition The life insurance market in Japan is mature and pricing is competitive. Rather than competing primarily based on price, we generally compete on the basis of customer service, including our needs-based approach to selling, the quality and diversity of our distribution capabilities, and our financial strength. Demographic trends in Japan suggest an increasing opportunity for product innovation, such as introducing insurance products that allow for savings and income and offering differentiated health products with value added services as a growing portion of the population prepares for retirement. The ability to sell through multiple and complementary distribution channels is also a competitive advantage; however, competition for sales personnel, as well as access to third-party distribution channels, is intense. |
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | |||||||||||
PGIM | Higher compensation expense(1) | Other related revenues tend to be higher(2) | ||||||||||||
Retirement Strategies - Institutional | Higher reserve gains(3) | Higher reserve gains(3) | Lower reserve gains(3) | Lower reserve gains(3) | ||||||||||
Individual Life | Lowest underwriting gains | Highest underwriting gains | ||||||||||||
Assurance IQ | Higher expenses ahead of annual Medicare enrollment | Higher revenue, and associated variable expenses, driven by annual Medicare enrollment | ||||||||||||
International Businesses | Highest premiums | Lowest premiums | ||||||||||||
Corporate & Other | Higher compensation expense(1) | |||||||||||||
All Businesses | Impact of annual assumption updates(4) | Higher expenses(5) |
Segment | Primary Type of Reinsurance | Purpose | ||||||
Corporate & Other | Ceded | Ceded reinsurance of certain retirement products in conjunction with our 2022 sale of the Full Service Retirement business. See Note 1 to the Consolidated Financial Statements for additional information regarding this sale. | ||||||
Retirement Strategies | Ceded/Assumed | Institutional Retirement Strategies Assumed reinsurance as part of our international reinsurance pension risk transfer products. Individual Retirement Strategies Ceded reinsurance includes the following products: •A portion of HDI v.3.0 variable annuity business issued between April 1, 2015 to December 31, 2016; •Certain fixed indexed annuity business (specifically for PruSecure® and SurePath®) issued effective October 15, 2019; and •Fixed indexed annuities and fixed annuities with guaranteed lifetime withdrawal benefits issued between July 1, 2019 and December 31, 2022. Assumed reinsurance in conjunction with our 2006 acquisition of The Allstate Corporation (“Allstate”) variable annuity business and reinsurance of certain annuity products retained in connection with the sale of PALAC. See Note 1 to the Consolidated Financial Statements for additional information regarding this sale. | ||||||
Group Insurance | Ceded | Ceded reinsurance on most products to limit losses from large claims (in response to client requests and for capital management purposes). | ||||||
Individual Life | Ceded/Assumed | Ceded reinsurance covering a variety of products to mitigate mortality risk. On policies sold since 2000, we have reinsured a significant portion of our mortality risk externally, with that portion varying over time depending on market factors and strategic objectives. Assumed reinsurance in conjunction with our 2013 acquisition of The Hartford’s individual life insurance business. | ||||||
International Businesses | Ceded | Ceded reinsurance to mitigate mortality and morbidity risk for certain products. |
Global Employee Profile | ||||||||||||||
Region | Number of Employees(1) | Full-time Equivalent Positions(2) | ||||||||||||
U.S. | 16,081 | 15,857 | ||||||||||||
Non-U.S. | 23,773 | 23,726 | ||||||||||||
Total | 39,854 | 39,583 |
U.S. Top Leadership Diversity Metrics | ||||||||||||||||||||||||||||||||||||||
Diverse(1) | Women | People of Color(1) | Asian | Black | Latinx | |||||||||||||||||||||||||||||||||
Top Leadership(2) | 58 | % | 41 | % | 28 | % | 13 | % | 6 | % | 8 | % | ||||||||||||||||||||||||||
1 Level Down | 47 | % | 40 | % | 13 | % | 13 | % | 0 | % | 0 | % | ||||||||||||||||||||||||||
2 Levels Down | 58 | % | 44 | % | 30 | % | 16 | % | 7 | % | 5 | % | ||||||||||||||||||||||||||
3 Levels Down | 58 | % | 40 | % | 28 | % | 13 | % | 6 | % | 8 | % |
Name | Age | Title | Other Public Directorships | |||||||||||||||||
Charles F. Lowrey | 65 | Chairman, Chief Executive Officer and President | None | |||||||||||||||||
Robert M. Falzon | 63 | Vice Chair | None | |||||||||||||||||
Ann M. Kappler | 64 | Executive Vice President and General Counsel | None | |||||||||||||||||
Kenneth Y. Tanji | 56 | Executive Vice President and Chief Financial Officer | None | |||||||||||||||||
Andrew F. Sullivan | 52 | Executive Vice President and Head of International Businesses and PGIM | None | |||||||||||||||||
Caroline A. Feeney | 53 | Executive Vice President and Head of U.S. Businesses | None | |||||||||||||||||
Lucien A. Alziari | 63 | Executive Vice President and Chief Human Resources Officer | None | |||||||||||||||||
Stacey Goodman | 60 | Executive Vice President and Chief Information Officer | None | |||||||||||||||||
Candace J. Woods | 62 | Senior Vice President and Chief Actuary | None | |||||||||||||||||
Timothy L. Schmidt | 64 | Senior Vice President and Chief Investment Officer | None |
ITEM 1A. | RISK FACTORS |
ITEM 1B. | UNRESOLVED STAFF COMMENTS |
ITEM 2. | PROPERTIES |
ITEM 3. | LEGAL PROCEEDINGS |
Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Program | Approximate Dollar Value of Shares that May Yet Be Purchased under the Program | ||||||||||||||||||||||
October 1, 2022 through October 31, 2022 | 1,309,560 | $ | 95.95 | 1,302,833 | ||||||||||||||||||||||
November 1, 2022 through November 30, 2022 | 1,178,286 | $ | 106.32 | 1,175,686 | ||||||||||||||||||||||
December 1, 2022 through December 31, 2022 | 1,237,783 | $ | 101.25 | 1,234,426 | ||||||||||||||||||||||
Total | 3,725,629 | $ | 100.99 | 3,712,945 | $ | 0 |
Page | |||||
As of December 31, 2022 | |||||
(in billions) | |||||
Long-duration insurance products with fixed and guaranteed terms | $ | 156 | |||
Contracts with adjustable crediting rates subject to guaranteed minimums | 36 | ||||
Participating contracts where investment income risk ultimately accrues to contractholders | 2 | ||||
Total | $ | 194 |
Account Values with Adjustable Crediting Rates Subject to Guaranteed Minimums: | ||||||||||||||||||||||||||||||||||||||
At guaranteed minimum | 1-49 bps above guaranteed minimum | 50-99 bps above guaranteed minimum | 100-150 bps above guaranteed minimum | Greater than 150 bps above guaranteed minimum | Total | |||||||||||||||||||||||||||||||||
($ in billions) | ||||||||||||||||||||||||||||||||||||||
Range of Guaranteed Minimum Crediting Rates: | ||||||||||||||||||||||||||||||||||||||
Less than 1.00% | $ | 1.0 | $ | 0.9 | $ | 0.0 | $ | 0.0 | $ | 0.0 | $ | 1.9 | ||||||||||||||||||||||||||
1.00% - 1.99% | 1.2 | 0.1 | 0.1 | 0.9 | 2.5 | 4.8 | ||||||||||||||||||||||||||||||||
2.00% - 2.99% | 1.1 | 0.0 | 1.6 | 1.6 | 2.8 | 7.1 | ||||||||||||||||||||||||||||||||
3.00% - 4.00% | 18.5 | 0.0 | 1.9 | 0.5 | 0.2 | 21.1 | ||||||||||||||||||||||||||||||||
Greater than 4.00% | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | ||||||||||||||||||||||||||||||||
Total(1) | $ | 22.6 | $ | 1.0 | $ | 3.6 | $ | 3.0 | $ | 5.5 | $ | 35.7 | ||||||||||||||||||||||||||
Percentage of total | 63 | % | 3 | % | 10 | % | 9 | % | 15 | % | 100 | % |
As of December 31, 2022 | |||||
(in billions) | |||||
Insurance products with fixed and guaranteed terms | $ | 130 | |||
Contracts with a market value adjustment if invested amount is not held to maturity | 25 | ||||
Contracts with adjustable crediting rates subject to guaranteed minimums | 10 | ||||
Total | $ | 165 |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Revenues | $ | 60,050 | $ | 70,934 | $ | 57,033 | |||||||||||
Benefits and expenses | 61,826 | 61,553 | 57,356 | ||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,776) | 9,381 | (323) | ||||||||||||||
Income tax expense (benefit) | (370) | 1,674 | (81) | ||||||||||||||
Income (loss) before equity in earnings of operating joint ventures | (1,406) | 7,707 | (242) | ||||||||||||||
Equity in earnings of operating joint ventures, net of taxes | (56) | 87 | 96 | ||||||||||||||
Net income (loss) | (1,462) | 7,794 | (146) | ||||||||||||||
Less: Income attributable to noncontrolling interests | (24) | 70 | 228 | ||||||||||||||
Net income (loss) attributable to Prudential Financial, Inc. | $ | (1,438) | $ | 7,724 | $ | (374) |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Adjusted operating income before income taxes by segment: | ||||||||||||||||||||
PGIM | $ | 843 | $ | 1,643 | $ | 1,262 | ||||||||||||||
U.S. Businesses: | ||||||||||||||||||||
Retirement Strategies | 4,223 | 4,079 | 2,855 | |||||||||||||||||
Group Insurance | (16) | (455) | (16) | |||||||||||||||||
Individual Life | (1,215) | 393 | (48) | |||||||||||||||||
Assurance IQ | (113) | (142) | (88) | |||||||||||||||||
Total U.S. Businesses | 2,879 | 3,875 | 2,703 | |||||||||||||||||
International Businesses | 2,404 | 3,390 | 2,952 | |||||||||||||||||
Corporate and Other | (1,476) | (1,607) | (1,967) | |||||||||||||||||
Total segment adjusted operating income before income taxes | 4,650 | 7,301 | 4,950 | |||||||||||||||||
Reconciling items: | ||||||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (5,670) | 1,947 | (4,140) | |||||||||||||||||
Charges related to realized investment gains (losses), net(1) | (531) | (320) | (160) | |||||||||||||||||
Market experience updates | 781 | 750 | (640) | |||||||||||||||||
Divested and Run-off Businesses(2): | ||||||||||||||||||||
Closed Block division | (32) | 140 | (24) | |||||||||||||||||
Other Divested and Run-off Businesses | 9 | 716 | (450) | |||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests(3) | (44) | (41) | 90 | |||||||||||||||||
Other adjustments(4) | (939) | (1,112) | 51 | |||||||||||||||||
Consolidated income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (1,776) | $ | 9,381 | $ | (323) |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in billions) | ||||||||||||||
Foreign currency hedging instruments: | ||||||||||||||
USD-denominated assets held in yen-based entities(1) | $ | 7.8 | $ | 9.5 | ||||||||||
Dual currency and synthetic dual currency investments(2) | 0.4 | 0.5 | ||||||||||||
Total foreign currency hedges | $ | 8.2 | $ | 10.0 |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Segment impacts of intercompany arrangements: | ||||||||||||||||||||
International Businesses | $ | (57) | $ | 15 | $ | 64 | ||||||||||||||
PGIM | 11 | (1) | (4) | |||||||||||||||||
Impact of intercompany arrangements(1) | (46) | 14 | 60 | |||||||||||||||||
Corporate and Other: | ||||||||||||||||||||
Impact of intercompany arrangements(1) | 46 | (14) | (60) | |||||||||||||||||
Settlement gains (losses) on forward currency contracts(2) | 21 | 33 | 67 | |||||||||||||||||
Net benefit (detriment) to Corporate and Other | 67 | 19 | 7 | |||||||||||||||||
Net impact on consolidated revenues and adjusted operating income | $ | 21 | $ | 33 | $ | 67 |
December 31, 2022 | ||||||||||||||||||||
Increase (Decrease) in | ||||||||||||||||||||
Hypothetical change in current assumptions: | Deferred Policy Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired | Future Policy Benefits and Policyholders’ Account Balances | Net Impact | |||||||||||||||||
(in millions) | ||||||||||||||||||||
Long-term interest rate: | ||||||||||||||||||||
Increase by 25 basis points | $ | 50 | $ | (75) | $ | 125 | ||||||||||||||
Decrease by 25 basis points | $ | (45) | $ | 85 | $ | (130) | ||||||||||||||
Long-term equity expected rate of return: | ||||||||||||||||||||
Increase by 50 basis points | $ | 145 | $ | (85) | $ | 230 | ||||||||||||||
Decrease by 50 basis points | $ | (90) | $ | 70 | $ | (160) | ||||||||||||||
NPR credit spread: | ||||||||||||||||||||
Increase by 50 basis points | $ | (255) | $ | (1,195) | $ | 940 | ||||||||||||||
Decrease by 50 basis points | $ | 280 | $ | 1,275 | $ | (995) | ||||||||||||||
Mortality: | ||||||||||||||||||||
Increase by 1% | $ | (35) | $ | (85) | $ | 50 | ||||||||||||||
Decrease by 1% | $ | 35 | $ | 85 | $ | (50) | ||||||||||||||
Lapse: | ||||||||||||||||||||
Increase by 10% | $ | (105) | $ | (540) | $ | 435 | ||||||||||||||
Decrease by 10% | $ | 110 | $ | 555 | $ | (445) |
December 31, 2022 | ||||||||||||||||||||
Assumption | Current Best Estimate Assumption | Best Estimate Assumption Change | Increase (Decrease) in Best Estimate Reserve (in millions) | |||||||||||||||||
Mortality Improvement | Based on “G2” industry mortality improvement scale applied to only healthy lives | Remove all mortality improvement | $(250) | |||||||||||||||||
Claim Incidence | Based on Company and industry experience. No reflection of future claim management efficiencies | Increase / decrease in claim incidence: +5% to -5% | $300 - $(300) | |||||||||||||||||
Average Ultimate Lapse Rate | Individual: 0.7% Group: 0.7% | -10 basis points to +10 basis points | $100 - $(100) | |||||||||||||||||
Investment Rate(1) | Weighted average of 5.18% | -25 basis points to +25 basis points | $375 - $(375) | |||||||||||||||||
Expected Future Premium Rate Increase Approvals(2) | Approximately $0.5 billion for the rate increase program | Decrease / increase unapproved rate increases by: -10% to +10% | $50 - $(50) |
For the year ended December 31, 2022 | ||||||||||||||
Increase/(Decrease) in Net Periodic Pension Cost | Increase/(Decrease) in Net Periodic Other Postretirement Cost | |||||||||||||
(in millions) | ||||||||||||||
Increase in expected rate of return by 100 bps | $ | (134) | $ | (14) | ||||||||||
Decrease in expected rate of return by 100 bps | $ | 134 | $ | 14 |
For the year ended December 31, 2022 | ||||||||||||||
Increase/(Decrease) in Net Periodic Pension Cost | Increase/(Decrease) in Net Periodic Other Postretirement Cost | |||||||||||||
(in millions) | ||||||||||||||
Increase in discount rate by 100 bps | $ | (91) | $ | 2 | ||||||||||
Decrease in discount rate by 100 bps | $ | 127 | $ | (2) |
December 31, 2022 | ||||||||||||||
Increase/(Decrease) in Pension Benefits Obligation | Increase/(Decrease) in Accumulated Postretirement Benefits Obligation | |||||||||||||
(in millions) | ||||||||||||||
Increase in discount rate by 100 bps | $ | (956) | $ | (91) | ||||||||||
Decrease in discount rate by 100 bps | $ | 1,123 | $ | 99 |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Operating results(1): | ||||||||||||||||||||
Revenues(2) | $ | 3,622 | $ | 4,493 | $ | 4,153 | ||||||||||||||
Expenses | 2,779 | 2,850 | 2,891 | |||||||||||||||||
Adjusted operating income | 843 | 1,643 | 1,262 | |||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (8) | (3) | 0 | |||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | (4) | 69 | 159 | |||||||||||||||||
Other adjustments(3) | (22) | (13) | 0 | |||||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | 809 | $ | 1,696 | $ | 1,421 |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Revenues by type: | |||||||||||||||||
Asset management fees by source: | |||||||||||||||||
Institutional customers | $ | 1,443 | $ | 1,439 | $ | 1,350 | |||||||||||
Retail customers(1) | 1,081 | 1,275 | 1,003 | ||||||||||||||
General account | 508 | 588 | 557 | ||||||||||||||
Total asset management fees | 3,032 | 3,302 | 2,910 | ||||||||||||||
Other related revenues by source: | |||||||||||||||||
Incentive fees | 85 | 154 | 206 | ||||||||||||||
Transaction fees | 14 | 27 | 26 | ||||||||||||||
Seed and co-investments | 3 | 49 | 122 | ||||||||||||||
Commercial mortgage(2) | 127 | 173 | 198 | ||||||||||||||
Total other related revenues | 229 | 403 | 552 | ||||||||||||||
Service, distribution and other revenues(3) | 361 | 788 | 691 | ||||||||||||||
Total revenues | $ | 3,622 | $ | 4,493 | $ | 4,153 |
December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in billions) | |||||||||||||||||
Assets Under Management(1) (at fair value): | |||||||||||||||||
Public equity | $ | 147.8 | $ | 216.2 | $ | 202.4 | |||||||||||
Public fixed income | 776.8 | 980.7 | 1,004.5 | ||||||||||||||
Real estate | 129.6 | 132.6 | 121.5 | ||||||||||||||
Private credit and other alternatives | 103.4 | 108.7 | 106.5 | ||||||||||||||
Multi-asset | 70.8 | 85.6 | 63.7 | ||||||||||||||
Total PGIM assets under management | $ | 1,228.4 | $ | 1,523.8 | $ | 1,498.6 | |||||||||||
Assets under management within other reporting segments(2) | 148.9 | 218.5 | 222.3 | ||||||||||||||
Total PFI assets under management | $ | 1,377.3 | $ | 1,742.3 | $ | 1,720.9 |
December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in billions) | |||||||||||||||||
Assets Under Management(1) (at fair value): | |||||||||||||||||
Institutional customers | $ | 549.2 | $ | 629.4 | $ | 614.9 | |||||||||||
Retail customers | 299.6 | 401.4 | 372.0 | ||||||||||||||
General account | 379.6 | 493.0 | 511.7 | ||||||||||||||
Total PGIM assets under management | $ | 1,228.4 | $ | 1,523.8 | $ | 1,498.6 | |||||||||||
Assets under management within other reporting segments(2) | 148.9 | 218.5 | 222.3 | ||||||||||||||
Total PFI assets under management | $ | 1,377.3 | $ | 1,742.3 | $ | 1,720.9 |
December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in billions) | |||||||||||||||||
Beginning assets under management | $ | 1,523.8 | $ | 1,498.6 | $ | 1,331.0 | |||||||||||
Institutional third-party flows | 3.0 | 10.9 | 3.0 | ||||||||||||||
Retail third-party flows | (23.2) | 0.1 | 17.2 | ||||||||||||||
Total third-party flows | (20.2) | 11.0 | 20.2 | ||||||||||||||
Affiliated flows(1) | 13.2 | (12.2) | (8.5) | ||||||||||||||
Market appreciation (depreciation)(2) | (240.9) | 35.4 | 146.7 | ||||||||||||||
Foreign exchange rate impact | (16.0) | (12.4) | 6.8 | ||||||||||||||
Net money market activity and other increases (decreases)(3) | (31.5) | 3.4 | 2.4 | ||||||||||||||
Ending assets under management | $ | 1,228.4 | $ | 1,523.8 | $ | 1,498.6 |
December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in billions) | |||||||||||||||||
Private capital deployed: | |||||||||||||||||
Real estate debt and equity | $ | 26.9 | $ | 34.7 | $ | 24.4 | |||||||||||
Private credit and equity | 16.1 | 14.5 | 12.6 | ||||||||||||||
Total private capital deployed | $ | 43.0 | $ | 49.2 | $ | 37.0 |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Adjusted operating income before income taxes: | ||||||||||||||||||||
U.S. Businesses: | ||||||||||||||||||||
Retirement Strategies | $ | 4,223 | $ | 4,079 | $ | 2,855 | ||||||||||||||
Group Insurance | (16) | (455) | (16) | |||||||||||||||||
Individual Life | (1,215) | 393 | (48) | |||||||||||||||||
Assurance IQ | (113) | (142) | (88) | |||||||||||||||||
Total U.S. Businesses | 2,879 | 3,875 | 2,703 | |||||||||||||||||
Reconciling items: | ||||||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (3,411) | 1,839 | (2,510) | |||||||||||||||||
Charges related to realized investment gains (losses), net | (654) | (296) | (121) | |||||||||||||||||
Market experience updates | 748 | 747 | (591) | |||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | 2 | 7 | 4 | |||||||||||||||||
Other adjustments(1) | (917) | (1,099) | 51 | |||||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (1,353) | $ | 5,073 | $ | (464) |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Operating results: | |||||||||||||||||
Revenues: | |||||||||||||||||
Institutional Retirement Strategies | $ | 19,441 | $ | 15,298 | $ | 10,051 | |||||||||||
Individual Retirement Strategies | 5,312 | 4,914 | 4,440 | ||||||||||||||
Total revenues | 24,753 | 20,212 | 14,491 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||
Institutional Retirement Strategies | 17,900 | 13,120 | 8,666 | ||||||||||||||
Individual Retirement Strategies | 2,630 | 3,013 | 2,970 | ||||||||||||||
Total benefits and expenses | 20,530 | 16,133 | 11,636 | ||||||||||||||
Adjusted operating income: | |||||||||||||||||
Institutional Retirement Strategies | 1,541 | 2,178 | 1,385 | ||||||||||||||
Individual Retirement Strategies | 2,682 | 1,901 | 1,470 | ||||||||||||||
Total adjusted operating income | 4,223 | 4,079 | 2,855 | ||||||||||||||
Realized investment gains (losses), net, and related adjustments | (1,806) | 1,938 | (2,918) | ||||||||||||||
Charges related to realized investment gains (losses), net | (629) | (482) | 3 | ||||||||||||||
Market experience updates | 379 | 657 | (324) | ||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | 2 | 6 | 3 | ||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | 2,169 | $ | 6,198 | $ | (381) |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Total Institutional Retirement Strategies: | ||||||||||||||||||||
Beginning total account value | $ | 245,720 | $ | 243,387 | $ | 227,596 | ||||||||||||||
Additions(1) | 31,773 | 21,967 | 22,469 | |||||||||||||||||
Withdrawals and benefits | (16,398) | (20,825) | (18,288) | |||||||||||||||||
Change in market value, interest credited and interest income | (4,110) | 1,881 | 8,854 | |||||||||||||||||
Other(2) | (5,167) | (690) | 2,756 | |||||||||||||||||
Ending total account value | $ | 251,818 | $ | 245,720 | $ | 243,387 |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Total Individual Retirement Strategies(1): | |||||||||||||||||
Beginning total account value | $ | 182,305 | $ | 176,280 | $ | 169,681 | |||||||||||
Sales | 6,027 | 6,599 | 6,815 | ||||||||||||||
Full surrenders and death benefits | (6,115) | (10,401) | (7,845) | ||||||||||||||
Sales, net of full surrenders and death benefits | (88) | (3,802) | (1,030) | ||||||||||||||
Partial withdrawals and other benefit payments | (4,670) | (5,712) | (5,191) | ||||||||||||||
Net flows | (4,758) | (9,514) | (6,221) | ||||||||||||||
Change in market value, interest credited and other activity(2) | (54,846) | 19,188 | 16,360 | ||||||||||||||
Policy charges | (2,679) | (3,649) | (3,540) | ||||||||||||||
Ending total account value(3) | $ | 120,022 | $ | 182,305 | $ | 176,280 |
December 31, | |||||||||||
2022 | 2021(1) | ||||||||||
(in millions) | |||||||||||
U.S. GAAP liability, including NPR, net of reinsurance recoverables | $ | 4,753 | $ | 13,028 | |||||||
NPR adjustment, net of reinsurance recoverables | 3,413 | 2,832 | |||||||||
Subtotal | 8,166 | 15,860 | |||||||||
Adjustments including risk margins and valuation methodology differences | (2,499) | (3,444) | |||||||||
Economic liability managed through the ALM strategy | $ | 5,667 | $ | 12,416 |
December 31, | ||||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||
Account Value | % of Total | Account Value(1) | % of Total | Account Value | % of Total | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Living benefit/GMDB features(2): | ||||||||||||||||||||||||||||||||||||||
Both ALM strategy and automatic rebalancing(3)(4) | $ | 69,282 | 61 | % | $ | 112,543 | 64 | % | $ | 112,177 | 66 | % | ||||||||||||||||||||||||||
ALM strategy only(4) | 1,972 | 2 | % | 7,278 | 4 | % | 7,410 | 4 | % | |||||||||||||||||||||||||||||
Automatic rebalancing only | 83 | 0 | % | 567 | 0 | % | 634 | 1 | % | |||||||||||||||||||||||||||||
External reinsurance(5) | 2,482 | 2 | % | 3,303 | 2 | % | 3,173 | 2 | % | |||||||||||||||||||||||||||||
PDI | 11,988 | 11 | % | 16,909 | 10 | % | 18,540 | 11 | % | |||||||||||||||||||||||||||||
Other products | 1,561 | 1 | % | 2,444 | 1 | % | 2,492 | 1 | % | |||||||||||||||||||||||||||||
Total living benefit/GMDB features | 87,368 | 143,044 | 144,426 | |||||||||||||||||||||||||||||||||||
GMDB features and other(6) | 26,573 | 23 | % | 33,395 | 19 | % | 26,120 | 15 | % | |||||||||||||||||||||||||||||
Total variable annuity account value | $ | 113,941 | $ | 176,439 | $ | 170,546 |
Year ended December 31, | |||||||||||||||||
2022 | 2021(1) | 2020(1) | |||||||||||||||
Results excluded from adjusted operating income: | (in millions)(2) | ||||||||||||||||
Change in the value of U.S. GAAP liability, pre-NPR(3) | $ | 4,035 | $ | 7,417 | $ | (4,979) | |||||||||||
Change in the NPR adjustment | 1,277 | (1,272) | 581 | ||||||||||||||
Change in the fair value of hedge assets, excluding capital hedges(4) | (4,226) | (4,270) | 2,251 | ||||||||||||||
Change in the fair value of capital hedges(5) | 598 | (1,268) | (900) | ||||||||||||||
Other(6) | (3,490) | 1,331 | 129 | ||||||||||||||
Realized investment gains (losses), net, and related adjustments | (1,806) | 1,938 | (2,918) | ||||||||||||||
Market experience updates(7) | 379 | 657 | (324) | ||||||||||||||
Charges related to realized investment gains (losses), net | (629) | (482) | 3 | ||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | 2 | 6 | 3 | ||||||||||||||
Total results excluded from adjusted operating income(8) | $ | (2,054) | $ | 2,119 | $ | (3,236) |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Operating results: | |||||||||||||||||
Revenues | $ | 6,123 | $ | 6,217 | $ | 5,786 | |||||||||||
Benefits and expenses | 6,139 | 6,672 | 5,802 | ||||||||||||||
Adjusted operating income | (16) | (455) | (16) | ||||||||||||||
Realized investment gains (losses), net, and related adjustments | (137) | (16) | 48 | ||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (153) | $ | (471) | $ | 32 | |||||||||||
Benefits ratio(1)(4): | |||||||||||||||||
Group life(2) | 93.2 | % | 102.7 | % | 93.4 | % | |||||||||||
Group disability(2) | 73.9 | % | 83.8 | % | 78.4 | % | |||||||||||
Total Group Insurance(2) | 88.4 | % | 98.3 | % | 90.2 | % | |||||||||||
Administrative operating expense ratio(3)(4): | |||||||||||||||||
Group life | 10.8 | % | 11.3 | % | 12.4 | % | |||||||||||
Group disability | 31.3 | % | 32.1 | % | 26.1 | % | |||||||||||
Total Group Insurance | 15.8 | % | 16.3 | % | 15.4 | % |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Annualized new business premiums(1): | |||||||||||||||||
Group life | $ | 283 | $ | 265 | $ | 243 | |||||||||||
Group disability | 196 | 221 | 163 | ||||||||||||||
Total | $ | 479 | $ | 486 | $ | 406 |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Operating results: | ||||||||||||||||||||
Revenues | $ | 7,074 | $ | 6,897 | $ | 6,398 | ||||||||||||||
Benefits and expenses | 8,289 | 6,504 | 6,446 | |||||||||||||||||
Adjusted operating income | (1,215) | 393 | (48) | |||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (1,468) | (83) | 359 | |||||||||||||||||
Charges related to realized investment gains (losses), net | (25) | 186 | (124) | |||||||||||||||||
Market experience updates | 369 | 90 | (267) | |||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | 0 | 1 | 1 | |||||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (2,339) | $ | 587 | $ | (79) |
2022 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prudential Advisors | Third Party | Total | Prudential Advisors | Third Party | Total | Prudential Advisors | Third Party | Total | ||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Life | $ | 109 | $ | 315 | $ | 424 | $ | 121 | $ | 417 | $ | 538 | $ | 100 | $ | 349 | $ | 449 | ||||||||||||||||||||||||||||||||||||||
Term Life | 18 | 75 | 93 | 20 | 95 | 115 | 26 | 122 | 148 | |||||||||||||||||||||||||||||||||||||||||||||||
Universal Life(1) | 6 | 86 | 92 | 8 | 94 | 102 | 20 | 165 | 185 | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | 133 | $ | 476 | $ | 609 | $ | 149 | $ | 606 | $ | 755 | $ | 146 | $ | 636 | $ | 782 |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Operating results: | |||||||||||||||||
Revenues | $ | 510 | $ | 558 | $ | 391 | |||||||||||
Expenses | 623 | 700 | 479 | ||||||||||||||
Adjusted operating income | (113) | (142) | (88) | ||||||||||||||
Realized investment gains (losses), net, and related adjustments | 0 | 0 | 1 | ||||||||||||||
Other adjustments(1)(2) | (917) | (1,099) | 51 | ||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (1,030) | $ | (1,241) | $ | (36) |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Operating results: | ||||||||||||||||||||
Revenues: | ||||||||||||||||||||
Life Planner | $ | 10,063 | $ | 10,643 | $ | 10,122 | ||||||||||||||
Gibraltar Life and Other | 10,011 | 11,272 | 11,454 | |||||||||||||||||
Total revenues | 20,074 | 21,915 | 21,576 | |||||||||||||||||
Benefits and expenses: | ||||||||||||||||||||
Life Planner | 8,625 | 8,869 | 8,618 | |||||||||||||||||
Gibraltar Life and Other | 9,045 | 9,656 | 10,006 | |||||||||||||||||
Total benefits and expenses | 17,670 | 18,525 | 18,624 | |||||||||||||||||
Adjusted operating income: | ||||||||||||||||||||
Life Planner | 1,438 | 1,774 | 1,504 | |||||||||||||||||
Gibraltar Life and Other | 966 | 1,616 | 1,448 | |||||||||||||||||
Total adjusted operating income | 2,404 | 3,390 | 2,952 | |||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (2,213) | 17 | 727 | |||||||||||||||||
Charges related to realized investment gains (losses), net | 118 | (32) | (42) | |||||||||||||||||
Market experience updates | 11 | 0 | (39) | |||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | 5 | (79) | (48) | |||||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | 325 | $ | 3,296 | $ | 3,550 |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Annualized new business premiums: | ||||||||||||||||||||
On an actual exchange rate basis: | ||||||||||||||||||||
Life Planner | $ | 941 | $ | 940 | $ | 1,041 | ||||||||||||||
Gibraltar Life and Other | 878 | 1,000 | 1,149 | |||||||||||||||||
Total | $ | 1,819 | $ | 1,940 | $ | 2,190 | ||||||||||||||
On a constant exchange rate basis: | ||||||||||||||||||||
Life Planner | 1,022 | 960 | 1,044 | |||||||||||||||||
Gibraltar Life and Other | 907 | 1,005 | 1,152 | |||||||||||||||||
Total | $ | 1,929 | $ | 1,965 | $ | 2,196 |
Year Ended December 31, 2022 | Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Life | Accident & Health | Retirement (1) | Investment Contracts (2) | Total | Life | Accident & Health | Retirement (1) | Investment Contracts (2) | Total | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Life Planner | $ | 566 | $ | 80 | $ | 333 | $ | 43 | $ | 1,022 | $ | 521 | $ | 67 | $ | 368 | $ | 4 | $ | 960 | ||||||||||||||||||||||||||||||||||||||||||
Gibraltar Life and Other: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Life Consultants | 179 | 28 | 30 | 301 | 538 | 260 | 26 | 40 | 161 | 487 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Banks(3) | 76 | 0 | 4 | 88 | 168 | 252 | 0 | 12 | 54 | 318 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Independent Agency | 83 | 12 | 105 | 1 | 201 | 73 | 23 | 96 | 8 | 200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal | 338 | 40 | 139 | 390 | 907 | 585 | 49 | 148 | 223 | 1,005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | 904 | $ | 120 | $ | 472 | $ | 433 | $ | 1,929 | $ | 1,106 | $ | 116 | $ | 516 | $ | 227 | $ | 1,965 |
Year Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
Life Planners: | ||||||||||||||||||||
Japan | 4,446 | 4,566 | 4,555 | |||||||||||||||||
All other countries | 1,478 | 1,458 | 1,511 | |||||||||||||||||
Gibraltar Life Consultants | 6,821 | 7,100 | 7,254 | |||||||||||||||||
Total | 12,745 | 13,124 | 13,320 |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Operating results: | ||||||||||||||||||||
Interest expense on debt | $ | (829) | $ | (827) | $ | (894) | ||||||||||||||
Investment income | 177 | 174 | 134 | |||||||||||||||||
Pension and employee benefits | 387 | 284 | 191 | |||||||||||||||||
Other corporate activities | (1,211) | (1,238) | (1,398) | |||||||||||||||||
Adjusted operating income | (1,476) | (1,607) | (1,967) | |||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (38) | 94 | (2,357) | |||||||||||||||||
Charges related to realized investment gains (losses), net | 5 | 8 | 3 | |||||||||||||||||
Market experience updates | 22 | 3 | (10) | |||||||||||||||||
Divested and Run-off Businesses | 9 | 716 | (450) | |||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | (47) | (38) | (25) | |||||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (1,525) | $ | (824) | $ | (4,806) |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Long-Term Care | $ | (418) | $ | 458 | $ | 351 | ||||||||||||||
Other | 427 | 258 | (801) | |||||||||||||||||
Total Divested and Run-off Businesses income (loss) excluded from adjusted operating income | $ | 9 | $ | 716 | $ | (450) |
Year ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
U.S. GAAP results: | |||||||||||||||||
Revenues | $ | 2,957 | $ | 5,947 | $ | 4,766 | |||||||||||
Benefits and expenses | 2,989 | 5,807 | 4,790 | ||||||||||||||
Income (loss) before income taxes and equity in earnings of operating joint ventures | $ | (32) | $ | 140 | $ | (24) |
Year Ended December 31, | ||||||||||||||||||||
2022 | 2021(1) | 2020(1) | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Expected federal income tax expense (benefit) at federal statutory rate | $ | (373) | $ | 1,970 | $ | (68) | ||||||||||||||
Non-taxable investment income | (86) | (292) | (228) | |||||||||||||||||
Foreign taxes at other than U.S. rate | 11 | 149 | 250 | |||||||||||||||||
Low-income housing and other tax credits | (128) | (126) | (112) | |||||||||||||||||
Changes in tax law | (11) | 10 | (192) | |||||||||||||||||
GILTI | 101 | (1) | (2) | |||||||||||||||||
Sale of subsidiary | 84 | (26) | 277 | |||||||||||||||||
Non-controlling interest | 5 | (14) | (48) | |||||||||||||||||
Non-deductible expenses | 21 | 11 | 14 | |||||||||||||||||
Change in valuation allowance | 16 | 13 | 17 | |||||||||||||||||
State taxes | 13 | 18 | 10 | |||||||||||||||||
Other | (23) | (38) | 1 | |||||||||||||||||
Reported income tax expense (benefit) | $ | (370) | $ | 1,674 | $ | (81) | ||||||||||||||
Effective tax rate | 20.8 | % | 17.8 | % | 25.1 | % | ||||||||||||||
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
International Businesses: | ||||||||||||||||||||
Investment gains (losses) on assets supporting experience-rated contractholder liabilities, net | $ | (201) | $ | 369 | $ | 68 | ||||||||||||||
Change in experience-rated contractholder liabilities due to asset value changes | 201 | (369) | (68) | |||||||||||||||||
Gains (losses), net, on experienced rated contracts | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||
Divested and Run-off Businesses: | ||||||||||||||||||||
Investment gains (losses) on assets supporting experience-rated contractholder liabilities, net | $ | (950) | $ | (616) | $ | 602 | ||||||||||||||
Change in experience-rated contractholder liabilities due to asset value changes | 818 | 657 | (625) | |||||||||||||||||
Gains (losses), net, on experienced rated contracts | $ | (132) | $ | 41 | $ | (23) | ||||||||||||||
Total: | ||||||||||||||||||||
Investment gains (losses) on assets supporting experience-rated contractholder liabilities, net | $ | (1,151) | $ | (247) | $ | 670 | ||||||||||||||
Change in experience-rated contractholder liabilities due to asset value changes | 1,019 | 288 | (693) | |||||||||||||||||
Gains (losses), net, on experienced rated contracts | $ | (132) | $ | 41 | $ | (23) |
As of December 31, 2022 | As of December 31, 2021(1) | ||||||||||||||||||||||||||||||||||||||||||||||
PFI excluding Closed Block Division | Closed Block Division | PFI excluding Closed Block Division | Closed Block Division | ||||||||||||||||||||||||||||||||||||||||||||
Total at Fair Value | Total Level 3(2) | Total at Fair Value | Total Level 3(2) | Total at Fair Value | Total Level 3(2) | Total at Fair Value | Total Level 3(2) | ||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | 277,648 | $ | 4,345 | $ | 30,071 | $ | 817 | $ | 334,006 | $ | 5,810 | $ | 38,404 | $ | 1,510 | |||||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities | 945 | 0 | 0 | 0 | 1,057 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Equity securities | 1,899 | 0 | 0 | 0 | 2,271 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
All other(3) | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Subtotal | 2,844 | 0 | 0 | 0 | 3,348 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Fixed maturities, trading | 5,051 | 289 | 900 | 15 | 7,686 | 403 | 1,137 | 18 | |||||||||||||||||||||||||||||||||||||||
Equity securities | 5,416 | 528 | 1,734 | 99 | 6,089 | 699 | 2,288 | 100 | |||||||||||||||||||||||||||||||||||||||
Commercial mortgage and other loans | 137 | 0 | 0 | 0 | 1,263 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Other invested assets(4) | 1,990 | 537 | 3 | 2 | 3,749 | 489 | 7 | 4 | |||||||||||||||||||||||||||||||||||||||
Short-term investments | 3,637 | 18 | 150 | 0 | 5,186 | 268 | 457 | 62 | |||||||||||||||||||||||||||||||||||||||
Cash equivalents | 6,398 | 0 | 1,076 | 0 | 4,857 | 48 | 402 | 22 | |||||||||||||||||||||||||||||||||||||||
Other assets | 176 | 176 | 0 | 0 | 164 | 164 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Separate account assets | 171,805 | 1,081 | 0 | 0 | 219,971 | 1,283 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Total assets | $ | 475,102 | $ | 6,974 | $ | 33,934 | $ | 933 | $ | 586,319 | $ | 9,164 | $ | 42,695 | $ | 1,716 | |||||||||||||||||||||||||||||||
Future policy benefits | $ | 4,746 | $ | 4,746 | $ | 0 | $ | 0 | $ | 9,068 | $ | 9,068 | $ | 0 | $ | 0 | |||||||||||||||||||||||||||||||
Policyholders’ account balances | 3,492 | 3,492 | 0 | 0 | 1,436 | 1,436 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Other liabilities(4) | 2,682 | 1 | 0 | 0 | 1,860 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Total liabilities | $ | 10,920 | $ | 8,239 | $ | 0 | $ | 0 | $ | 12,364 | $ | 10,504 | $ | 0 | $ | 0 |
December 31, 2022 | ||||||||||||||||||||||||||
PFI Excluding Closed Block Division | Closed Block Division | Total | ||||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||
Public, available-for-sale, at fair value | $ | 221,106 | 60.8 | % | $ | 21,140 | $ | 242,246 | ||||||||||||||||||
Public, held-to-maturity, at amortized cost, net of allowance | 1,229 | 0.3 | 0 | 1,229 | ||||||||||||||||||||||
Private, available-for-sale, at fair value | 55,814 | 15.4 | 8,931 | 64,745 | ||||||||||||||||||||||
Private, held-to-maturity, at amortized cost, net of allowance | 67 | 0.0 | 0 | 67 | ||||||||||||||||||||||
Fixed maturities, trading, at fair value | 4,838 | 1.3 | 900 | 5,738 | ||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 2,844 | 0.8 | 0 | 2,844 | ||||||||||||||||||||||
Equity securities, at fair value | 4,671 | 1.3 | 1,733 | 6,404 | ||||||||||||||||||||||
Commercial mortgage and other loans, at book value, net of allowance | 48,682 | 13.4 | 7,926 | 56,608 | ||||||||||||||||||||||
Policy loans, at outstanding balance | 6,409 | 1.8 | 3,637 | 10,046 | ||||||||||||||||||||||
Other invested assets, net of allowance(1) | 13,277 | 3.7 | 4,254 | 17,531 | ||||||||||||||||||||||
Short-term investments, net of allowance | 4,236 | 1.2 | 337 | 4,573 | ||||||||||||||||||||||
Total general account investments | 363,173 | 100.0 | % | 48,858 | 412,031 | |||||||||||||||||||||
Invested assets of other entities and operations(2) | 5,410 | 0 | 5,410 | |||||||||||||||||||||||
Total investments | $ | 368,583 | $ | 48,858 | $ | 417,441 | ||||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||||
PFI Excluding Closed Block Division(3) | Closed Block Division | Total | ||||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||
Public, available-for-sale, at fair value | $ | 276,868 | 65.0 | % | $ | 28,167 | $ | 305,035 | ||||||||||||||||||
Public, held-to-maturity, at amortized cost, net of allowance | 1,413 | 0.3 | 0 | 1,413 | ||||||||||||||||||||||
Private, available-for-sale, at fair value | 56,660 | 13.3 | 10,237 | 66,897 | ||||||||||||||||||||||
Private, held-to-maturity, at amortized cost, net of allowance | 101 | 0.1 | 0 | 101 | ||||||||||||||||||||||
Fixed maturities, trading, at fair value | 7,473 | 1.8 | 1,137 | 8,610 | ||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 3,358 | 0.8 | 0 | 3,358 | ||||||||||||||||||||||
Equity securities, at fair value | 5,587 | 1.3 | 2,288 | 7,875 | ||||||||||||||||||||||
Commercial mortgage and other loans, at book value, net of allowance | 49,146 | 11.6 | 8,241 | 57,387 | ||||||||||||||||||||||
Policy loans, at outstanding balance | 6,571 | 1.5 | 3,815 | 10,386 | ||||||||||||||||||||||
Other invested assets, net of allowance(1) | 12,485 | 2.9 | 4,358 | 16,843 | ||||||||||||||||||||||
Short-term investments, net of allowance | 6,043 | 1.4 | 557 | 6,600 | ||||||||||||||||||||||
Total general account investments | 425,705 | 100.0 | % | 58,800 | 484,505 | |||||||||||||||||||||
Invested assets of other entities and operations(2) | 7,694 | 0 | 7,694 | |||||||||||||||||||||||
Total investments | $ | 433,399 | $ | 58,800 | $ | 492,199 |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Fixed maturities: | ||||||||||||||
Public, available-for-sale, at fair value | $ | 112,013 | $ | 146,600 | ||||||||||
Public, held-to-maturity, at amortized cost, net of allowance | 1,229 | 1,413 | ||||||||||||
Private, available-for-sale, at fair value | 19,268 | 21,079 | ||||||||||||
Private, held-to-maturity, at amortized cost, net of allowance | 67 | 101 | ||||||||||||
Fixed maturities, trading, at fair value | 612 | 839 | ||||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | 2,844 | 3,328 | ||||||||||||
Equity securities, at fair value | 1,806 | 2,187 | ||||||||||||
Commercial mortgage and other loans, at book value, net of allowance | 18,080 | 19,969 | ||||||||||||
Policy loans, at outstanding balance | 2,607 | 2,726 | ||||||||||||
Other invested assets(1) | 5,272 | 4,203 | ||||||||||||
Short-term investments, net of allowance | 100 | 692 | ||||||||||||
Total Japanese general account investments | $ | 163,898 | $ | 203,137 |
Year Ended December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
PFI Excluding Closed Block Division and Japanese Operations | Japanese Insurance Operations | PFI Excluding Closed Block Division | Closed Block Division | Total(5) | |||||||||||||||||||||||||||||||||||||||||||
Yield(1) | Amount | Yield(1) | Amount | Yield(1) | Amount | Amount | Amount | ||||||||||||||||||||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities(2) | 4.56 | % | $ | 7,036 | 2.75 | % | $ | 3,831 | 3.71 | % | $ | 10,867 | $ | 1,375 | $ | 12,242 | |||||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | 1.68 | 123 | 1.01 | 30 | 1.49 | 153 | 0 | 153 | |||||||||||||||||||||||||||||||||||||||
Equity securities | 1.95 | 56 | 3.59 | 67 | 2.59 | 123 | 37 | 160 | |||||||||||||||||||||||||||||||||||||||
Commercial mortgage and other loans | 3.67 | 1,164 | 3.67 | 686 | 3.67 | 1,850 | 322 | 2,172 | |||||||||||||||||||||||||||||||||||||||
Policy loans | 4.94 | 184 | 3.90 | 99 | 4.52 | 283 | 216 | 499 | |||||||||||||||||||||||||||||||||||||||
Short-term investments and cash equivalents | 2.70 | 340 | 3.75 | 31 | 2.75 | 371 | 24 | 395 | |||||||||||||||||||||||||||||||||||||||
Gross investment income | 4.19 | 8,903 | 2.86 | 4,744 | 3.61 | 13,647 | 1,974 | 15,621 | |||||||||||||||||||||||||||||||||||||||
Investment expenses | (0.13) | (350) | (0.13) | (281) | (0.13) | (631) | (155) | (786) | |||||||||||||||||||||||||||||||||||||||
Investment income after investment expenses | 4.06 | % | 8,553 | 2.73 | % | 4,463 | 3.48 | % | 13,016 | 1,819 | 14,835 | ||||||||||||||||||||||||||||||||||||
Other invested assets(3) | 744 | 208 | 952 | 157 | 1,109 | ||||||||||||||||||||||||||||||||||||||||||
Investment results of other entities and operations(4) | 93 | 0 | 93 | 0 | 93 | ||||||||||||||||||||||||||||||||||||||||||
Total investment income | $ | 9,390 | $ | 4,671 | $ | 14,061 | $ | 1,976 | $ | 16,037 |
Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||
PFI Excluding Closed Block Division and Japanese Operations(6) | Japanese Insurance Operations | PFI Excluding Closed Block Division(6) | Closed Block Division | Total(5) | |||||||||||||||||||||||||||||||||||||||||||
Yield(1) | Amount | Yield(1) | Amount | Yield(1) | Amount | Amount | Amount | ||||||||||||||||||||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities(2) | 4.68 | % | $ | 7,084 | 2.72 | % | $ | 3,921 | 3.72 | % | $ | 11,005 | $ | 1,461 | $ | 12,466 | |||||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | 3.48 | 561 | 0.93 | 30 | 3.05 | 591 | 0 | 591 | |||||||||||||||||||||||||||||||||||||||
Equity securities | 1.44 | 42 | 3.52 | 76 | 2.32 | 118 | 44 | 162 | |||||||||||||||||||||||||||||||||||||||
Commercial mortgage and other loans | 4.16 | 1,401 | 3.92 | 768 | 4.07 | 2,169 | 367 | 2,536 | |||||||||||||||||||||||||||||||||||||||
Policy loans | 5.09 | 196 | 4.05 | 114 | 4.65 | 310 | 222 | 532 | |||||||||||||||||||||||||||||||||||||||
Short-term investments and cash equivalents | 0.48 | 55 | 0.48 | 4 | 0.48 | 59 | 3 | 62 | |||||||||||||||||||||||||||||||||||||||
Gross investment income | 4.26 | 9,339 | 2.85 | 4,913 | 3.63 | 14,252 | 2,097 | 16,349 | |||||||||||||||||||||||||||||||||||||||
Investment expenses | (0.14) | (254) | (0.14) | (241) | (0.14) | (495) | (124) | (619) | |||||||||||||||||||||||||||||||||||||||
Investment income after investment expenses | 4.12 | % | 9,085 | 2.71 | % | 4,672 | 3.49 | % | 13,757 | 1,973 | 15,730 | ||||||||||||||||||||||||||||||||||||
Other invested assets(3) | 1,413 | 457 | 1,870 | 527 | 2,397 | ||||||||||||||||||||||||||||||||||||||||||
Investment results of other entities and operations(4) | 160 | 0 | 160 | 0 | 160 | ||||||||||||||||||||||||||||||||||||||||||
Total investment income | $ | 10,658 | $ | 5,129 | $ | 15,787 | $ | 2,500 | $ | 18,287 |
Year Ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||
PFI Excluding Closed Block Division and Japanese Operations | Japanese Insurance Operations | PFI Excluding Closed Block Division | Closed Block Division | Total(5) | |||||||||||||||||||||||||||||||||||||||||||
Yield(1) | Amount | Yield(1) | Amount | Yield(1) | Amount | Amount | Amount | ||||||||||||||||||||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities(2) | 4.59 | % | $ | 7,416 | 2.78 | % | $ | 3,875 | 3.75 | % | $ | 11,291 | $ | 1,566 | $ | 12,857 | |||||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | 3.22 | 637 | 1.88 | 52 | 3.06 | 689 | 0 | 689 | |||||||||||||||||||||||||||||||||||||||
Equity securities | 2.01 | 48 | 3.62 | 72 | 2.74 | 120 | 42 | 162 | |||||||||||||||||||||||||||||||||||||||
Commercial mortgage and other loans | 3.95 | 1,377 | 2.89 | 731 | 3.91 | 2,108 | 358 | 2,466 | |||||||||||||||||||||||||||||||||||||||
Policy loans | 5.31 | 238 | 3.23 | 98 | 4.47 | 336 | 247 | 583 | |||||||||||||||||||||||||||||||||||||||
Short-term investments and cash equivalents | 0.83 | 171 | 0.86 | 14 | 0.83 | 185 | 6 | 191 | |||||||||||||||||||||||||||||||||||||||
Gross investment income | 4.06 | 9,887 | 2.89 | 4,842 | 3.58 | 14,729 | 2,219 | 16,948 | |||||||||||||||||||||||||||||||||||||||
Investment expenses | (0.12) | (272) | (0.14) | (245) | (0.13) | (517) | (136) | (653) | |||||||||||||||||||||||||||||||||||||||
Investment income after investment expenses | 3.94 | % | 9,615 | 2.75 | % | 4,597 | 3.45 | % | 14,212 | 2,083 | 16,295 | ||||||||||||||||||||||||||||||||||||
Other invested assets(3) | 413 | 245 | 658 | 157 | 815 | ||||||||||||||||||||||||||||||||||||||||||
Investment results of other entities and operations(4) | 300 | 0 | 300 | 0 | 300 | ||||||||||||||||||||||||||||||||||||||||||
Total investment income | $ | 10,328 | $ | 4,842 | $ | 15,170 | $ | 2,240 | $ | 17,410 |
Years Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
PFI excluding Closed Block Division: | ||||||||||||||||||||
Realized investment gains (losses), net: | ||||||||||||||||||||
(Addition to) release of allowance for credit losses on fixed maturities | $ | (5) | $ | 16 | $ | (105) | ||||||||||||||
Write-downs on fixed maturities(1) | (85) | (1) | (220) | |||||||||||||||||
Net gains (losses) on sales and maturities | (1,027) | 1,445 | 777 | |||||||||||||||||
Fixed maturity securities(2) | (1,117) | 1,460 | 452 | |||||||||||||||||
(Addition to) release of allowance for credit losses on loans | (65) | 87 | 0 | |||||||||||||||||
Net gains (losses) on sales and maturities | (70) | 1 | 10 | |||||||||||||||||
Commercial mortgage and other loans | (135) | 88 | 10 | |||||||||||||||||
Derivatives | (2,060) | 1,463 | (4,571) | |||||||||||||||||
OTTI losses on other invested assets recognized in earnings | (69) | (52) | (33) | |||||||||||||||||
(Addition to) release of allowance for credit losses on other invested assets | (4) | 0 | (1) | |||||||||||||||||
Other net gains (losses) | 48 | 162 | 17 | |||||||||||||||||
Other | (25) | 110 | (17) | |||||||||||||||||
Subtotal | (3,337) | 3,121 | (4,126) | |||||||||||||||||
Investment results of other entities and operations(3) | 238 | 96 | 57 | |||||||||||||||||
Total — PFI excluding Closed Block Division | (3,099) | 3,217 | (4,069) | |||||||||||||||||
Related adjustments | (2,571) | (1,270) | (71) | |||||||||||||||||
Realized investment gains (losses), net, and related adjustments | (5,670) | 1,947 | (4,140) | |||||||||||||||||
Charges related to realized investment gains (losses), net | (531) | (320) | (160) | |||||||||||||||||
Realized investment gains (losses), net, and charges related to realized investment gains (losses), net and adjustments | $ | (6,201) | $ | 1,627 | $ | (4,300) | ||||||||||||||
Closed Block Division: | ||||||||||||||||||||
Realized investment gains (losses), net: | ||||||||||||||||||||
(Addition to) release of allowance for credit losses on fixed maturities | $ | (17) | $ | 8 | $ | (27) | ||||||||||||||
Write-downs on fixed maturities(1) | (31) | 0 | (84) | |||||||||||||||||
Net gains (losses) on sales and maturities | (318) | 466 | 388 | |||||||||||||||||
Fixed maturity securities(2) | (366) | 474 | 277 | |||||||||||||||||
(Addition to) release of allowance for credit losses on loans | (14) | 11 | 3 | |||||||||||||||||
Net gains (losses) on sales and maturities | (26) | 0 | (3) | |||||||||||||||||
Commercial mortgage and other loans | (40) | 11 | 0 | |||||||||||||||||
Derivatives | 145 | 318 | (87) | |||||||||||||||||
OTTI losses on other invested assets recognized in earnings | 0 | 0 | 0 | |||||||||||||||||
(Addition to) release of allowance for credit losses on other invested assets | (2) | 0 | 0 | |||||||||||||||||
Other net gains (losses) | (7) | 4 | (8) | |||||||||||||||||
Other | (9) | 4 | (8) | |||||||||||||||||
Subtotal — Closed Block Division | (270) | 807 | 182 | |||||||||||||||||
Consolidated PFI realized investment gains (losses), net | $ | (3,369) | $ | 4,024 | $ | (3,887) |
December 31, 2022 | ||||||||||||||
Amortized Cost | % of Total | |||||||||||||
($ in millions) | ||||||||||||||
Corporate & government securities: | ||||||||||||||
Maturing in 2023 | $ | 7,890 | 2.6 | % | ||||||||||
Maturing in 2024 | 10,824 | 3.6 | ||||||||||||
Maturing in 2025 | 10,646 | 3.5 | ||||||||||||
Maturing in 2026 | 11,174 | 3.7 | ||||||||||||
Maturing in 2027 | 14,088 | 4.7 | ||||||||||||
Maturing in 2028 | 11,420 | 3.8 | ||||||||||||
Maturing in 2029 | 12,771 | 4.2 | ||||||||||||
Maturing in 2030 | 10,942 | 3.6 | ||||||||||||
Maturing in 2031 | 12,044 | 4.0 | ||||||||||||
Maturing in 2032 | 11,465 | 3.8 | ||||||||||||
Maturing in 2033 | 6,831 | 2.3 | ||||||||||||
Maturing in 2034 and beyond | 161,752 | 53.6 | ||||||||||||
Total corporate & government securities | 281,847 | 93.4 | ||||||||||||
Asset-backed securities | 10,060 | 3.3 | ||||||||||||
Commercial mortgage-backed securities | 7,331 | 2.4 | ||||||||||||
Residential mortgage-backed securities | 2,624 | 0.9 | ||||||||||||
Total fixed maturities | $ | 301,862 | 100.0 | % |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Industry(1) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | ACL | Fair Value | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | ACL | Fair Value | |||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finance | $ | 40,144 | $ | 277 | $ | 4,719 | $ | 2 | $ | 35,700 | $ | 37,669 | $ | 3,362 | $ | 175 | $ | 1 | $ | 40,855 | |||||||||||||||||||||||||||||||||||||||
Consumer non-cyclical | 31,546 | 387 | 4,219 | 16 | 27,698 | 30,345 | 3,675 | 182 | 0 | 33,838 | |||||||||||||||||||||||||||||||||||||||||||||||||
Utility | 25,871 | 350 | 3,443 | 27 | 22,751 | 23,617 | 3,076 | 114 | 21 | 26,558 | |||||||||||||||||||||||||||||||||||||||||||||||||
Capital goods | 16,612 | 196 | 2,100 | 36 | 14,672 | 14,556 | 1,352 | 85 | 9 | 15,814 | |||||||||||||||||||||||||||||||||||||||||||||||||
Consumer cyclical | 10,659 | 165 | 1,026 | 0 | 9,798 | 10,504 | 1,049 | 52 | 0 | 11,501 | |||||||||||||||||||||||||||||||||||||||||||||||||
Foreign agencies | 3,952 | 123 | 289 | 0 | 3,786 | 5,204 | 603 | 21 | 0 | 5,786 | |||||||||||||||||||||||||||||||||||||||||||||||||
Energy | 11,488 | 181 | 1,166 | 0 | 10,503 | 11,487 | 1,336 | 60 | 0 | 12,763 | |||||||||||||||||||||||||||||||||||||||||||||||||
Communications | 6,556 | 160 | 898 | 14 | 5,804 | 6,524 | 1,041 | 53 | 39 | 7,473 | |||||||||||||||||||||||||||||||||||||||||||||||||
Basic industry | 6,746 | 103 | 780 | 2 | 6,067 | 6,385 | 662 | 41 | 1 | 7,005 | |||||||||||||||||||||||||||||||||||||||||||||||||
Transportation | 9,894 | 175 | 1,183 | 4 | 8,882 | 9,532 | 997 | 69 | 19 | 10,441 | |||||||||||||||||||||||||||||||||||||||||||||||||
Technology | 4,460 | 32 | 523 | 0 | 3,969 | 4,723 | 274 | 41 | 3 | 4,953 | |||||||||||||||||||||||||||||||||||||||||||||||||
Industrial other | 4,544 | 35 | 953 | 0 | 3,626 | 4,340 | 540 | 35 | 0 | 4,845 | |||||||||||||||||||||||||||||||||||||||||||||||||
Total corporate securities | 172,472 | 2,184 | 21,299 | 101 | 153,256 | 164,886 | 17,967 | 928 | 93 | 181,832 | |||||||||||||||||||||||||||||||||||||||||||||||||
Foreign government(2) | 73,638 | 4,490 | 5,316 | 0 | 72,812 | 82,752 | 11,741 | 521 | 1 | 93,971 | |||||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed(3) | 2,481 | 28 | 215 | 0 | 2,294 | 2,451 | 117 | 13 | 0 | 2,555 | |||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed | 10,060 | 151 | 206 | 0 | 10,005 | 8,678 | 114 | 10 | 0 | 8,782 | |||||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 7,331 | 18 | 521 | 0 | 6,828 | 8,434 | 459 | 15 | 0 | 8,878 | |||||||||||||||||||||||||||||||||||||||||||||||||
U.S. Government | 24,857 | 1,089 | 3,482 | 0 | 22,464 | 20,747 | 5,133 | 21 | 0 | 25,859 | |||||||||||||||||||||||||||||||||||||||||||||||||
State & Municipal | 9,725 | 226 | 690 | 0 | 9,261 | 9,992 | 1,667 | 8 | 0 | 11,651 | |||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed maturities, available-for-sale(4) | $ | 300,564 | $ | 8,186 | $ | 31,729 | $ | 101 | $ | 276,920 | $ | 297,940 | $ | 37,198 | $ | 1,516 | $ | 94 | $ | 333,528 |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Industry(1) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ACL | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ACL | |||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finance | $ | 430 | $ | 24 | $ | 0 | $ | 454 | $ | 2 | $ | 486 | $ | 49 | $ | 0 | $ | 535 | $ | 5 | |||||||||||||||||||||||||||||||||||||||
Basic industry | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 9 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Total corporate securities | 430 | 24 | 0 | 454 | 2 | 495 | 49 | 0 | 544 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
Foreign government(2) | 725 | 128 | 0 | 853 | 0 | 833 | 221 | 0 | 1,054 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed(3) | 143 | 5 | 0 | 148 | 0 | 191 | 14 | 0 | 205 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed maturities, held-to-maturity | $ | 1,298 | $ | 157 | $ | 0 | $ | 1,455 | $ | 2 | $ | 1,519 | $ | 284 | $ | 0 | $ | 1,803 | $ | 5 |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NAIC Designation(1)(2) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses(3) | ACL | Fair Value | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses(3) | ACL | Fair Value | |||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 | $ | 206,050 | $ | 7,044 | $ | 20,290 | $ | 0 | $ | 192,804 | $ | 207,926 | $ | 28,904 | $ | 666 | $ | 0 | $ | 236,164 | |||||||||||||||||||||||||||||||||||||||
2 | 76,161 | 940 | 9,519 | 0 | 67,582 | 70,437 | 7,283 | 408 | 0 | 77,312 | |||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal High or Highest Quality Securities(4) | 282,211 | 7,984 | 29,809 | 0 | 260,386 | 278,363 | 36,187 | 1,074 | 0 | 313,476 | |||||||||||||||||||||||||||||||||||||||||||||||||
3 | 10,938 | 104 | 1,163 | 0 | 9,879 | 12,279 | 716 | 235 | 0 | 12,760 | |||||||||||||||||||||||||||||||||||||||||||||||||
4 | 5,016 | 50 | 435 | 1 | 4,630 | 5,475 | 194 | 140 | 9 | 5,520 | |||||||||||||||||||||||||||||||||||||||||||||||||
5 | 1,921 | 17 | 258 | 24 | 1,656 | 1,389 | 68 | 47 | 27 | 1,383 | |||||||||||||||||||||||||||||||||||||||||||||||||
6 | 478 | 31 | 64 | 76 | 369 | 434 | 33 | 20 | 58 | 389 | |||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal Other Securities(5)(6) | 18,353 | 202 | 1,920 | 101 | 16,534 | 19,577 | 1,011 | 442 | 94 | 20,052 | |||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed maturities, available-for-sale(7) | $ | 300,564 | $ | 8,186 | $ | 31,729 | $ | 101 | $ | 276,920 | $ | 297,940 | $ | 37,198 | $ | 1,516 | $ | 94 | $ | 333,528 |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NAIC Designation(1) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses(2) | Fair Value | ACL | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses(2) | Fair Value | ACL | |||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 | $ | 1,217 | $ | 153 | $ | 0 | $ | 1,370 | $ | 1 | $ | 1,428 | $ | 276 | $ | 0 | $ | 1,704 | $ | 3 | |||||||||||||||||||||||||||||||||||||||
2 | 81 | 4 | 0 | 85 | 1 | 91 | 8 | 0 | 99 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal High or Highest Quality Securities(3) | 1,298 | 157 | 0 | 1,455 | 2 | 1,519 | 284 | 0 | 1,803 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal Other Securities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed maturities, held-to-maturity | $ | 1,298 | $ | 157 | $ | 0 | $ | 1,455 | $ | 2 | $ | 1,519 | $ | 284 | $ | 0 | $ | 1,803 | $ | 5 |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
Asset-Backed Securities(2) | Commercial Mortgage-Backed Securities(3) | Asset-Backed Securities(2) | Commercial Mortgage-Backed Securities(3) | ||||||||||||||||||||||||||||||||||||||||||||
Low Issue Composite Rating(1) | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
AAA | $ | 7,078 | $ | 7,070 | $ | 7,320 | $ | 6,817 | $ | 7,180 | $ | 7,225 | $ | 8,423 | $ | 8,867 | |||||||||||||||||||||||||||||||
AA | 2,741 | 2,660 | 0 | 0 | 1,395 | 1,395 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
A | 162 | 151 | 2 | 2 | 12 | 12 | 2 | 2 | |||||||||||||||||||||||||||||||||||||||
BBB | 20 | 20 | 9 | 9 | 18 | 20 | 9 | 9 | |||||||||||||||||||||||||||||||||||||||
BB and below | 59 | 104 | 0 | 0 | 73 | 130 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
Total(4) | $ | 10,060 | $ | 10,005 | $ | 7,331 | $ | 6,828 | $ | 8,678 | $ | 8,782 | $ | 8,434 | $ | 8,878 |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||
Collateralized Loan Obligations | |||||||||||||||||||||||
Low Issue Composite Rating(1) | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||
(in millions) | |||||||||||||||||||||||
AAA | $ | 6,132 | $ | 6,143 | $ | 6,361 | $ | 6,388 | |||||||||||||||
AA | 2,687 | 2,606 | 1,295 | 1,292 | |||||||||||||||||||
A | 13 | 12 | 10 | 10 | |||||||||||||||||||
BBB | 15 | 13 | 10 | 10 | |||||||||||||||||||
BB and below | 11 | 9 | 8 | 8 | |||||||||||||||||||
Total(2)(3) | $ | 8,858 | $ | 8,783 | $ | 7,684 | $ | 7,708 |
December 31, 2022 | December 31, 2021 | |||||||||||||
(in millions) | ||||||||||||||
Commercial mortgage and agricultural property loans | $ | 48,240 | $ | 48,550 | ||||||||||
Uncollateralized loans | 463 | 561 | ||||||||||||
Residential property loans | 43 | 67 | ||||||||||||
Other collateralized loans | 108 | 70 | ||||||||||||
Total recorded investment gross of allowance(1) | 48,854 | 49,248 | ||||||||||||
Allowance for credit losses | (172) | (102) | ||||||||||||
Total net commercial mortgage and other loans(2) | $ | 48,682 | $ | 49,146 |
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||
Gross Carrying Value | % of Total | Gross Carrying Value | % of Total | |||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||||
Commercial mortgage and agricultural property loans by region: | ||||||||||||||||||||||||||
U.S. Regions(1): | ||||||||||||||||||||||||||
Pacific | $ | 17,509 | 36.3 | % | $ | 17,744 | 36.5 | % | ||||||||||||||||||
South Atlantic | 7,642 | 15.8 | 7,570 | 15.6 | ||||||||||||||||||||||
Middle Atlantic | 5,364 | 11.1 | 5,179 | 10.7 | ||||||||||||||||||||||
East North Central | 2,587 | 5.4 | 2,490 | 5.1 | ||||||||||||||||||||||
West South Central | 5,091 | 10.6 | 4,965 | 10.2 | ||||||||||||||||||||||
Mountain | 2,025 | 4.2 | 2,203 | 4.5 | ||||||||||||||||||||||
New England | 1,286 | 2.7 | 1,409 | 2.9 | ||||||||||||||||||||||
West North Central | 485 | 1.0 | 468 | 1.0 | ||||||||||||||||||||||
East South Central | 1,247 | 2.6 | 1,099 | 2.3 | ||||||||||||||||||||||
Subtotal-U.S. | 43,236 | 89.7 | 43,127 | 88.8 | ||||||||||||||||||||||
Europe | 3,157 | 6.5 | 3,308 | 6.8 | ||||||||||||||||||||||
Asia | 789 | 1.6 | 919 | 1.9 | ||||||||||||||||||||||
Other | 1,058 | 2.2 | 1,196 | 2.5 | ||||||||||||||||||||||
Total commercial mortgage and agricultural property loans(2) | $ | 48,240 | 100.0 | % | $ | 48,550 | 100.0 | % |
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||
Gross Carrying Value | % of Total | Gross Carrying Value | % of Total | |||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||||
Commercial mortgage and agricultural property loans by property type: | ||||||||||||||||||||||||||
Industrial | $ | 11,853 | 24.6 | % | $ | 11,773 | 24.3 | % | ||||||||||||||||||
Retail | 4,800 | 10.0 | 5,294 | 10.9 | ||||||||||||||||||||||
Office | 7,568 | 15.7 | 8,454 | 17.4 | ||||||||||||||||||||||
Apartments/Multi-Family | 13,503 | 28.0 | 13,734 | 28.3 | ||||||||||||||||||||||
Agricultural properties | 5,587 | 11.5 | 4,375 | 9.0 | ||||||||||||||||||||||
Hospitality | 1,733 | 3.6 | 1,601 | 3.3 | ||||||||||||||||||||||
Other | 3,196 | 6.6 | 3,319 | 6.8 | ||||||||||||||||||||||
Total commercial mortgage and agricultural property loans(1) | $ | 48,240 | 100.0 | % | $ | 48,550 | 100.0 | % |
December 31, 2022 | ||||||||||||||||||||||||||
Debt Service Coverage Ratio | ||||||||||||||||||||||||||
> 1.2x | 1.0x to < 1.2x | < 1.0x | Total Commercial Mortgage and Agricultural Property Loans | |||||||||||||||||||||||
Loan-to-Value Ratio | (in millions) | |||||||||||||||||||||||||
0%-59.99% | $ | 25,806 | $ | 1,368 | $ | 596 | $ | 27,770 | ||||||||||||||||||
60%-69.99% | 12,211 | 1,047 | 979 | 14,237 | ||||||||||||||||||||||
70%-79.99% | 3,918 | 719 | 271 | 4,908 | ||||||||||||||||||||||
80% or greater | 885 | 160 | 280 | 1,325 | ||||||||||||||||||||||
Total commercial mortgage and agricultural property loans | $ | 42,820 | $ | 3,294 | $ | 2,126 | $ | 48,240 |
December 31, 2022 | ||||||||||||||
Gross Carrying Value | % of Total | |||||||||||||
Year of Origination | ($ in millions) | |||||||||||||
2022 | $ | 4,669 | 9.7 | % | ||||||||||
2021 | 7,515 | 15.5 | ||||||||||||
2020 | 3,680 | 7.6 | ||||||||||||
2019 | 6,682 | 13.9 | ||||||||||||
2018 | 6,584 | 13.6 | ||||||||||||
2017 | 4,331 | 9.0 | ||||||||||||
2016 | 4,300 | 8.9 | ||||||||||||
2015 & Prior | 10,446 | 21.7 | ||||||||||||
Revolving Loans | 33 | 0.1 | ||||||||||||
Total commercial mortgage and agricultural property loans | $ | 48,240 | 100.0 | % |
December 31, 2022 | ||||||||||||||
Gross Carrying Value | % of Total | |||||||||||||
Vintage | ($ in millions) | |||||||||||||
Maturing in 2023 | $ | 1,930 | 4.0 | % | ||||||||||
Maturing in 2024 | 3,262 | 6.7 | ||||||||||||
Maturing in 2025 | 5,930 | 12.1 | ||||||||||||
Maturing in 2026 | 5,276 | 10.8 | ||||||||||||
Maturing in 2027 | 4,643 | 9.5 | ||||||||||||
Maturing in 2028 | 5,643 | 11.6 | ||||||||||||
Maturing in 2029 | 4,905 | 10.0 | ||||||||||||
Maturing in 2030 | 3,773 | 7.7 | ||||||||||||
Maturing in 2031 | 2,900 | 5.9 | ||||||||||||
Maturing in 2032 | 2,970 | 6.1 | ||||||||||||
Maturing in 2033 | 1,335 | 2.7 | ||||||||||||
Maturing in 2034 and beyond | 6,287 | 12.9 | ||||||||||||
Total commercial mortgage and other loans | $ | 48,854 | 100.0 | % |
December 31, 2022 | December 31, 2021 | |||||||||||||
(in millions) | ||||||||||||||
Allowance, beginning of year | $ | 102 | $ | 207 | ||||||||||
Addition to (release of) allowance for credit losses | 66 | (87) | ||||||||||||
Reclassified (to) from “Assets held-for-sale”(1) | 0 | (15) | ||||||||||||
Other | 4 | (3) | ||||||||||||
Allowance, end of period | $ | 172 | $ | 102 |
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Mutual funds | $ | 759 | $ | 433 | $ | 2 | $ | 1,190 | $ | 1,158 | $ | 699 | $ | 0 | $ | 1,857 | ||||||||||||||||||||||||||||||||||
Other Common Stocks | 2,581 | 921 | 87 | 3,415 | 2,553 | 1,073 | 34 | 3,592 | ||||||||||||||||||||||||||||||||||||||||||
Non-redeemable Preferred Stocks | 30 | 41 | 5 | 66 | 97 | 49 | 8 | 138 | ||||||||||||||||||||||||||||||||||||||||||
Total equity securities, at fair value(1) | $ | 3,370 | $ | 1,395 | $ | 94 | $ | 4,671 | $ | 3,808 | $ | 1,821 | $ | 42 | $ | 5,587 |
December 31, 2022 | December 31, 2021 | |||||||||||||
(in millions) | ||||||||||||||
LPs/LLCs: | ||||||||||||||
Equity method: | ||||||||||||||
Private equity | $ | 5,760 | $ | 5,163 | ||||||||||
Hedge funds | 2,420 | 2,044 | ||||||||||||
Real estate-related | 1,763 | 1,487 | ||||||||||||
Subtotal equity method | 9,943 | 8,694 | ||||||||||||
Fair value: | ||||||||||||||
Private equity | 909 | 1,124 | ||||||||||||
Hedge funds | 1,000 | 1,078 | ||||||||||||
Real estate-related | 37 | 34 | ||||||||||||
Subtotal fair value | 1,946 | 2,236 | ||||||||||||
Total LPs/LLCs | 11,889 | 10,930 | ||||||||||||
Real estate held through direct ownership(1) | 705 | 889 | ||||||||||||
Derivative instruments | 21 | 337 | ||||||||||||
Other(2) | 662 | 329 | ||||||||||||
Total other invested assets(3) | $ | 13,277 | $ | 12,485 |
December 31, 2022 | December 31, 2021 | |||||||||||||
(in millions) | ||||||||||||||
Fixed maturities: | ||||||||||||||
Public, available-for-sale, at fair value(1) | $ | 523 | $ | 478 | ||||||||||
Private, available-for-sale, at fair value | 205 | 0 | ||||||||||||
Fixed maturities, trading, at fair value(1) | 213 | 213 | ||||||||||||
Equity securities, at fair value | 746 | 699 | ||||||||||||
Commercial mortgage and other loans, at book value(2) | 137 | 1,279 | ||||||||||||
Other invested assets | 3,568 | 4,990 | ||||||||||||
Short-term investments | 18 | 35 | ||||||||||||
Total investments | $ | 5,410 | $ | 7,694 |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Equity(1) | $ | 36,077 | $ | 40,552 | |||||||
Junior subordinated debt (including hybrid securities) | 9,094 | 7,619 | |||||||||
Other capital debt | 4,977 | 5,073 | |||||||||
Total capital | $ | 50,148 | $ | 53,244 |
Ratio | |||||
Prudential of Japan consolidated(1) | 771 | % | |||
Gibraltar Life consolidated(2) | 874 | % |
Dividend Amount | Shares Repurchased | ||||||||||||||||||||||
Quarterly period ended: | Per Share | Aggregate | Shares | Total Cost | |||||||||||||||||||
(in millions, except per share data) | |||||||||||||||||||||||
December 31, 2022 | $ | 1.20 | $ | 449 | 3.7 | $ | 375 | ||||||||||||||||
September 30, 2022 | $ | 1.20 | $ | 454 | 3.9 | $ | 375 | ||||||||||||||||
June 30, 2022 | $ | 1.20 | $ | 457 | 3.6 | $ | 375 | ||||||||||||||||
March 31, 2022 | $ | 1.20 | $ | 462 | 3.3 | $ | 375 |
Dividend Amount | Shares Repurchased | ||||||||||||||||||||||
Year ended: | Per Share | Aggregate | Shares | Total Cost | |||||||||||||||||||
(in millions, except per share data) | |||||||||||||||||||||||
December 31, 2022 | $ | 4.80 | $ | 1,822 | 14.5 | $ | 1,500 | ||||||||||||||||
December 31, 2021 | $ | 4.60 | $ | 1,821 | 24.5 | $ | 2,500 | ||||||||||||||||
December 31, 2020 | $ | 4.40 | $ | 1,769 | 6.7 | $ | 500 | ||||||||||||||||
December 31, 2019 | $ | 4.00 | $ | 1,644 | 27.2 | $ | 2,500 | ||||||||||||||||
December 31, 2018 | $ | 3.60 | $ | 1,525 | 14.9 | $ | 1,500 |
Year Ended December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Highly Liquid Assets, beginning of period | $ | 3,553 | $ | 5,560 | |||||||
Dividends and/or returns of capital from subsidiaries(1) | 1,584 | 3,339 | |||||||||
Affiliated loans/(borrowings) - (capital activities) | (417) | 406 | |||||||||
Capital contributions to subsidiaries(2) | (2,527) | (197) | |||||||||
Total Business Capital Activity | (1,360) | 3,548 | |||||||||
Share repurchases(3) | (1,488) | (2,500) | |||||||||
Common Stock dividends(4) | (1,817) | (1,814) | |||||||||
Acquisition/Disposition activity(5) | 4,481 | 648 | |||||||||
Total Share Repurchases, Dividends and Acquisition/Disposition Activity | 1,176 | (3,666) | |||||||||
Proceeds from the issuance of debt | 2,474 | 0 | |||||||||
Repayments of debt | (1,005) | (1,308) | |||||||||
Total Debt Activity | 1,469 | (1,308) | |||||||||
Proceeds from stock-based compensation and exercise of stock options | 317 | 343 | |||||||||
Interest income from subsidiaries on intercompany agreements, net of interest paid | 219 | 238 | |||||||||
Swap terminations | (27) | (94) | |||||||||
Net income tax receipts & payments | 231 | 330 | |||||||||
Interest paid on external debt | (942) | (963) | |||||||||
Affiliated (borrowings)/loans - (operating activities)(6) | 110 | (331) | |||||||||
Other, net | (211) | (104) | |||||||||
Total Other Activity | (303) | (581) | |||||||||
Net increase (decrease) in highly liquid assets | 982 | (2,007) | |||||||||
Highly Liquid Assets, end of period | $ | 4,535 | $ | 3,553 |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in billions) | |||||||||||
PICA | $ | 232.2 | $ | 227.1 | |||||||
PLIC | 48.4 | 49.6 | |||||||||
Pruco Life | 64.9 | 56.1 | |||||||||
PRIAC | 0.0 | 0.6 | |||||||||
PALAC | 0.0 | 0.0 | |||||||||
Other(1) | (85.1) | (90.0) | |||||||||
Total future policy benefits and policyholders’ account balances(2)(3) | $ | 260.4 | $ | 243.4 |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in billions) | |||||||||||
Prudential of Japan(1) | $ | 61.6 | $ | 63.7 | |||||||
Gibraltar Life(2) | 102.7 | 110.5 | |||||||||
Other international insurance subsidiaries, excluding Japan | 3.4 | 2.8 | |||||||||
Other(3) | (8.0) | (7.9) | |||||||||
Total future policy benefits and policyholders’ account balances(4) | $ | 159.7 | $ | 169.1 |
December 31, 2022 | |||||||||||||||||||||||||||||
Prudential Insurance(1) | PLIC | Pruco Life | Total | December 31, 2021(2) | |||||||||||||||||||||||||
(in billions) | |||||||||||||||||||||||||||||
Cash and short-term investments | $ | 4.1 | $ | 1.7 | $ | 2.5 | $ | 8.3 | $ | 14.0 | |||||||||||||||||||
Fixed maturity investments(3): | |||||||||||||||||||||||||||||
High or highest quality | 109.7 | 27.1 | 19.1 | 155.9 | 214.9 | ||||||||||||||||||||||||
Other than high or highest quality | 7.6 | 2.7 | 1.9 | 12.2 | 16.2 | ||||||||||||||||||||||||
Subtotal | 117.3 | 29.8 | 21.0 | 168.1 | 231.1 | ||||||||||||||||||||||||
Public equity securities, at fair value | 1.2 | 1.7 | 0.1 | 3.0 | 4.2 | ||||||||||||||||||||||||
Total | $ | 122.6 | $ | 33.2 | $ | 23.6 | $ | 179.4 | $ | 249.3 |
December 31, 2022 | |||||||||||||||||||||||||||||
Prudential of Japan | Gibraltar Life(1) | All Other(2) | Total | December 31, 2021 | |||||||||||||||||||||||||
(in billions) | |||||||||||||||||||||||||||||
Cash and short-term investments | $ | 0.3 | $ | 0.7 | $ | 0.1 | $ | 1.1 | $ | 4.9 | |||||||||||||||||||
Fixed maturity investments(3): | |||||||||||||||||||||||||||||
High or highest quality(4) | 32.2 | 65.7 | 10.9 | 108.8 | 138.0 | ||||||||||||||||||||||||
Other than high or highest quality | 0.4 | 1.2 | 2.4 | 4.0 | 5.0 | ||||||||||||||||||||||||
Subtotal | 32.6 | 66.9 | 13.3 | 112.8 | 143.0 | ||||||||||||||||||||||||
Public equity securities | 2.1 | 1.6 | 0.1 | 3.8 | 4.5 | ||||||||||||||||||||||||
Total | $ | 35.0 | $ | 69.2 | $ | 13.5 | $ | 117.7 | $ | 152.4 |
Year ended December 31, | |||||||||||
Cash Settlements: Received (Paid) | 2022 | 2021 | |||||||||
(in millions) | |||||||||||
Income Hedges (External)(1) | $ | 21 | $ | 33 | |||||||
Equity Hedges: | |||||||||||
Internal(2) | 691 | 488 | |||||||||
External(3) | 10 | (137) | |||||||||
Total Equity Hedges | 701 | 351 | |||||||||
Total Cash Settlements | $ | 722 | $ | 384 |
As of December 31, | |||||||||||
Assets (Liabilities): | 2022 | 2021 | |||||||||
(in millions) | |||||||||||
Income Hedges (External)(4) | $ | (9) | $ | 47 | |||||||
Equity Hedges: | |||||||||||
Internal(2) | 1,229 | 955 | |||||||||
External | (123) | (20) | |||||||||
Total Equity Hedges(5) | 1,106 | 935 | |||||||||
Total Assets (Liabilities) | $ | 1,097 | $ | 982 |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
PFI Excluding Closed Block Division | Closed Block Division | Consolidated | PFI Excluding Closed Block Division | Closed Block Division | Consolidated | ||||||||||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||||||||||||||
Securities sold under agreements to repurchase | $ | 3,548 | $ | 3,041 | $ | 6,589 | $ | 7,393 | $ | 2,792 | $ | 10,185 | |||||||||||||||||||||||
Cash collateral for loaned securities(1) | 5,847 | 253 | 6,100 | 4,168 | 82 | 4,250 | |||||||||||||||||||||||||||||
Securities sold but not yet purchased | 0 | 0 | 0 | 3 | 0 | 3 | |||||||||||||||||||||||||||||
Total(2)(3) | $ | 9,395 | $ | 3,294 | $ | 12,689 | $ | 11,564 | $ | 2,874 | $ | 14,438 | |||||||||||||||||||||||
Portion of above securities that may be returned to the Company overnight requiring immediate return of the cash collateral | $ | 8,622 | $ | 3,189 | $ | 11,811 | $ | 10,637 | $ | 2,874 | $ | 13,511 | |||||||||||||||||||||||
Weighted average maturity, in days(4) | 17 | 5 | 31 | N/A |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
Prudential Financial | Subsidiaries | Consolidated | Prudential Financial | Subsidiaries | Consolidated | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
General obligation short-term debt: | |||||||||||||||||||||||||||||||||||
Commercial paper | $ | 25 | $ | 413 | $ | 438 | $ | 25 | $ | 395 | $ | 420 | |||||||||||||||||||||||
Current portion of long-term debt | 0 | 173 | 173 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
Other short-term debt | 0 | 0 | 0 | 0 | 98 | 98 | |||||||||||||||||||||||||||||
Subtotal | 25 | 586 | 611 | 25 | 493 | 518 | |||||||||||||||||||||||||||||
General obligation long-term debt: | |||||||||||||||||||||||||||||||||||
Senior debt | 10,115 | 0 | 10,115 | 10,109 | 173 | 10,282 | |||||||||||||||||||||||||||||
Junior subordinated debt | 9,047 | 47 | 9,094 | 7,564 | 54 | 7,618 | |||||||||||||||||||||||||||||
Surplus notes(1) | 0 | 345 | 345 | 0 | 344 | 344 | |||||||||||||||||||||||||||||
Subtotal | 19,162 | 392 | 19,554 | 17,673 | 571 | 18,244 | |||||||||||||||||||||||||||||
Total general obligations | 19,187 | 978 | 20,165 | 17,698 | 1,064 | 18,762 | |||||||||||||||||||||||||||||
Limited and non-recourse borrowings(2) | |||||||||||||||||||||||||||||||||||
Short-term debt | 0 | 9 | 9 | 0 | 7 | 7 | |||||||||||||||||||||||||||||
Current portion of long-term debt | 0 | 155 | 155 | 0 | 197 | 197 | |||||||||||||||||||||||||||||
Long-term debt | 0 | 354 | 354 | 0 | 378 | 378 | |||||||||||||||||||||||||||||
Subtotal | 0 | 518 | 518 | 0 | 582 | 582 | |||||||||||||||||||||||||||||
Total borrowings | $ | 19,187 | $ | 1,496 | $ | 20,683 | $ | 17,698 | $ | 1,646 | $ | 19,344 |
Surplus Notes | Outstanding as of December 31, 2022 | |||||||||||||||||||||||||
Credit-Linked Note Structures: | Original Issue Dates | Maturity Dates | Facility Size | |||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||||
XXX | 2012-2021 | 2022-2036 | $ | 1,600 | (1) | $ | 1,750 | |||||||||||||||||||
AXXX | 2013 | 2033 | 3,500 | 3,500 | ||||||||||||||||||||||
XXX | 2014-2018 | 2022-2034 | 2,080 | (2) | 2,100 | |||||||||||||||||||||
XXX | 2014-2017 | 2024-2037 | 2,330 | 2,400 | ||||||||||||||||||||||
AXXX | 2017 | 2037 | 1,540 | 2,000 | ||||||||||||||||||||||
XXX | 2018 | 2038 | 920 | 1,600 | ||||||||||||||||||||||
AXXX | 2020 | 2032 | 2,100 | 2,700 | ||||||||||||||||||||||
Total Credit-Linked Note Structures | $ | 14,070 | $ | 16,050 |
Estimated Payments Due by Period | |||||||||||||||||||||||||||||
2023 | 2024-2025 | 2026-2027 | 2028 and thereafter | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Short-term and long-term debt obligations(1) | $ | 1,770 | $ | 2,591 | $ | 2,391 | $ | 36,072 | $ | 42,824 | |||||||||||||||||||
Operating lease obligations(2) | 116 | 172 | 57 | 57 | 402 | ||||||||||||||||||||||||
Purchase obligations: | |||||||||||||||||||||||||||||
Commitments to purchase or fund investments(3) | 4,263 | 2,515 | 570 | 1,211 | 8,559 | ||||||||||||||||||||||||
Commercial mortgage loan commitments(4) | 1,828 | 110 | 5 | 52 | 1,995 | ||||||||||||||||||||||||
Other liabilities: | |||||||||||||||||||||||||||||
Insurance liabilities(5) | 38,631 | 56,401 | 56,757 | 797,018 | 948,807 | ||||||||||||||||||||||||
Other(6) | 12,754 | 182 | 65 | 82 | 13,083 | ||||||||||||||||||||||||
Total | $ | 59,362 | $ | 61,971 | $ | 59,845 | $ | 834,492 | $ | 1,015,670 |
A.M. Best(1) | S&P(2) | Moody’s(3) | Fitch(4) | |||||||||||||||||||||||
Last review date | 12/15/2022 | 11/29/2022 | 11/22/2021 | 12/16/2022 | ||||||||||||||||||||||
Current outlook | Stable | Stable | Stable | Stable | ||||||||||||||||||||||
Financial Strength Ratings: | ||||||||||||||||||||||||||
The Prudential Insurance Company of America | A+ | AA- | Aa3 | AA- | ||||||||||||||||||||||
Pruco Life Insurance Company | A+ | AA- | Aa3 | AA- | ||||||||||||||||||||||
Pruco Life Insurance Company of New Jersey | A+ | AA- | NR* | AA- | ||||||||||||||||||||||
The Prudential Life Insurance Company Ltd. (Prudential of Japan) | NR | A+ | NR | NR | ||||||||||||||||||||||
Gibraltar Life Insurance Company, Ltd. | NR | A+ | NR | NR | ||||||||||||||||||||||
The Prudential Gibraltar Financial Life Insurance Co. Ltd | NR | A+ | NR | NR | ||||||||||||||||||||||
Credit Ratings: | ||||||||||||||||||||||||||
Prudential Financial, Inc.: | ||||||||||||||||||||||||||
Short-term borrowings | AMB-1 | A-1 | P-2 | F1 | ||||||||||||||||||||||
Long-term senior debt | a- | A | A3 | A- | ||||||||||||||||||||||
Junior subordinated long-term debt | bbb | BBB+ | Baa1 | BBB | ||||||||||||||||||||||
The Prudential Insurance Company of America: | ||||||||||||||||||||||||||
Capital and surplus notes | a | A | A2 | A | ||||||||||||||||||||||
Prudential Funding, LLC: | ||||||||||||||||||||||||||
Short-term debt | AMB-1 | A-1+ | P-1 | F1+ | ||||||||||||||||||||||
Long-term senior debt | a+ | AA- | A1 | A+ | ||||||||||||||||||||||
PRICOA Global Funding I: | ||||||||||||||||||||||||||
Long-term senior debt | aa- | AA- | Aa3 | AA- |
As of December 31, 2022 | As of December 31, 2021 | |||||||||||||||||||||||||||||||||||||
Notional | Fair Value | Hypothetical Change in Fair Value | Notional | Fair Value | Hypothetical Change in Fair Value | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Financial assets with interest rate risk: | ||||||||||||||||||||||||||||||||||||||
Fixed maturities(1) | $ | 316,070 | $ | (30,524) | $ | 415,769 | $ | (43,547) | ||||||||||||||||||||||||||||||
Commercial mortgage and other loans | 52,479 | (2,300) | 67,998 | (3,069) | ||||||||||||||||||||||||||||||||||
Derivatives with interest rate risk: | ||||||||||||||||||||||||||||||||||||||
Swaps | $ | 268,764 | (8,565) | (3,631) | $ | 269,823 | (1,748) | (5,389) | ||||||||||||||||||||||||||||||
Futures | 19,452 | (12) | (309) | 25,122 | 57 | (1,327) | ||||||||||||||||||||||||||||||||
Options | 49,351 | (938) | 241 | 97,101 | (187) | (209) | ||||||||||||||||||||||||||||||||
Forwards | 38,899 | (581) | (185) | 38,394 | (159) | (73) | ||||||||||||||||||||||||||||||||
Synthetic GICs | 84,338 | 0 | (6) | 81,984 | 1 | 0 | ||||||||||||||||||||||||||||||||
Variable annuity and other living benefit feature embedded derivatives | (4,746) | 2,357 | (13,231) | 5,807 | ||||||||||||||||||||||||||||||||||
Indexed universal life contracts | (986) | 190 | (1,436) | 205 | ||||||||||||||||||||||||||||||||||
Indexed annuity contracts | (2,506) | (457) | (2,041) | (344) | ||||||||||||||||||||||||||||||||||
Total embedded derivatives(2) | (8,238) | 2,090 | (16,708) | 5,668 | ||||||||||||||||||||||||||||||||||
Financial liabilities with interest rate risk(3): | ||||||||||||||||||||||||||||||||||||||
Short-term and long-term debt | 19,441 | 3,091 | 22,648 | 4,231 | ||||||||||||||||||||||||||||||||||
Policyholders’ account balances—investment contracts | 66,602 | 1,944 | 103,064 | 3,520 | ||||||||||||||||||||||||||||||||||
Net estimated potential loss | $ | (29,589) | $ | (40,195) |
As of December 31, 2022 | As of December 31, 2021 | ||||||||||||||||||||||||||||||||||
Notional | Fair Value | Hypothetical Change in Fair Value | Notional | Fair Value | Hypothetical Change in Fair Value | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Equity securities(1) | $ | 9,049 | $ | (905) | $ | 11,296 | $ | (1,130) | |||||||||||||||||||||||||||
Equity-based derivatives(2) | $ | 51,501 | (961) | (73) | $ | 103,944 | (1,095) | (934) | |||||||||||||||||||||||||||
Variable annuity and other living benefit feature embedded derivatives | (4,746) | (627) | (13,231) | (1,563) | |||||||||||||||||||||||||||||||
Indexed universal life contracts | (986) | 24 | (1,436) | 54 | |||||||||||||||||||||||||||||||
Indexed annuity contracts | (2,506) | 841 | (2,041) | 680 | |||||||||||||||||||||||||||||||
Total embedded derivatives(2)(3) | (8,238) | 238 | (16,708) | (829) | |||||||||||||||||||||||||||||||
Net estimated potential loss | $ | (740) | $ | (2,893) |
As of December 31, 2022 | As of December 31, 2021 | ||||||||||||||||||||||
Fair Value | Hypothetical Change in Fair Value | Fair Value | Hypothetical Change in Fair Value | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Unhedged portion of equity investment in international subsidiaries and foreign currency denominated investments in domestic general account portfolio | $ | 3,797 | $ | 380 | $ | 3,375 | $ | 338 |
Page | |||||
2022 | 2021 | ||||||||||
ASSETS | |||||||||||
Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2022-$ | $ | $ | |||||||||
Fixed maturities, held-to-maturity, at amortized cost, net of allowance for credit losses (allowance for credit losses: 2022-$ | |||||||||||
Fixed maturities, trading, at fair value (amortized cost: 2022-$ | |||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | |||||||||||
Equity securities, at fair value (cost: 2022-$ | |||||||||||
Commercial mortgage and other loans (net of $ | |||||||||||
Policy loans | |||||||||||
Other invested assets (net of $ value at December 31, 2022 and 2021, respectively)(1) | |||||||||||
Short-term investments (net of allowance for credit losses: 2022-$ | |||||||||||
Total investments | |||||||||||
Cash and cash equivalents(1) | |||||||||||
Accrued investment income(1) | |||||||||||
Deferred policy acquisition costs | |||||||||||
Value of business acquired | |||||||||||
Income tax assets | |||||||||||
Assets held-for-sale(2) | |||||||||||
Other assets (net of allowance for credit losses: 2022-$ | |||||||||||
Separate account assets | |||||||||||
TOTAL ASSETS | $ | $ | |||||||||
LIABILITIES AND EQUITY | |||||||||||
LIABILITIES | |||||||||||
Future policy benefits | $ | $ | |||||||||
Policyholders’ account balances | |||||||||||
Policyholders’ dividends | |||||||||||
Securities sold under agreements to repurchase | |||||||||||
Cash collateral for loaned securities | |||||||||||
Income taxes | |||||||||||
Short-term debt | |||||||||||
Long-term debt | |||||||||||
Liabilities held-for-sale(2) | |||||||||||
Other liabilities (including allowance for credit losses: 2022-$ | |||||||||||
Notes issued by consolidated variable interest entities(1) | |||||||||||
Separate account liabilities | |||||||||||
Total liabilities | |||||||||||
COMMITMENTS AND CONTINGENT LIABILITIES (See Note 23) | |||||||||||
EQUITY | |||||||||||
Preferred Stock ($ | |||||||||||
Common Stock ($ | |||||||||||
Additional paid-in capital | |||||||||||
Common Stock held in treasury, at cost ( | ( | ( | |||||||||
Accumulated other comprehensive income (loss) | ( | ||||||||||
Retained earnings | |||||||||||
Total Prudential Financial, Inc. equity | |||||||||||
Noncontrolling interests | |||||||||||
Total equity | |||||||||||
TOTAL LIABILITIES AND EQUITY | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
REVENUES | |||||||||||||||||
Premiums | $ | $ | $ | ||||||||||||||
Policy charges and fee income | |||||||||||||||||
Net investment income | |||||||||||||||||
Asset management and service fees | |||||||||||||||||
Other income (loss) | ( | ||||||||||||||||
Realized investment gains (losses), net | ( | ( | |||||||||||||||
Total revenues | |||||||||||||||||
BENEFITS AND EXPENSES | |||||||||||||||||
Policyholders’ benefits | |||||||||||||||||
Interest credited to policyholders’ account balances | |||||||||||||||||
Dividends to policyholders | |||||||||||||||||
Amortization of deferred policy acquisition costs | |||||||||||||||||
Goodwill impairment | |||||||||||||||||
General and administrative expenses | |||||||||||||||||
Total benefits and expenses | |||||||||||||||||
INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | ( | ( | |||||||||||||||
Total income tax expense (benefit) | ( | ( | |||||||||||||||
INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | ( | ( | |||||||||||||||
Equity in earnings of operating joint ventures, net of taxes | ( | ||||||||||||||||
NET INCOME (LOSS) | ( | ( | |||||||||||||||
Less: Income (loss) attributable to noncontrolling interests | ( | ||||||||||||||||
NET INCOME (LOSS) ATTRIBUTABLE TO PRUDENTIAL FINANCIAL, INC. | $ | ( | $ | $ | ( | ||||||||||||
EARNINGS PER SHARE | |||||||||||||||||
Basic earnings per share-Common Stock: | |||||||||||||||||
Net income (loss) attributable to Prudential Financial, Inc. | $ | ( | $ | $ | ( | ||||||||||||
Diluted earnings per share-Common Stock: | |||||||||||||||||
Net income (loss) attributable to Prudential Financial, Inc. | $ | ( | $ | $ | ( | ||||||||||||
Dividends declared per share of Common Stock | $ | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
NET INCOME (LOSS) | $ | ( | $ | $ | ( | ||||||||||||
Other comprehensive income (loss), before tax: | |||||||||||||||||
Foreign currency translation adjustments for the period | ( | ( | |||||||||||||||
Net unrealized investment gains (losses) | ( | ( | |||||||||||||||
Defined benefit pension and postretirement unrecognized periodic benefit (cost) | |||||||||||||||||
Total | ( | ( | |||||||||||||||
Less: Income tax expense (benefit) related to other comprehensive income (loss) | ( | ( | |||||||||||||||
Other comprehensive income (loss), net of taxes | ( | ( | |||||||||||||||
Comprehensive income (loss) | ( | ( | |||||||||||||||
Less: Comprehensive income (loss) attributable to noncontrolling interests | ( | ||||||||||||||||
Comprehensive income (loss) attributable to Prudential Financial, Inc. | $ | ( | $ | ( | $ |
Common Stock | Additional Paid-in Capital | Retained Earnings | Common Stock Held In Treasury | Accumulated Other Comprehensive Income (Loss) | Total Prudential Financial, Inc. Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2019 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
Cumulative effect of adoption of accounting changes(1) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Common Stock acquired | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Contributions from noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Consolidations/(deconsolidations) of noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation programs | |||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared on Common Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | |||||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income (loss) | |||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2020 | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Common Stock acquired | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Contributions from noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Consolidations/(deconsolidations) of noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation programs | |||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared on Common Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | |||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income (loss) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2021 | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Common Stock acquired | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Contributions from noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Consolidations/(deconsolidations) of noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation programs | |||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared on Common Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2022 | $ | $ | $ | $ | ( | $ | ( | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||||||
Net income (loss) | $ | ( | $ | $ | ( | |||||||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||||||||
Realized investment (gains) losses, net | ( | |||||||||||||||||||
Policy charges and fee income | ( | ( | ( | |||||||||||||||||
Interest credited to policyholders’ account balances | ||||||||||||||||||||
Goodwill impairment | ||||||||||||||||||||
Depreciation and amortization | ||||||||||||||||||||
(Gains) losses on assets supporting experience-rated contractholder liabilities, net | ( | |||||||||||||||||||
Change in: | ||||||||||||||||||||
Deferred policy acquisition costs | ( | ( | ||||||||||||||||||
Future policy benefits and other insurance liabilities | ||||||||||||||||||||
Income taxes | ( | ( | ( | |||||||||||||||||
Derivatives, net | ( | ( | ( | |||||||||||||||||
Other, net(1) | ( | ( | ( | |||||||||||||||||
Cash flows from (used in) operating activities | ||||||||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||||||||||
Proceeds from the sale/maturity/prepayment of: | ||||||||||||||||||||
Fixed maturities, available-for-sale | ||||||||||||||||||||
Fixed maturities, held-to-maturity | ||||||||||||||||||||
Fixed maturities, trading | ||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ||||||||||||||||||||
Equity securities | ||||||||||||||||||||
Commercial mortgage and other loans | ||||||||||||||||||||
Policy loans | ||||||||||||||||||||
Other invested assets | ||||||||||||||||||||
Short-term investments | ||||||||||||||||||||
Payments for the purchase/origination of: | ||||||||||||||||||||
Fixed maturities, available-for-sale | ( | ( | ( | |||||||||||||||||
Fixed maturities, trading | ( | ( | ( | |||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ( | ( | ( | |||||||||||||||||
Equity securities | ( | ( | ( | |||||||||||||||||
Commercial mortgage and other loans | ( | ( | ( | |||||||||||||||||
Policy loans | ( | ( | ( | |||||||||||||||||
Other invested assets | ( | ( | ( | |||||||||||||||||
Short-term investments | ( | ( | ( | |||||||||||||||||
Dispositions, net of cash disposed(2) | ||||||||||||||||||||
Derivatives, net | ( | ( | ||||||||||||||||||
Other, net | ( | ( | ( | |||||||||||||||||
Cash flows from (used in) investing activities | ( | ( | ( | |||||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||||||
Policyholders’ account deposits | ||||||||||||||||||||
Policyholders’ account withdrawals | ( | ( | ( | |||||||||||||||||
Net change in securities sold under agreements to repurchase and cash collateral for loaned securities | ( | |||||||||||||||||||
Cash dividends paid on Common Stock | ( | ( | ( | |||||||||||||||||
Net change in financing arrangements (maturities 90 days or less) | ( | ( | ||||||||||||||||||
Common Stock acquired | ( | ( | ( | |||||||||||||||||
Common Stock reissued for exercise of stock options | ||||||||||||||||||||
Proceeds from the issuance of debt (maturities longer than 90 days) | ||||||||||||||||||||
Repayments of debt (maturities longer than 90 days) | ( | ( | ( | |||||||||||||||||
Proceeds from notes issued by consolidated VIEs | ||||||||||||||||||||
Repayments of notes issued by consolidated VIEs | ( | |||||||||||||||||||
Other, net(3) | ( | ( | ||||||||||||||||||
Cash flows from (used in) financing activities | ( | |||||||||||||||||||
Effect of foreign exchange rate changes on cash balances | ( | ( | ||||||||||||||||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS INCLUDING BALANCES CLASSIFIED AS HELD-FOR-SALE | ( | |||||||||||||||||||
NET CHANGE IN CASH BALANCES CLASSIFIED AS HELD-FOR-SALE(2) | ( | |||||||||||||||||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS | ( | ( | ||||||||||||||||||
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF YEAR | ||||||||||||||||||||
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF YEAR | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
SUPPLEMENTAL CASH FLOW INFORMATION | ||||||||||||||||||||
Income taxes paid, net of refunds | $ | $ | $ | |||||||||||||||||
Interest paid | $ | $ | $ | |||||||||||||||||
HELD-FOR-SALE CLASSIFICATION(2) | ||||||||||||||||||||
Assets classified as held-for-sale | $ | ( | $ | $ | ||||||||||||||||
Liabilities classified as held-for-sale | ( | |||||||||||||||||||
Net assets classified as held-for-sale | $ | ( | $ | $ |
NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||
Treasury Stock shares issued for stock-based compensation programs | $ | $ | $ | |||||||||||||||||
Novation of annuity contracts(4) | $ | $ | $ | |||||||||||||||||
Significant Pension Risk Transfer transactions: | ||||||||||||||||||||
Assets received, excluding cash and cash equivalents | $ | $ | $ | |||||||||||||||||
Liabilities assumed | ||||||||||||||||||||
Net cash received | $ | $ | $ | |||||||||||||||||
RECONCILIATION TO STATEMENTS OF FINANCIAL POSITION | ||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | |||||||||||||||||
Restricted cash and restricted cash equivalents (included in “Other assets”) | ||||||||||||||||||||
Total cash, cash equivalents, restricted cash and restricted cash equivalents | $ | $ | $ |
December 31, 2021 | |||||||||||||||||
Retirement Full Service | Individual Annuities PALAC | Total | |||||||||||||||
(in millions) | |||||||||||||||||
Assets held-for-sale: | |||||||||||||||||
Fixed maturities, available-for-sale, at fair value(1) | $ | $ | $ | ||||||||||||||
Fixed maturities, trading, at fair value | |||||||||||||||||
Assets supporting experience-rated contractholder liabilities, at fair value | |||||||||||||||||
Equity securities | |||||||||||||||||
Commercial mortgage and other loans(1) | |||||||||||||||||
Policy loans | |||||||||||||||||
Other invested assets | |||||||||||||||||
Short-term investments | |||||||||||||||||
Cash and cash equivalents | |||||||||||||||||
Accrued investment income | |||||||||||||||||
Deferred policy acquisition costs | |||||||||||||||||
Value of business acquired | |||||||||||||||||
Other assets(2) | |||||||||||||||||
Separate account assets | |||||||||||||||||
Total assets held-for-sale | $ | $ | $ | ||||||||||||||
Liabilities held-for-sale: | |||||||||||||||||
Future policy benefits | $ | $ | $ | ||||||||||||||
Policyholders’ account balances | |||||||||||||||||
Other liabilities | |||||||||||||||||
Separate account liabilities | |||||||||||||||||
Total liabilities held-for-sale | $ | $ | $ |
ASU 2018-12 Amended Topic | Description | Method of adoption | Effect on the financial statements or other significant matters | |||||||||||||||||
Cash flow assumptions used to measure the liability for future policy benefits for non-participating traditional and limited-pay insurance products | Requires an entity to review and, if necessary, update the cash flow assumptions used to measure the liability for future policy benefits, for both changes in future assumptions and actual experience, at least annually using a retrospective update method with a cumulative catch-up adjustment recorded in a separate line item in the Consolidated Statements of Operations. | An entity may choose one of two adoption methods for the liability for future policy benefits: (1) a modified retrospective transition method whereby the entity may choose to apply the amendments to contracts in force as of the beginning of the prior year (if early adoption is elected) or as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or (2) a full retrospective transition method. | The Company will adopt this guidance effective January 1, 2023 using the modified retrospective transition method. As a result of the modified retrospective transition method, the Company expects the vast majority of the impact of updating cash flow assumptions as of the transition date to be reflected in the pattern of earnings in subsequent periods. The Company also expects some decrease to “Retained earnings” upon adoption from cash flow assumption updates isolated to the impact on certain issue year cohorts. | |||||||||||||||||
Discount rate assumption used to measure the liability for future policy benefits for non-participating traditional and limited-pay insurance products | Requires discount rate assumptions to be based on an upper-medium grade fixed income instrument yield, which will be updated each quarter with the impact recorded through OCI. An entity shall maximize the use of relevant observable information and minimize the use of unobservable information in determining the discount rate assumptions. | As noted above, an entity may choose either a modified retrospective transition method or full retrospective transition method for the liability for future policy benefits. Under either method, for balance sheet remeasurement purposes, the liability for future policy benefits will be remeasured using current discount rates as of either the beginning of the prior year (if early adoption is elected) or the beginning of the earliest period presented with the impact recorded as a cumulative effect adjustment to AOCI. | As noted above, the Company will adopt the guidance for the liability for future policy benefits effective January 1, 2023 using the modified retrospective transition method. Based on interest rates as of September 30, 2022, the Company expects an increase to AOCI as a result of remeasuring in-force contract liabilities using upper-medium grade fixed income instrument yields. The adjustment will largely reflect the difference between discount rates locked-in at contract inception versus discount rates as of the adoption date. | |||||||||||||||||
Amortization of deferred acquisition costs (DAC) and other balances | Requires DAC and other balances, such as unearned revenue reserves and DSI, to be amortized on a constant level basis over the expected term of the related contract, independent of expected profitability. | An entity may apply one of two adoption methods: (1) a modified retrospective transition method whereby the entity may choose to apply the amendments to contracts in force as of the beginning of the prior year (if early adoption is elected) or as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or (2) if an entity chooses a full retrospective transition method for its liability for future policy benefits, as described above, it is required to also use a full retrospective transition method for DAC and other balances. | The Company will adopt this guidance effective January 1, 2023 using the modified retrospective transition method. Under the modified retrospective transition method, the Company does not expect a significant impact to the balance sheet, other than the impact of the removal of any related amounts in AOCI. |
Market Risk Benefits (“MRB”) | Requires an entity to measure all market risk benefits (e.g., living benefit and death benefit guarantees associated with variable annuities) at fair value, and record MRB assets and liabilities separately on the Consolidated Statements of Financial Position. Changes in fair value of market risk benefits are recorded in net income, except for the portion of the change in MRB liabilities attributable to changes in an entity’s NPR, which is recognized in OCI. | An entity shall adopt the guidance for market risk benefits using the retrospective transition method, which includes a cumulative effect adjustment on the balance sheet as of either the beginning of prior year (if early adoption is elected) or the beginning of the earliest period presented. An entity shall maximize the use of relevant observable information and minimize the use of unobservable information in determining the balance of the market risk benefits upon adoption. | The Company will adopt this guidance effective January 1, 2023 using the retrospective transition method. Upon adoption, the Company expects a decrease to “Retained earnings” and offsetting increase to AOCI from reclassifying the cumulative effect of changes in NPR from retained earnings to AOCI. There will also be an impact to “Retained earnings” for the difference between the fair value and carrying value of benefits not currently measured at fair value (e.g., guaranteed minimum death benefits on variable annuities). |
Standard | Description | Effective date and method of adoption | Effect on the financial statements or other significant matters | |||||||||||||||||
ASU 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosure | This ASU eliminates the accounting guidance for Troubled Debt Restructurings (“TDR”) for creditors and adds enhanced disclosure requirements for certain loan refinancings and restructurings by creditors made to borrowers experiencing financial difficulty. Following adoption of the ASU, all loan refinancings and restructurings are subject to the modification guidance in ASC 310-20. This ASU also amends the guidance on the vintage disclosures to require disclosure of current-period gross write-offs by year of origination. | January 1, 2023 using the prospective method with an option to apply a modified retrospective transition method for the recognition and measurement of TDRs which will include a cumulative effect adjustment on the balance sheet in the period of adoption. | The Company does not expect the adoption of the ASU to have a significant impact on the Consolidated Financial Statements and Notes to the Consolidated Financial Statements. |
December 31, 2022 | |||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||
U.S. public corporate securities | |||||||||||||||||||||||||||||
U.S. private corporate securities(1) | |||||||||||||||||||||||||||||
Foreign public corporate securities | |||||||||||||||||||||||||||||
Foreign private corporate securities | |||||||||||||||||||||||||||||
Asset-backed securities(2) | |||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||
Residential mortgage-backed securities(3) | |||||||||||||||||||||||||||||
Total fixed maturities, available-for-sale(1) | $ | $ | $ | $ | $ |
December 31, 2022 | |||||||||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Allowance for Credit Losses | Amortized Cost, Net of Allowance | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity: | |||||||||||||||||||||||||||||||||||
Foreign government bonds | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Foreign public corporate securities | |||||||||||||||||||||||||||||||||||
Foreign private corporate securities | |||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities(3) | |||||||||||||||||||||||||||||||||||
Total fixed maturities, held-to-maturity(4) | $ | $ | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||
U.S. public corporate securities | |||||||||||||||||||||||||||||
U.S. private corporate securities(2) | |||||||||||||||||||||||||||||
Foreign public corporate securities | |||||||||||||||||||||||||||||
Foreign private corporate securities | |||||||||||||||||||||||||||||
Asset-backed securities(3) | |||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||
Residential mortgage-backed securities(4) | |||||||||||||||||||||||||||||
Total fixed maturities, available-for-sale(1)(2) | $ | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Allowance for Credit Losses | Amortized Cost, Net of Allowance | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity: | |||||||||||||||||||||||||||||||||||
Foreign government bonds | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Foreign public corporate securities | |||||||||||||||||||||||||||||||||||
Foreign private corporate securities | |||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities(4) | |||||||||||||||||||||||||||||||||||
Total fixed maturities, held-to-maturity(5) | $ | $ | $ | $ | $ | $ |
December 31, 2022 | ||||||||||||||||||||||||||||||||||||||
Less Than Twelve Months | Twelve Months or More | Total | ||||||||||||||||||||||||||||||||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | ||||||||||||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | ||||||||||||||||||||||||||||||||||||||
Foreign government bonds | ||||||||||||||||||||||||||||||||||||||
U.S. public corporate securities | ||||||||||||||||||||||||||||||||||||||
U.S. private corporate securities | ||||||||||||||||||||||||||||||||||||||
Foreign public corporate securities | ||||||||||||||||||||||||||||||||||||||
Foreign private corporate securities | ||||||||||||||||||||||||||||||||||||||
Asset-backed securities | ||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||||||||||||||||||||
Total fixed maturities, available-for-sale | $ | $ | $ | $ | $ | $ |
December 31, 2021 | ||||||||||||||||||||||||||||||||||||||
Less Than Twelve Months | Twelve Months or More | Total | ||||||||||||||||||||||||||||||||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | ||||||||||||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | ||||||||||||||||||||||||||||||||||||||
Foreign government bonds | ||||||||||||||||||||||||||||||||||||||
U.S. public corporate securities | ||||||||||||||||||||||||||||||||||||||
U.S. private corporate securities | ||||||||||||||||||||||||||||||||||||||
Foreign public corporate securities | ||||||||||||||||||||||||||||||||||||||
Foreign private corporate securities | ||||||||||||||||||||||||||||||||||||||
Asset-backed securities | ||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||||||||||||||||||||
Total fixed maturities, available-for-sale(1) | $ | $ | $ | $ | $ | $ |
December 31, 2022 | ||||||||||||||||||||||||||
Available-for-Sale | Held-to-Maturity | |||||||||||||||||||||||||
Amortized Cost | Fair Value | Amortized Cost, Net of Allowance | Fair Value | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||
Due in one year or less | $ | $ | $ | $ | ||||||||||||||||||||||
Due after one year through five years | ||||||||||||||||||||||||||
Due after five years through ten years | ||||||||||||||||||||||||||
Due after ten years(1) | ||||||||||||||||||||||||||
Asset-backed securities | ||||||||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
Years Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Fixed maturities, available-for-sale: | ||||||||||||||||||||
Proceeds from sales(1) | $ | $ | $ | |||||||||||||||||
Proceeds from maturities/prepayments | ||||||||||||||||||||
Gross investment gains from sales and maturities | ||||||||||||||||||||
Gross investment losses from sales and maturities | ( | ( | ( | |||||||||||||||||
Write-downs recognized in earnings(2) | ( | ( | ( | |||||||||||||||||
(Addition to) release of allowance for credit losses | ( | ( | ||||||||||||||||||
Fixed maturities, held-to-maturity: | ||||||||||||||||||||
Proceeds from maturities/prepayments(3) | $ | $ | $ | |||||||||||||||||
(Addition to) release of allowance for credit losses |
Year Ended December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||
U.S. Treasury Securities and Obligations of U.S. States | Foreign Government Bonds | U.S. and Foreign Corporate Securities | Asset-Backed Securities | Commercial Mortgage-Backed Securities | Residential Mortgage-Backed Securities | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Additions to allowance for credit losses not previously recorded | |||||||||||||||||||||||||||||||||||||||||
Reductions for securities sold during the period | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Reductions for securities with intent to sell | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Additions (reductions) on securities with previous allowance | ( | ||||||||||||||||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
U.S. Treasury Securities and Obligations of U.S. States | Foreign Government Bonds | U.S. and Foreign Corporate Securities | Asset-Backed Securities | Commercial Mortgage-Backed Securities | Residential Mortgage-Backed Securities | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Additions to allowance for credit losses not previously recorded | |||||||||||||||||||||||||||||||||||||||||
Reductions for securities sold during the period | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Additions (reductions) on securities with previous allowance | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Reclassified to “Assets held-for sale”(1). | ( | ( | |||||||||||||||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
U.S. Treasury Securities and Obligations of U.S. States | Foreign Government Bonds | U.S. and Foreign Corporate Securities | Asset-Backed Securities | Commercial Mortgage-Backed Securities | Residential Mortgage-Backed Securities | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Additions to allowance for credit losses not previously recorded | |||||||||||||||||||||||||||||||||||||||||
Reductions for securities sold during the period | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Additions (reductions) on securities with previous allowance | |||||||||||||||||||||||||||||||||||||||||
Write-downs charged against the allowance | ( | ( | |||||||||||||||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||
U.S. Treasury Securities and Obligations of U.S. States | Foreign Government Bonds | U.S. and Foreign Corporate Securities | Asset-Backed Securities | Commercial Mortgage-Backed Securities | Residential Mortgage-Backed Securities | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity: | |||||||||||||||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Current period provision for expected losses | ( | ( | |||||||||||||||||||||||||||||||||||||||
Change in foreign exchange | ( | ( | |||||||||||||||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
U.S. Treasury Securities and Obligations of U.S. States | Foreign Government Bonds | U.S. and Foreign Corporate Securities | Asset-Backed Securities | Commercial Mortgage-Backed Securities | Residential Mortgage-Backed Securities | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity: | |||||||||||||||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Current period provision for expected losses. | ( | ( | |||||||||||||||||||||||||||||||||||||||
Change in foreign exchange | ( | ( | |||||||||||||||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
U.S. Treasury Securities and Obligations of U.S. States | Foreign Government Bonds | U.S. and Foreign Corporate Securities | Asset-Backed Securities | Commercial Mortgage-Backed Securities | Residential Mortgage-Backed Securities | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity: | |||||||||||||||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Cumulative effect of adoption of ASU 2016-13 | |||||||||||||||||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ |
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||
Assets Held-for-Sale(1) | ||||||||||||||||||||||||||||||||||||||
Amortized Cost or Cost | Fair Value | Amortized Cost or Cost | Fair Value | Amortized Cost or Cost | Fair Value | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Short-term investments and cash equivalents | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||||||||
Corporate securities | ||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities(2) | ||||||||||||||||||||||||||||||||||||||
Asset-backed securities(3) | ||||||||||||||||||||||||||||||||||||||
Foreign government bonds | ||||||||||||||||||||||||||||||||||||||
U.S. government authorities and agencies and obligations of U.S. states | ||||||||||||||||||||||||||||||||||||||
Total fixed maturities(4) | ||||||||||||||||||||||||||||||||||||||
Equity securities | ||||||||||||||||||||||||||||||||||||||
Total assets supporting experience-rated contractholder liabilities(5) | $ | $ | $ | $ | $ | $ |
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||
Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Investments in Japanese government and government agency securities: | ||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | $ | $ | $ | ||||||||||||||||||||||
Fixed maturities, held-to-maturity | ||||||||||||||||||||||||||
Fixed maturities, trading | ||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ | ||||||||||||||||||||||
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||
Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Investments in Brazil government and government agency securities: | ||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | $ | $ | $ | ||||||||||||||||||||||
Short-term investments | ||||||||||||||||||||||||||
Cash equivalents | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
December 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||
Amount (in millions) | % of Total | Amount (in millions) | % of Total | |||||||||||||||||||||||
Commercial mortgage and agricultural property loans by property type: | ||||||||||||||||||||||||||
Office | $ | % | $ | % | ||||||||||||||||||||||
Retail | ||||||||||||||||||||||||||
Apartments/Multi-Family | ||||||||||||||||||||||||||
Industrial | ||||||||||||||||||||||||||
Hospitality | ||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||
Total commercial mortgage loans | ||||||||||||||||||||||||||
Agricultural property loans | ||||||||||||||||||||||||||
Total commercial mortgage and agricultural property loans | % | % | ||||||||||||||||||||||||
Allowance for credit losses | ( | ( | ||||||||||||||||||||||||
Total net commercial mortgage and agricultural property loans | ||||||||||||||||||||||||||
Other loans: | ||||||||||||||||||||||||||
Uncollateralized loans | ||||||||||||||||||||||||||
Residential property loans | ||||||||||||||||||||||||||
Other collateralized loans | ||||||||||||||||||||||||||
Total other loans | ||||||||||||||||||||||||||
Allowance for credit losses | ( | ( | ||||||||||||||||||||||||
Total net other loans | ||||||||||||||||||||||||||
Total net commercial mortgage and other loans(1)(2) | $ | $ |
Commercial Mortgage Loans | Agricultural Property Loans | Residential Property Loans | Other Collateralized Loans | Uncollateralized Loans | Total | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Cumulative effect of adoption of ASU 2016-13 | ||||||||||||||||||||||||||||||||||||||
Addition to (release of) allowance for expected losses | ||||||||||||||||||||||||||||||||||||||
Write-downs charged against allowance | ( | ( | ||||||||||||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2020 | ||||||||||||||||||||||||||||||||||||||
Addition to (release of) allowance for expected losses | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Reclassified to “Asset held-for-sale”(1) | ( | ( | ||||||||||||||||||||||||||||||||||||
Other | ( | ( | ||||||||||||||||||||||||||||||||||||
Balance at December 31, 2021 | ||||||||||||||||||||||||||||||||||||||
Addition to (release of) allowance for expected losses | ( | |||||||||||||||||||||||||||||||||||||
Other | ( | |||||||||||||||||||||||||||||||||||||
Balance at December 31, 2022 | $ | $ | $ | $ | $ | $ |
December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortized Cost by Origination Year | |||||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2020 | 2019 | 2018 | Prior | Revolving Loans | Total | ||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | |||||||||||||||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
0%-59.99% | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
60%-69.99% | |||||||||||||||||||||||||||||||||||||||||||||||
70%-79.99% | |||||||||||||||||||||||||||||||||||||||||||||||
80% or greater | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Debt Service Coverage Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
Greater or Equal to 1.2x | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
1.0 - 1.2x | |||||||||||||||||||||||||||||||||||||||||||||||
Less than 1.0x | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Agricultural property loan | |||||||||||||||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
0%-59.99% | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
60%-69.99% | |||||||||||||||||||||||||||||||||||||||||||||||
70%-79.99% | |||||||||||||||||||||||||||||||||||||||||||||||
80% or greater | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Debt Service Coverage Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
Greater or Equal to 1.2x | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
1.0 - 1.2x | |||||||||||||||||||||||||||||||||||||||||||||||
Less than 1.0x | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortized Cost by Origination Year | |||||||||||||||||||||||||||||||||||||||||||||||
2021 | 2020 | 2019 | 2018 | 2017 | Prior | Revolving Loans | Total(1) | ||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | |||||||||||||||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
0%-59.99% | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
60%-69.99% | |||||||||||||||||||||||||||||||||||||||||||||||
70%-79.99% | |||||||||||||||||||||||||||||||||||||||||||||||
80% or greater | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Debt Service Coverage Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
Greater or Equal to 1.2x | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
1.0 - 1.2x | |||||||||||||||||||||||||||||||||||||||||||||||
Less than 1.0x | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Agricultural property loans | |||||||||||||||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
0%-59.99% | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
60%-69.99% | |||||||||||||||||||||||||||||||||||||||||||||||
70%-79.99% | |||||||||||||||||||||||||||||||||||||||||||||||
80% or greater | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Debt Service Coverage Ratio: | |||||||||||||||||||||||||||||||||||||||||||||||
Greater or Equal to 1.2x | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
1.0 - 1.2x | |||||||||||||||||||||||||||||||||||||||||||||||
Less than 1.0x | |||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
Current | 30-59 Days Past Due | 60-89 Days Past Due | 90 Days or More Past Due(1) | Total Past Due | Total Loans | Non-Accrual Status(2) | ||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
Agricultural property loans | ||||||||||||||||||||||||||||||||||||||||||||
Residential property loans | ||||||||||||||||||||||||||||||||||||||||||||
Other collateralized loans | ||||||||||||||||||||||||||||||||||||||||||||
Uncollateralized loans | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ |
December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
Current | 30-59 Days Past Due | 60-89 Days Past Due | 90 Days or More Past Due(1) | Total Past Due | Total Loans | Non-Accrual Status(2) | ||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
Agricultural property loans | ||||||||||||||||||||||||||||||||||||||||||||
Residential property loans | ||||||||||||||||||||||||||||||||||||||||||||
Other collateralized loans | ||||||||||||||||||||||||||||||||||||||||||||
Uncollateralized loans | ||||||||||||||||||||||||||||||||||||||||||||
Total(3) | $ | $ | $ | $ | $ | $ | $ |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
LPs/LLCs: | ||||||||||||||
Equity method: | ||||||||||||||
Private equity | $ | $ | ||||||||||||
Hedge funds | ||||||||||||||
Real estate-related | ||||||||||||||
Subtotal equity method | ||||||||||||||
Fair value: | ||||||||||||||
Private equity | ||||||||||||||
Hedge funds | ||||||||||||||
Real estate-related | ||||||||||||||
Subtotal fair value | ||||||||||||||
Total LPs/LLCs | ||||||||||||||
Real estate held through direct ownership(1) | ||||||||||||||
Derivative instruments | ||||||||||||||
Other(2) | ||||||||||||||
Total other invested assets(3) | $ | $ |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
STATEMENTS OF FINANCIAL POSITION | ||||||||||||||
Total assets(1) | $ | $ | ||||||||||||
Total liabilities(2) | $ | $ | ||||||||||||
Partners’ capital | ||||||||||||||
Total liabilities and partners’ capital | $ | $ | ||||||||||||
Total liabilities and partners’ capital included above | $ | $ | ||||||||||||
Equity in LP/LLC interests not included above | ||||||||||||||
Carrying value(3) | $ | $ |
Years Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
STATEMENTS OF OPERATIONS | ||||||||||||||||||||
Total revenue(1) | $ | $ | $ | |||||||||||||||||
Total expenses(2) | ( | ( | ( | |||||||||||||||||
Net earnings (losses) | $ | $ | $ | |||||||||||||||||
Equity in net earnings (losses) included above | $ | $ | $ | |||||||||||||||||
Equity in net earnings (losses) of LP/LLC interests not included above | ||||||||||||||||||||
Total equity in net earnings (losses) | $ | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Fixed maturities | $ | $ | |||||||||
Equity securities | |||||||||||
Commercial mortgage and other loans | |||||||||||
Policy loans | |||||||||||
Other invested assets | |||||||||||
Short-term investments and cash equivalents | |||||||||||
Total accrued investment income(1) | $ | $ |
Years Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Fixed maturities, available-for-sale(1) | $ | $ | $ | |||||||||||||||||
Fixed maturities, held-to-maturity(1) | ||||||||||||||||||||
Fixed maturities, trading | ||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ||||||||||||||||||||
Equity securities | ||||||||||||||||||||
Commercial mortgage and other loans | ||||||||||||||||||||
Policy loans | ||||||||||||||||||||
Other invested assets | ||||||||||||||||||||
Short-term investments and cash equivalents | ||||||||||||||||||||
Gross investment income | ||||||||||||||||||||
Less: investment expenses | ( | ( | ( | |||||||||||||||||
Net investment income | $ | $ | $ |
Years Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Fixed maturities(1) | $ | ( | $ | $ | ||||||||||||||||
Commercial mortgage and other loans | ( | |||||||||||||||||||
Investment real estate | ( | |||||||||||||||||||
LPs/LLCs | ( | ( | ||||||||||||||||||
Derivatives | ( | ( | ||||||||||||||||||
Other | ||||||||||||||||||||
Realized investment gains (losses), net | $ | ( | $ | $ | ( |
December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Fixed maturity securities, available-for-sale with an allowance(1) | $ | ( | $ | $ | ( | |||||||||||||||
Fixed maturity securities, available-for-sale without an allowance(1) | ( | |||||||||||||||||||
Derivatives designated as cash flow hedges(2) | ( | |||||||||||||||||||
Derivatives designated as fair value hedges(2) | ( | ( | ||||||||||||||||||
Other investments(3) | ( | |||||||||||||||||||
Net unrealized gains (losses) on investments | $ | ( | $ | $ |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
Remaining Contractual Maturities of the Agreements | Remaining Contractual Maturities of the Agreements | ||||||||||||||||||||||||||||||||||||||||||||||
Overnight & Continuous | Up to 30 Days | 30 to 90 Days | Total | Overnight & Continuous | Up to 30 Days | 30 to 90 Days | Total | ||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities | |||||||||||||||||||||||||||||||||||||||||||||||
Total securities sold under agreements to repurchase | $ | $ | $ | $ | $ | $ | $ | $ |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
Remaining Contractual Maturities of the Agreements | Remaining Contractual Maturities of the Agreements | ||||||||||||||||||||||||||||||||||
Overnight & Continuous | Up to 30 Days | Total | Overnight & Continuous | Up to 30 Days | Total | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||||||||
U.S. public corporate securities | |||||||||||||||||||||||||||||||||||
Foreign public corporate securities | |||||||||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||||||||
Total cash collateral for loaned securities(1) | $ | $ | $ | $ | $ | $ |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Fixed maturities(1) | $ | $ | ||||||||||||
Fixed maturities, trading | ||||||||||||||
Assets supporting experience-rated contractholder liabilities | ||||||||||||||
Separate account assets | ||||||||||||||
Equity securities | ||||||||||||||
Other | ||||||||||||||
Total securities pledged(2) | $ | $ |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Securities sold under agreements to repurchase | $ | $ | ||||||||||||
Cash collateral for loaned securities | ||||||||||||||
Separate account liabilities | ||||||||||||||
Long-term debt | ||||||||||||||
Total liabilities supported by the pledged collateral | $ | $ |
December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Assets on deposit with governmental authorities or trustees | $ | $ | ||||||||||||
Assets held in voluntary trusts(1) | ||||||||||||||
Assets held in trust related to reinsurance and other agreements(2) | ||||||||||||||
Securities restricted as to sale(3) | ||||||||||||||
Total assets on deposit, assets held in trust and securities restricted as to sale(4) | $ | $ |
Consolidated VIEs for which the Company is the Investment Manager(1) | Other Consolidated VIEs(1) | |||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | $ | $ | $ | ||||||||||||||||||||||
Fixed maturities, held-to-maturity | ||||||||||||||||||||||||||
Fixed maturities, trading | ||||||||||||||||||||||||||
Equity securities | ||||||||||||||||||||||||||
Commercial mortgage and other loans | ||||||||||||||||||||||||||
Other invested assets | ||||||||||||||||||||||||||
Cash and cash equivalents | ||||||||||||||||||||||||||
Accrued investment income | ||||||||||||||||||||||||||
Other assets | ||||||||||||||||||||||||||
Total assets of consolidated VIEs | $ | $ | $ | $ | ||||||||||||||||||||||
Other liabilities | $ | $ | $ | $ | ||||||||||||||||||||||
Notes issued by consolidated VIEs(2) | ||||||||||||||||||||||||||
Total liabilities of consolidated VIEs | $ | $ | $ | $ |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
Primary Underlying Risk/ Instrument Type | Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||
Notional | Assets | Liabilities | Notional | Assets | Liabilities | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||
Interest Rate | |||||||||||||||||||||||||||||||||||
Interest Rate Swaps | $ | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||||||||||
Interest Rate Forwards | ( | ( | |||||||||||||||||||||||||||||||||
Foreign Currency | |||||||||||||||||||||||||||||||||||
Foreign Currency Forwards | ( | ( | |||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||
Foreign Currency Swaps | ( | ( | |||||||||||||||||||||||||||||||||
Total Derivatives Designated as Hedge Accounting Instruments | $ | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||||||||||
Derivatives Not Qualifying as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||
Interest Rate | |||||||||||||||||||||||||||||||||||
Interest Rate Swaps | $ | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||||||||||
Interest Rate Futures | ( | ( | |||||||||||||||||||||||||||||||||
Interest Rate Options | ( | ( | |||||||||||||||||||||||||||||||||
Interest Rate Forwards | ( | ( | |||||||||||||||||||||||||||||||||
Foreign Currency | |||||||||||||||||||||||||||||||||||
Foreign Currency Forwards | ( | ( | |||||||||||||||||||||||||||||||||
Foreign Currency Options | |||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||
Foreign Currency Swaps | ( | ( | |||||||||||||||||||||||||||||||||
Credit | |||||||||||||||||||||||||||||||||||
Credit Default Swaps | ( | ( | |||||||||||||||||||||||||||||||||
Equity | |||||||||||||||||||||||||||||||||||
Equity Futures | ( | ( | |||||||||||||||||||||||||||||||||
Equity Options | ( | ( | |||||||||||||||||||||||||||||||||
Total Return Swaps | ( | ( | |||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||
Other(1) | |||||||||||||||||||||||||||||||||||
Synthetic GICs | ( | ||||||||||||||||||||||||||||||||||
Total Derivatives Not Qualifying as Hedge Accounting Instruments | $ | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||||||||||
Total Derivatives(2)(3)(4) | $ | $ | $ | ( | $ | $ | $ | ( |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||
Balance Sheet Line Item in which Hedged Item is Recorded | Carrying Amount of the Hedged Assets (Liabilities) | Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets (Liabilities)(1) | Carrying Amount of the Hedged Assets (Liabilities) | Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets (Liabilities)(1) | |||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Fixed maturities, available-for-sale, at fair value | $ | $ | $ | $ | |||||||||||||||||||
Commercial mortgage and other loans | $ | $ | $ | $ | |||||||||||||||||||
Policyholders’ account balances | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||
Future policy benefits | $ | ( | $ | $ | ( | $ | ( |
December 31, 2022 | ||||||||||||||||||||||||||||||||
Gross Amounts of Recognized Financial Instruments | Gross Amounts Offset in the Statements of Financial Position | Net Amounts Presented in the Statements of Financial Position | Financial Instruments/ Collateral(1) | Net Amount | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Offsetting of Financial Assets: | ||||||||||||||||||||||||||||||||
Derivatives | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
Securities purchased under agreement to resell | ( | |||||||||||||||||||||||||||||||
Total Assets | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
Offsetting of Financial Liabilities: | ||||||||||||||||||||||||||||||||
Derivatives | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
Securities sold under agreement to repurchase | ( | |||||||||||||||||||||||||||||||
Total Liabilities | $ | $ | ( | $ | $ | ( | $ |
December 31, 2021 | ||||||||||||||||||||||||||||||||
Gross Amounts of Recognized Financial Instruments | Gross Amounts Offset in the Statements of Financial Position | Net Amounts Presented in the Statements of Financial Position | Financial Instruments/ Collateral(1) | Net Amount | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Offsetting of Financial Assets(2): | ||||||||||||||||||||||||||||||||
Derivatives | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
Securities purchased under agreement to resell | ( | |||||||||||||||||||||||||||||||
Total Assets | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
Offsetting of Financial Liabilities(2): | ||||||||||||||||||||||||||||||||
Derivatives | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
Securities sold under agreement to repurchase | ( | |||||||||||||||||||||||||||||||
Total Liabilities | $ | $ | ( | $ | $ | ( | $ |
Year Ended December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||||||||
Fair value hedges | |||||||||||||||||||||||||||||||||||||||||
Gains (losses) on derivatives designated as hedge instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||
Currency | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Total gains (losses) on derivatives designated as hedge instruments | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Gains (losses) on the hedged item: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ||||||||||||||||||||||||||||||||||||||||
Currency | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on hedged item | ( | ||||||||||||||||||||||||||||||||||||||||
Amortization for gains (losses) excluded from assessment of the effectiveness | |||||||||||||||||||||||||||||||||||||||||
Currency | ( | ( | |||||||||||||||||||||||||||||||||||||||
Total amortization for gains (losses) excluded from assessment of the effectiveness | ( | ( | |||||||||||||||||||||||||||||||||||||||
Total gains (losses) on fair value hedges net of hedged item | ( | ||||||||||||||||||||||||||||||||||||||||
Cash flow hedges | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Currency | |||||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on cash flow hedges | |||||||||||||||||||||||||||||||||||||||||
Net investment hedges | |||||||||||||||||||||||||||||||||||||||||
Currency | |||||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on net investment hedges | |||||||||||||||||||||||||||||||||||||||||
Derivatives Not Qualifying as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ||||||||||||||||||||||||||||||||||||||||
Currency | ( | ( | |||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Credit | |||||||||||||||||||||||||||||||||||||||||
Equity | |||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||
Embedded Derivatives | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on derivatives not qualifying as hedge accounting instruments | ( | ||||||||||||||||||||||||||||||||||||||||
Total | $ | ( | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||||||||
Fair value hedges | |||||||||||||||||||||||||||||||||||||||||
Gains (losses) on derivatives designated as hedge instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | $ | $ | ( | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on derivatives designated as hedge instruments | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Gains (losses) on the hedged item: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ||||||||||||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on hedged item | ( | ||||||||||||||||||||||||||||||||||||||||
Amortization for gains (losses) excluded from assessment of the effectiveness | |||||||||||||||||||||||||||||||||||||||||
Currency ............................................. | ( | ( | |||||||||||||||||||||||||||||||||||||||
Total amortization for gains (losses) excluded from assessment of the effectiveness ...................................... | ( | ( | |||||||||||||||||||||||||||||||||||||||
Total gains (losses) on fair value hedges net of hedged item | ( | ( | |||||||||||||||||||||||||||||||||||||||
Cash flow hedges | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ( | |||||||||||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on cash flow hedges | |||||||||||||||||||||||||||||||||||||||||
Net investment hedges | |||||||||||||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on net investment hedges | ( | ||||||||||||||||||||||||||||||||||||||||
Derivatives Not Qualifying as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ||||||||||||||||||||||||||||||||||||||||
Currency | ( | ( | |||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Credit | |||||||||||||||||||||||||||||||||||||||||
Equity | ( | ||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||
Embedded Derivatives | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on derivatives not qualifying as hedge accounting instruments | |||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives Designated as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||||||||
Fair value hedges | |||||||||||||||||||||||||||||||||||||||||
Gains (losses) on derivatives designated as hedge instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | $ | ( | $ | ( | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Currency | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on derivatives designated as hedge instruments | ( | ( | |||||||||||||||||||||||||||||||||||||||
Gains (losses) on the hedged item: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ( | |||||||||||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on hedged item | ( | ( | |||||||||||||||||||||||||||||||||||||||
Amortization for gains (losses) excluded from assessment of the effectiveness | |||||||||||||||||||||||||||||||||||||||||
Currency ............................................. | ( | ||||||||||||||||||||||||||||||||||||||||
Total amortization for gains (losses) excluded from assessment of the effectiveness ...................................... | ( | ||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on fair value hedges net of hedged item | ( | ||||||||||||||||||||||||||||||||||||||||
Cash flow hedges | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | ( | ||||||||||||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | ( | ( | |||||||||||||||||||||||||||||||||||||||
Total gains (losses) on cash flow hedges | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
Net investment hedges | |||||||||||||||||||||||||||||||||||||||||
Currency | ( | ( | |||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on net investment hedges | ( | ( | |||||||||||||||||||||||||||||||||||||||
Derivatives Not Qualifying as Hedge Accounting Instruments: | |||||||||||||||||||||||||||||||||||||||||
Interest Rate | |||||||||||||||||||||||||||||||||||||||||
Currency | ( | ||||||||||||||||||||||||||||||||||||||||
Currency/Interest Rate | ( | ( | |||||||||||||||||||||||||||||||||||||||
Credit | ( | ||||||||||||||||||||||||||||||||||||||||
Equity | ( | ||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||
Embedded Derivatives | ( | ||||||||||||||||||||||||||||||||||||||||
Total gains (losses) on derivatives not qualifying as hedge accounting instruments | ( | ( | |||||||||||||||||||||||||||||||||||||||
Total | $ | ( | $ | $ | ( | $ | ( | $ | $ | $ | ( |
(in millions) | |||||
Balance, December 31, 2019 | $ | ||||
Amount recorded in AOCI | |||||
Interest Rate | |||||
Currency | ( | ||||
Currency/Interest Rate | ( | ||||
Total amount recorded in AOCI | ( | ||||
Amount reclassified from AOCI to income | |||||
Interest Rate | ( | ||||
Currency | ( | ||||
Currency/Interest Rate | ( | ||||
( | |||||
Balance, December 31, 2020 | $ | ( | |||
Amount recorded in AOCI | |||||
Interest Rate | ( | ||||
Currency | |||||
Currency/Interest Rate | |||||
Total amount recorded in AOCI | |||||
Amount reclassified from AOCI to income | |||||
Interest Rate | |||||
Currency | |||||
Currency/Interest Rate | ( | ||||
( | |||||
Balance, December 31, 2021 | $ | ||||
Amount recorded in AOCI | |||||
Interest Rate | ( | ||||
Currency | |||||
Currency/Interest Rate | |||||
Total amount recorded in AOCI | |||||
Amount reclassified from AOCI to income | |||||
Interest Rate | |||||
Currency | ( | ||||
Currency/Interest Rate | ( | ||||
( | |||||
Balance, December 31, 2022 | $ |
December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
NAIC Rating Designation of Underlying Credit Obligation(1) | ||||||||||||||||||||||||||||||||||||||||||||
NAIC 1 | NAIC 2 | NAIC 3 | NAIC 4 | NAIC 5 | NAIC 6 | Total | ||||||||||||||||||||||||||||||||||||||
Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Single name reference(2) | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Index reference(2) | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ( | $ | $ | $ | $ | $ | $ | $ | $ | ( |
December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
NAIC Rating Designation of Underlying Credit Obligation(1) | ||||||||||||||||||||||||||||||||||||||||||||
NAIC 1 | NAIC 2 | NAIC 3 | NAIC 4 | NAIC 5 | NAIC 6 | Total(3) | ||||||||||||||||||||||||||||||||||||||
Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | Gross Notional | Fair Value | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Single name reference(2) | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Index reference(2) | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ |
As of December 31, 2022 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Netting(2) | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||
U.S. corporate public securities | |||||||||||||||||||||||||||||
U.S. corporate private securities(3) | |||||||||||||||||||||||||||||
Foreign corporate public securities | |||||||||||||||||||||||||||||
Foreign corporate private securities | |||||||||||||||||||||||||||||
Asset-backed securities(4) | |||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||
Residential mortgage-backed securities | |||||||||||||||||||||||||||||
Subtotal | $ | $ | $ | $ | |||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities: | |||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | |||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||
Corporate securities | |||||||||||||||||||||||||||||
Asset-backed securities(4) | |||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||
Residential mortgage-backed securities | |||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||
All other(5) | |||||||||||||||||||||||||||||
Subtotal | |||||||||||||||||||||||||||||
Fixed maturities, trading | |||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||
Commercial mortgage and other loans | |||||||||||||||||||||||||||||
Other invested assets(6) | ( | ||||||||||||||||||||||||||||
Short-term investments | |||||||||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||||||||
Other assets | |||||||||||||||||||||||||||||
Separate account assets(7)(8) | |||||||||||||||||||||||||||||
Total assets | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||
Future policy benefits(9) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Policyholders’ account balances | |||||||||||||||||||||||||||||
Other liabilities | ( | ||||||||||||||||||||||||||||
Notes issued by consolidated VIEs | |||||||||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ | ( | $ |
As of December 31, 2021(1) | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Netting(2) | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||
U.S. corporate public securities | |||||||||||||||||||||||||||||
U.S. corporate private securities(3) | |||||||||||||||||||||||||||||
Foreign corporate public securities | |||||||||||||||||||||||||||||
Foreign corporate private securities | |||||||||||||||||||||||||||||
Asset-backed securities(4) | |||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||
Residential mortgage-backed securities | |||||||||||||||||||||||||||||
Subtotal | |||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities: | |||||||||||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||||||||||||||||||||||||||||
Obligations of U.S. states and their political subdivisions | |||||||||||||||||||||||||||||
Foreign government bonds | |||||||||||||||||||||||||||||
Corporate securities | |||||||||||||||||||||||||||||
Asset-backed securities(4) | |||||||||||||||||||||||||||||
Commercial mortgage-backed securities | |||||||||||||||||||||||||||||
Residential mortgage-backed securities | |||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||
All other(5) | |||||||||||||||||||||||||||||
Subtotal | |||||||||||||||||||||||||||||
Fixed maturities, trading | |||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||
Commercial mortgage and other loans | |||||||||||||||||||||||||||||
Other invested assets(6) | ( | ||||||||||||||||||||||||||||
Short-term investments | |||||||||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||||||||
Other assets | |||||||||||||||||||||||||||||
Separate account assets(7)(8) | |||||||||||||||||||||||||||||
Total assets | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||
Future policy benefits(9) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Policyholders’ account balances | |||||||||||||||||||||||||||||
Other liabilities | ( | ||||||||||||||||||||||||||||
Notes issued by consolidated VIEs | |||||||||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ | ( | $ |
As of December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||
Fair Value | Valuation Techniques | Unobservable Inputs | Minimum | Maximum | Weighted Average | Impact of Increase in Input on Fair Value(1) | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||
Corporate securities(2)(3) | $ | Discounted cash flow(5) | Discount rate | Decrease | |||||||||||||||||||||||||||||||||||||
Market comparables | EBITDA multiples(4) | Increase | |||||||||||||||||||||||||||||||||||||||
Liquidation | Liquidation value | Increase | |||||||||||||||||||||||||||||||||||||||
Equity securities | $ | Discounted cash flow(5) | Discount rate | Decrease | |||||||||||||||||||||||||||||||||||||
Market comparables | EBITDA multiples(4) | Increase | |||||||||||||||||||||||||||||||||||||||
Net Asset Value | Share price | $ | $ | $ | Increase | ||||||||||||||||||||||||||||||||||||
Separate account assets-commercial mortgage loans(6) | $ | Discounted cash flow | Spread | Decrease | |||||||||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||||||||
Future policy benefits(7) | $ | Discounted cash flow | Lapse rate(9) | Decrease | |||||||||||||||||||||||||||||||||||||
Spread over SOFR(10) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Utilization rate(11) | Increase | ||||||||||||||||||||||||||||||||||||||||
Withdrawal rate | See table footnote (12) below. | ||||||||||||||||||||||||||||||||||||||||
Mortality rate(13) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Equity volatility curve | Increase | ||||||||||||||||||||||||||||||||||||||||
Policyholders’ account balances(8) | $ | Discounted cash flow | Lapse rate(9) | Decrease | |||||||||||||||||||||||||||||||||||||
Spread over SOFR(10) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Mortality rate(13) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Equity volatility curve | Increase | ||||||||||||||||||||||||||||||||||||||||
Option Budget(14) | ( | Increase |
As of December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
Fair Value | Valuation Techniques | Unobservable Inputs | Minimum | Maximum | Weighted Average | Impact of Increase in Input on Fair Value(1) | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||
Corporate securities(2)(3) | $ | Discounted cash flow(5) | Discount rate | Decrease | |||||||||||||||||||||||||||||||||||||
Market comparables | EBITDA multiples(4) | Increase | |||||||||||||||||||||||||||||||||||||||
Liquidation | Liquidation value | Increase | |||||||||||||||||||||||||||||||||||||||
Equity securities | $ | Discounted cash flow(5) | Discount rate | Decrease | |||||||||||||||||||||||||||||||||||||
Market comparables | EBITDA multiples(4) | Increase | |||||||||||||||||||||||||||||||||||||||
Net Asset Value | Share price | $ | $ | $ | Increase | ||||||||||||||||||||||||||||||||||||
Separate account assets-commercial mortgage loans(6) | $ | Discounted cash flow | Spread | Decrease | |||||||||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||||||||
Future policy benefits(7) | $ | Discounted cash flow | Lapse rate(9) | Decrease | |||||||||||||||||||||||||||||||||||||
Spread over LIBOR(10) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Utilization rate(11) | Increase | ||||||||||||||||||||||||||||||||||||||||
Withdrawal rate | See table footnote (12) below. | ||||||||||||||||||||||||||||||||||||||||
Mortality rate(13) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Equity volatility curve | Increase | ||||||||||||||||||||||||||||||||||||||||
Policyholders’ account balances(8) | $ | Discounted cash flow | Lapse rate(9) | Decrease | |||||||||||||||||||||||||||||||||||||
Spread over LIBOR(10) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Mortality rate(13) | Decrease | ||||||||||||||||||||||||||||||||||||||||
Equity volatility curve | Increase |
Year Ended December 31, 2022 | |||||||||||||||||||||||||||||||||||
Fair Value, beginning of period | Total realized and unrealized gains (losses) | Purchases | Sales | Issuances | Settlements | Other(1) | Transfers into Level 3 | Transfers out of Level 3 | Fair Value, end of period | Unrealized gains (losses) for assets still held(3) | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||||||||
U.S. government | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
U.S. states | ( | ( | |||||||||||||||||||||||||||||||||
Foreign government | ( | ( | ( | ||||||||||||||||||||||||||||||||
Corporate securities(4) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Structured securities(5) | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities: | |||||||||||||||||||||||||||||||||||
Foreign government | |||||||||||||||||||||||||||||||||||
Corporate securities(4) | |||||||||||||||||||||||||||||||||||
Structured securities(5) | |||||||||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||||||||
All other activity | |||||||||||||||||||||||||||||||||||
Other assets: | |||||||||||||||||||||||||||||||||||
Fixed maturities, trading | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Equity securities | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Other invested assets | ( | ( | ( | ||||||||||||||||||||||||||||||||
Short-term investments | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Cash equivalents | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Other assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Separate account assets(6) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||
Future policy benefits | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Policyholders’ account balances(7) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Other liabilities | ( | ( | |||||||||||||||||||||||||||||||||
Notes issued by consolidated VIEs |
Year Ended December 31, 2022 | ||||||||||||||||||||||||||||||||
Total realized and unrealized gains (losses) | Unrealized gains (losses) for assets still held(3) | |||||||||||||||||||||||||||||||
Realized investment gains (losses), net | Other income (loss) | Interest credited to policyholders’ account balances | Included in other comprehensive income (losses) | Net investment income | Realized investment gains (losses), net | Other income (loss) | Interest credited to policyholders’ account balances | Included in other comprehensive income (losses)(8) | ||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | ( | $ | $ | $ | ( | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ||||||||||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||||||||
Fixed maturities, trading | ( | ( | ||||||||||||||||||||||||||||||
Equity securities | ( | ( | ||||||||||||||||||||||||||||||
Other invested assets | ( | ( | ||||||||||||||||||||||||||||||
Short-term investments | ( | ( | ||||||||||||||||||||||||||||||
Cash equivalents | ( | ( | ||||||||||||||||||||||||||||||
Other assets | ( | ( | ||||||||||||||||||||||||||||||
Separate account assets(6) | ( | ( | ||||||||||||||||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||||||
Future policy benefits | ( | |||||||||||||||||||||||||||||||
Policyholders’ account balances | ( | |||||||||||||||||||||||||||||||
Other liabilities | ||||||||||||||||||||||||||||||||
Notes issued by consolidated VIEs | ||||||||||||||||||||||||||||||||
Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||
Fair Value, beginning of period | Total realized and unrealized gains (losses) | Purchases | Sales | Issuances | Settlements | Other(1) | Transfers into Level 3 | Transfers out of Level 3(2) | Fair Value, end of period | Unrealized gains (losses) for assets still held(3) | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale: | |||||||||||||||||||||||||||||||||||
U.S. government | $ | $ | $ | $ | ( | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
U.S. states | |||||||||||||||||||||||||||||||||||
Foreign government | ( | ||||||||||||||||||||||||||||||||||
Corporate securities(4) | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Structured securities(5) | ( | ( | ( | ||||||||||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities: | |||||||||||||||||||||||||||||||||||
Foreign government | ( | ( | |||||||||||||||||||||||||||||||||
Corporate securities(4) | ( | ( | ( | ||||||||||||||||||||||||||||||||
Structured securities(5) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||||||||||||||
All other activity | ( | ( | |||||||||||||||||||||||||||||||||
Other assets: | |||||||||||||||||||||||||||||||||||
Fixed maturities, trading | ( | ( | ( | ||||||||||||||||||||||||||||||||
Equity securities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Other invested assets | ( | ( | |||||||||||||||||||||||||||||||||
Short-term investments | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Cash equivalents | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Other assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Separate account assets(6) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||
Future policy benefits | ( | ( | ( | ||||||||||||||||||||||||||||||||
Policyholders’ account balances(7) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Other liabilities | |||||||||||||||||||||||||||||||||||
Notes issued by consolidated VIEs |
Year Ended December 31, 2021 | ||||||||||||||||||||||||||||||||
Total realized and unrealized gains (losses) | Unrealized gains (losses) for assets still held(3) | |||||||||||||||||||||||||||||||
Realized investment gains (losses), net | Other income (loss) | Interest credited to policyholders’ account balances | Included in other comprehensive income (losses) | Net investment income | Realized investment gains (losses), net | Other income (loss) | Interest credited to policyholders’ account balances | Included in other comprehensive income (losses)(8) | ||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | $ | $ | $ | ( | $ | $ | ( | $ | $ | $ | ( | ||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ( | |||||||||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||||||||
Fixed maturities, trading | ||||||||||||||||||||||||||||||||
Equity securities | ||||||||||||||||||||||||||||||||
Other invested assets | ||||||||||||||||||||||||||||||||
Short-term investments | ( | |||||||||||||||||||||||||||||||
Cash equivalents | ( | ( | ||||||||||||||||||||||||||||||
Other assets | ( | ( | ||||||||||||||||||||||||||||||
Separate account assets(6) | ||||||||||||||||||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||||||
Future policy benefits | ||||||||||||||||||||||||||||||||
Policyholders’ account balances | ( | ( | ||||||||||||||||||||||||||||||
Other liabilities | ||||||||||||||||||||||||||||||||
Notes issued by consolidated VIEs |
Year Ended December 31, 2020 | ||||||||||||||||||||||||||||||||
Total realized and unrealized gains (losses) | Unrealized gains (losses) for assets still held(3) | |||||||||||||||||||||||||||||||
Realized investment gains (losses), net | Other income (loss) | Interest credited to policyholders’ account balances | Included in other comprehensive income (losses) | Net investment income | Realized investment gains (losses), net | Other income (loss) | Interest credited to policyholders’ account balances | Included in other comprehensive income (losses)(8) | ||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Fixed maturities, available-for-sale | $ | ( | $ | $ | $ | $ | $ | ( | $ | $ | $ | |||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ( | ( | ||||||||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||||||||
Fixed maturities, trading | ( | ( | ||||||||||||||||||||||||||||||
Equity securities | ||||||||||||||||||||||||||||||||
Other invested assets | ||||||||||||||||||||||||||||||||
Short-term investments | ( | |||||||||||||||||||||||||||||||
Cash equivalents | ||||||||||||||||||||||||||||||||
Other assets | ||||||||||||||||||||||||||||||||
Separate account assets(6) | ||||||||||||||||||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||||||
Future policy benefits | ( | ( | ||||||||||||||||||||||||||||||
Policyholders’ account balances | ( | ( | ||||||||||||||||||||||||||||||
Other liabilities | ||||||||||||||||||||||||||||||||
Notes issued by consolidated VIEs |
As of December 31, 2022 | ||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Netting(1) | Total | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Derivative Assets: | ||||||||||||||||||||||||||||||||
Interest Rate | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Currency | ||||||||||||||||||||||||||||||||
Credit | ||||||||||||||||||||||||||||||||
Currency/Interest Rate | ||||||||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||||||||
Netting(1) | ( | ( | ||||||||||||||||||||||||||||||
$ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Derivative Liabilities: | ||||||||||||||||||||||||||||||||
Interest Rate | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Currency | ||||||||||||||||||||||||||||||||
Credit | ||||||||||||||||||||||||||||||||
Currency/Interest Rate | ||||||||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||||||||
Netting(1) | ( | ( | ||||||||||||||||||||||||||||||
$ | $ | $ | $ | ( | $ |
As of December 31, 2021 | ||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Netting(1) | Total | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Derivative Assets(2): | ||||||||||||||||||||||||||||||||
Interest Rate | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Currency | ||||||||||||||||||||||||||||||||
Credit | ||||||||||||||||||||||||||||||||
Currency/Interest Rate | ||||||||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||||||||
Netting(1) | ( | ( | ||||||||||||||||||||||||||||||
$ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Derivative Liabilities(2): | ||||||||||||||||||||||||||||||||
Interest Rate | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Currency | ||||||||||||||||||||||||||||||||
Credit | ||||||||||||||||||||||||||||||||
Currency/Interest Rate | ||||||||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||||||||
Netting(1) | ( | ( | ||||||||||||||||||||||||||||||
$ | $ | $ | $ | ( | $ |
Year Ended December 31, 2022 | |||||||||||||||||||||||||||||||||||
Fair Value, beginning of period | Total realized and unrealized gains (losses) (1) | Purchases | Sales | Issuances | Settlements | Other | Transfers into Level 3 (2) | Transfers out of Level 3 (2) | Fair Value, end of period | Unrealized gains (losses) for assets still held (1) | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Net Derivative - Equity | $ | $ | $ | $ | ( | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
Net Derivative - Interest Rate | ( |
Year Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||
Fair Value, beginning of period | Total realized and unrealized gains (losses) (1) | Purchases | Sales | Issuances | Settlements | Other | Transfers into Level 3 (2) | Transfers out of Level 3 (2) | Fair Value, end of period | Unrealized gains (losses) for assets still held (1) | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Net Derivative - Equity | $ | $ | $ | $ | $ | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||
Net Derivative - Interest Rate |
Year Ended December 31, 2020 | |||||||||||||||||||||||||||||||||||
Fair Value, beginning of period | Total realized and unrealized gains (losses) (1) | Purchases | Sales | Issuances | Settlements | Other | Transfers into Level 3 (2) | Transfers out of Level 3 (2) | Fair Value, end of period | Unrealized gains (losses) for assets still held (1) | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Net Derivative - Equity | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Net Derivative - Interest Rate | ( |
Year Ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Gains (Losses): | |||||||||||||||||
Mortgage servicing rights(1) | $ | ( | $ | $ | ( | ||||||||||||
Investment real estate | $ | ( | $ | ( | $ | ( | |||||||||||
Investment in JV/LP | $ | ( | $ | $ | |||||||||||||
Goodwill Impairment(2) | $ | ( | $ | ( | $ |
Year Ended December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Carrying value after measurement as of period end | |||||||||||
Mortgage servicing rights(1) | $ | $ | |||||||||
Investment real estate(3) | $ | $ | |||||||||
Investment in JV/LP(3) | $ | $ | |||||||||
Goodwill(2) | $ | $ |
Year Ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Liabilities: | |||||||||||||||||
Notes issued by consolidated VIEs: | |||||||||||||||||
Changes in fair value | $ | $ | $ | ( |
Year Ended December 31, | |||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Commercial mortgage and other loans: | |||||||||||||||||
Interest income | $ | $ | $ | ||||||||||||||
Notes issued by consolidated VIEs: | |||||||||||||||||
Interest expense | $ | $ | $ |
Year Ended December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Commercial mortgage and other loans(1): | |||||||||||
Fair value as of period end | $ | $ | |||||||||
Aggregate contractual principal as of period end | $ | $ | |||||||||
Other assets: | |||||||||||
Fair value as of period end | $ | $ | |||||||||
December 31, 2022 | |||||||||||||||||||||||||||||
Fair Value | Carrying Amount(2) | ||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity(3) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | |||||||||||||||||||||||||||||
Commercial mortgage and other loans | |||||||||||||||||||||||||||||
Policy loans | |||||||||||||||||||||||||||||
Other invested assets | |||||||||||||||||||||||||||||
Short-term investments | |||||||||||||||||||||||||||||
Cash and cash equivalents | |||||||||||||||||||||||||||||
Accrued investment income | |||||||||||||||||||||||||||||
Other assets | |||||||||||||||||||||||||||||
Total assets | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
Policyholders’ account balances—investment contracts | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Securities sold under agreements to repurchase | |||||||||||||||||||||||||||||
Cash collateral for loaned securities | |||||||||||||||||||||||||||||
Short-term debt | |||||||||||||||||||||||||||||
Long-term debt(4) | |||||||||||||||||||||||||||||
Notes issued by consolidated VIEs | |||||||||||||||||||||||||||||
Other liabilities | |||||||||||||||||||||||||||||
Separate account liabilities—investment contracts | |||||||||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ | $ |
December 31, 2021(1) | |||||||||||||||||||||||||||||
Fair Value | Carrying Amount(2) | ||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Fixed maturities, held-to-maturity(3) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Assets supporting experience-rated contractholder liabilities | |||||||||||||||||||||||||||||
Commercial mortgage and other loans | |||||||||||||||||||||||||||||
Policy loans | |||||||||||||||||||||||||||||
Other invested assets | |||||||||||||||||||||||||||||
Short-term investments | |||||||||||||||||||||||||||||
Cash and cash equivalents | |||||||||||||||||||||||||||||
Accrued investment income | |||||||||||||||||||||||||||||
Other assets | |||||||||||||||||||||||||||||
Total assets | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
Policyholders’ account balances—investment contracts | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Securities sold under agreements to repurchase | |||||||||||||||||||||||||||||
Cash collateral for loaned securities | |||||||||||||||||||||||||||||
Short-term debt | |||||||||||||||||||||||||||||
Long-term debt(4) | |||||||||||||||||||||||||||||
Notes issued by consolidated VIEs | |||||||||||||||||||||||||||||
Other liabilities | |||||||||||||||||||||||||||||
Separate account liabilities—investment contracts | |||||||||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Balance, beginning of period | $ | $ | $ | ||||||||||||||
Capitalization of commissions, sales and issue expenses | |||||||||||||||||
Amortization—Impact of assumption and experience unlocking and true-ups | ( | ( | |||||||||||||||
Amortization—All other | ( | ( | ( | ||||||||||||||
Change due to unrealized investment gains and losses | ( | ||||||||||||||||
Foreign currency translation | ( | ( | |||||||||||||||
Reclassified to “Assets held-for-sale”(1) | ( | ||||||||||||||||
Other(2) | ( | ( | |||||||||||||||
Balance, end of period | $ | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Balance, beginning of period | $ | $ | $ | ||||||||||||||
Amortization—Impact of assumption and experience unlocking and true-ups | ( | ( | |||||||||||||||
Amortization—All other | ( | ( | ( | ||||||||||||||
Change due to unrealized investment gains and losses | |||||||||||||||||
Interest | |||||||||||||||||
Foreign currency translation | ( | ( | |||||||||||||||
Reclassified to “Assets held-for-sale”(1) | ( | ||||||||||||||||
Other | ( | ||||||||||||||||
Balance, end of period | $ | $ | $ |
VOBA Balance | |||||
(in millions) | |||||
Gibraltar Life | $ | ||||
Gibraltar BSN Life Berhad | |||||
Aoba Life | |||||
Total | $ |
2023 | 2024 | 2025 | 2026 | 2027 | Thereafter | Total | |||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Estimated future VOBA amortization | $ | $ | $ | $ | $ | $ | $ |
2022 | 2021(1) | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Investment in operating joint ventures | $ | $ | $ | |||||||||||||||||
Dividends received from operating joint ventures | $ | $ | $ | |||||||||||||||||
After-tax equity in earnings of operating joint ventures | $ | ( | $ | $ |
PGIM | Assurance IQ | International Businesses | Corporate and Other | Other(1) | Total | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Goodwill balance, December 31, 2019: | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Foreign currency translation and other(2) | ( | ||||||||||||||||||||||||||||||||||
Goodwill balance, December 31, 2020: | |||||||||||||||||||||||||||||||||||
Acquisitions(3) | |||||||||||||||||||||||||||||||||||
Impairments | ( | ( | |||||||||||||||||||||||||||||||||
Foreign currency translation | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Reclassified to “Assets held-for-sale”(4) | ( | ( | |||||||||||||||||||||||||||||||||
Goodwill balance, December 31, 2021: | |||||||||||||||||||||||||||||||||||
Impairments | ( | ( | |||||||||||||||||||||||||||||||||
Foreign currency translation | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Goodwill balance, December 31, 2022: | $ | $ | $ | $ | $ | $ |
2022 | 2021 | ||||||||||||||||||||||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Subject to amortization: | |||||||||||||||||||||||||||||||||||
Mortgage servicing rights | $ | $ | ( | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Customer relationships | ( | ( | |||||||||||||||||||||||||||||||||
Software and other | ( | ( | |||||||||||||||||||||||||||||||||
Not subject to amortization | N/A | N/A | |||||||||||||||||||||||||||||||||
Total(1) | $ | $ |
2023 | 2024 | 2025 | 2026 | 2027 | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Estimated future amortization expense of other intangibles | $ | $ | $ | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
($ in millions) | |||||||||||
Operating Leases: | |||||||||||
$ | $ | ||||||||||
$ | $ | ||||||||||
Weighted average remaining lease term | |||||||||||
Weighted average discount rate | % | % |
December 31, 2022 | |||||
(in millions) | |||||
2023 | $ | ||||
2024 | |||||
2025 | |||||
2026 | |||||
2027 | |||||
Thereafter | |||||
Total lease payments | |||||
Less imputed interest | ( | ||||
Total | $ |
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Life insurance | $ | $ | |||||||||
Individual and group annuities and supplementary contracts | |||||||||||
Other contract liabilities | |||||||||||
Included in “Liabilities held-for-sale”(1) | ( | ||||||||||
Subtotal future policy benefits excluding unpaid claims and claim settlement expenses | |||||||||||
Unpaid claims and claim settlement expenses | |||||||||||
Total future policy benefits | $ | $ |
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Individual annuities | $ | $ | |||||||||
Group annuities | |||||||||||
Guaranteed investment contracts and guaranteed interest accounts | |||||||||||
Funding agreements | |||||||||||
Interest-sensitive life contracts | |||||||||||
Dividend accumulation and other deposit type funds | |||||||||||
Included in “Liabilities held-for-sale”(1) | ( | ||||||||||
Total policyholders’ account balances | $ | $ |
December 31, 2022 | December 31, 2021 | ||||||||||||||||||||||
In the Event of Death | At Annuitization / Accumulation(1) | In the Event of Death | At Annuitization / Accumulation(1) | ||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||
Annuity Contracts | |||||||||||||||||||||||
Return of net deposits | |||||||||||||||||||||||
Account value | $ | $ | $ | $ | |||||||||||||||||||
Net amount at risk | $ | $ | $ | $ | |||||||||||||||||||
Average attained age of contractholders | |||||||||||||||||||||||
Minimum return or contract value | |||||||||||||||||||||||
Account value | $ | $ | $ | $ | |||||||||||||||||||
Net amount at risk | $ | $ | $ | $ | |||||||||||||||||||
Average attained age of contractholders | |||||||||||||||||||||||
Average period remaining until earliest expected annuitization | N/A | N/A |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
In the Event of Death | |||||||||||
($ in millions) | |||||||||||
Variable Life, Variable Universal Life and Universal Life Contracts | |||||||||||
Separate account value | $ | $ | |||||||||
General account value | $ | $ | |||||||||
Net amount at risk | $ | $ | |||||||||
Average attained age of contractholders |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Equity funds | $ | $ | |||||||||
Bond funds | |||||||||||
Money market funds | |||||||||||
Total | $ | $ |
GMDB | GMIB | GMAB/GMWB/GMIWB | |||||||||||||||||||||
Variable Life, Variable Universal Life and Universal Life | Annuity | Annuity | Annuity | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Balance at December 31, 2019 | $ | $ | $ | $ | |||||||||||||||||||
Incurred guarantee benefits(1) | |||||||||||||||||||||||
Paid guarantee benefits | ( | ( | ( | ||||||||||||||||||||
Change in unrealized investment gains and losses | ( | ||||||||||||||||||||||
Other(2)(3) | ( | ( | ( | ||||||||||||||||||||
Balance at December 31, 2020 | |||||||||||||||||||||||
Incurred guarantee benefits(1) | ( | ( | |||||||||||||||||||||
Paid guarantee benefits | ( | ( | |||||||||||||||||||||
Change in unrealized investment gains and losses | ( | ( | ( | ||||||||||||||||||||
Reclassified to “Liabilities held-for-sale”(4) | ( | ( | ( | ||||||||||||||||||||
Other(2)(5) | ( | ( | ( | ||||||||||||||||||||
Balance at December 31, 2021 | |||||||||||||||||||||||
Incurred guarantee benefits(1) | ( | ( | |||||||||||||||||||||
Paid guarantee benefits | ( | ( | ( | ||||||||||||||||||||
Change in unrealized investment gains and losses | ( | ( | ( | ||||||||||||||||||||
Other(2)(4) | ( | ( | |||||||||||||||||||||
Balance at December 31, 2022 | $ | $ | $ | $ |
Sales Inducements | |||||
(in millions) | |||||
Balance at December 31, 2019 | $ | ||||
Capitalization | |||||
Amortization—Impact of assumption and experience unlocking and true-ups | |||||
Amortization—All other | ( | ||||
Change in unrealized investment gains and losses | ( | ||||
Balance at December 31, 2020 | |||||
Capitalization | |||||
Amortization—Impact of assumption and experience unlocking and true-ups | |||||
Amortization—All other | ( | ||||
Change in unrealized investment gains and losses | |||||
Reclassified to “Assets held-for-sale”(1) | ( | ||||
Other(2) | ( | ||||
Balance at December 31, 2021 | |||||
Capitalization | |||||
Amortization—Impact of assumption and experience unlocking and true-ups | ( | ||||
Amortization—All other | ( | ||||
Change in unrealized investment gains and losses | |||||
Other(1) | |||||
Balance at December 31, 2022 | $ |
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Direct premiums | $ | $ | $ | ||||||||||||||
Reinsurance assumed | |||||||||||||||||
Reinsurance ceded | ( | ( | ( | ||||||||||||||
Premiums | $ | $ | $ | ||||||||||||||
Direct policy charges and fee income | $ | $ | $ | ||||||||||||||
Reinsurance assumed | |||||||||||||||||
Reinsurance ceded | ( | ( | ( | ||||||||||||||
Policy charges and fee income | $ | $ | $ | ||||||||||||||
Direct policyholders’ benefits | $ | $ | $ | ||||||||||||||
Reinsurance assumed | |||||||||||||||||
Reinsurance ceded | ( | ( | ( | ||||||||||||||
Policyholders’ benefits | $ | $ | $ |
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Individual and group annuities(1) | $ | $ | |||||||||
Life insurance(2) | |||||||||||
Other reinsurance | |||||||||||
Total reinsurance recoverables(3)(4) | $ | $ |
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Closed Block liabilities | |||||||||||
Future policy benefits | $ | $ | |||||||||
Policyholders’ dividends payable | |||||||||||
Policyholders’ dividend obligation | |||||||||||
Policyholders’ account balances | |||||||||||
Other Closed Block liabilities | |||||||||||
Total Closed Block liabilities | |||||||||||
Closed Block assets | |||||||||||
Fixed maturities, available-for-sale, at fair value | |||||||||||
Fixed maturities, trading, at fair value | |||||||||||
Equity securities, at fair value | |||||||||||
Commercial mortgage and other loans | |||||||||||
Policy loans | |||||||||||
Other invested assets | |||||||||||
Short-term investments | |||||||||||
Total investments | |||||||||||
Cash and cash equivalents | |||||||||||
Accrued investment income | |||||||||||
Other Closed Block assets | |||||||||||
Total Closed Block assets | |||||||||||
Excess of reported Closed Block liabilities over Closed Block assets | |||||||||||
Portion of above representing accumulated other comprehensive income (loss): | |||||||||||
Net unrealized investment gains (losses) | ( | ||||||||||
Allocated to policyholder dividend obligation | ( | ||||||||||
Future earnings to be recognized from Closed Block assets and Closed Block liabilities | $ | $ |
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Balance, January 1 | $ | $ | |||||||||
Impact from earnings allocable to policyholder dividend obligation | ( | ||||||||||
Change in net unrealized investment gains (losses) allocated to policyholder dividend obligation | ( | ( | |||||||||
Balance, December 31 | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Revenues | |||||||||||||||||
Premiums | $ | $ | $ | ||||||||||||||
Net investment income | |||||||||||||||||
Realized investment gains (losses), net | ( | ||||||||||||||||
Other income (loss) | ( | ||||||||||||||||
Total Closed Block revenues | |||||||||||||||||
Benefits and Expenses | |||||||||||||||||
Policyholders’ benefits | |||||||||||||||||
Interest credited to policyholders’ account balances | |||||||||||||||||
Dividends to policyholders | |||||||||||||||||
General and administrative expenses | |||||||||||||||||
Total Closed Block benefits and expenses | |||||||||||||||||
Closed Block revenues, net of Closed Block benefits and expenses, before income taxes | ( | ||||||||||||||||
Income tax expense (benefit) | ( | ( | |||||||||||||||
Closed Block revenues, net of Closed Block benefits and expenses and income taxes | $ | $ | $ |
Year Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Current tax expense (benefit): | ||||||||||||||||||||
U.S. | $ | $ | $ | ( | ||||||||||||||||
State and local | ||||||||||||||||||||
Foreign | ||||||||||||||||||||
Total current tax expense (benefit) | ||||||||||||||||||||
Deferred tax expense (benefit): | ||||||||||||||||||||
U.S. | ( | ( | ||||||||||||||||||
State and local | ( | |||||||||||||||||||
Foreign | ( | ( | ( | |||||||||||||||||
Total deferred tax expense (benefit) | ( | ( | ( | |||||||||||||||||
Total income tax expense (benefit) on income (loss) before equity in earnings of operating joint ventures | ( | ( | ||||||||||||||||||
Income tax expense (benefit) on equity in earnings of operating joint ventures | ||||||||||||||||||||
Income tax expense (benefit) on discontinued operations | ||||||||||||||||||||
Income tax expense (benefit) reported in equity related to: | ||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | ||||||||||||||||||
Total income taxes | $ | ( | $ | ( | $ |
Year Ended December 31, | ||||||||||||||||||||
2022 | 2021(1) | 2020(1) | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Expected federal income tax expense (benefit) | $ | ( | $ | $ | ( | |||||||||||||||
Non-taxable investment income | ( | ( | ( | |||||||||||||||||
Foreign taxes at other than U.S. rate | ||||||||||||||||||||
Low-income housing and other tax credits | ( | ( | ( | |||||||||||||||||
Changes in tax law | ( | ( | ||||||||||||||||||
GILTI | ( | ( | ||||||||||||||||||
Sale of subsidiary | ( | |||||||||||||||||||
Non-controlling interest | ( | ( | ||||||||||||||||||
Non-deductible expenses | ||||||||||||||||||||
Change in valuation allowance | ||||||||||||||||||||
State taxes | ||||||||||||||||||||
Other | ( | ( | ||||||||||||||||||
Reported income tax expense (benefit) | $ | ( | $ | $ | ( | |||||||||||||||
Effective tax rate | % | % | % |
As of December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Deferred tax assets: | ||||||||||||||
Insurance reserves | $ | $ | ||||||||||||
Net unrealized investment losses | ||||||||||||||
Policyholders’ dividends | ||||||||||||||
Net operating and capital loss carryforwards | ||||||||||||||
Employee benefits | ||||||||||||||
Investments | ||||||||||||||
Goodwill and other intangibles | ||||||||||||||
Deferred tax assets before valuation allowance | ||||||||||||||
Valuation allowance | ( | ( | ||||||||||||
Deferred tax assets after valuation allowance | ||||||||||||||
Deferred tax liabilities: | ||||||||||||||
Insurance reserves | ||||||||||||||
Net unrealized investment gains | ||||||||||||||
Deferred policy acquisition costs | ||||||||||||||
Value of business acquired | ||||||||||||||
Other | ||||||||||||||
Deferred tax liabilities | ||||||||||||||
Net deferred tax asset (liability) | $ | $ | ( |
Federal | State | Foreign Operations | Total | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Balance at January 1, 2020 | $ | $ | $ | $ | ||||||||||||||||||||||
Charged to costs and expenses | ||||||||||||||||||||||||||
Other adjustments | ( | ( | ||||||||||||||||||||||||
Balance at December 31, 2020 | ||||||||||||||||||||||||||
Charged to costs and expenses | ( | |||||||||||||||||||||||||
Other adjustments | ( | ( | ( | |||||||||||||||||||||||
Balance at December 31, 2021 | ||||||||||||||||||||||||||
Charged to costs and expenses | ||||||||||||||||||||||||||
Other adjustments | ( | ( | ( | |||||||||||||||||||||||
Balance at December 31, 2022 | $ | $ | $ | $ |
As of December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Federal net operating and capital loss carryforwards | $ | $ | ||||||||||||
State net operating and capital loss carryforwards(1) | $ | $ | ||||||||||||
Foreign net operating and capital loss carryforwards(2) | $ | $ | ||||||||||||
Federal foreign tax credit carryforwards(3) | $ | $ | ||||||||||||
General business credits | $ | $ | ||||||||||||
Unremitted earnings are indefinitely reinvested | Unremitted earnings are not indefinitely reinvested | ||||
Insurance operations in Chile and China and non-insurance operations in Korea and certain operations in Italy, France and Luxembourg | Insurance operations in Argentina, India, Indonesia, Ghana, Kenya and South Africa, and non-insurance operations in China, India, Taiwan and certain Germany and Luxembourg entities. |
At December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Undistributed earnings of foreign subsidiaries (assuming indefinite reinvestment only for Withholding or other non-U.S. Taxes) | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Balance at January 1, | $ | $ | $ | |||||||||||||||||
Increases in unrecognized tax benefits—prior years | ||||||||||||||||||||
(Decreases) in unrecognized tax benefits—prior years | ( | ( | ( | |||||||||||||||||
Increases in unrecognized tax benefits—current year | ||||||||||||||||||||
(Decreases) in unrecognized tax benefits—current year | ( | |||||||||||||||||||
Settlements with taxing authorities | ||||||||||||||||||||
Balance at December 31, | $ | $ | $ | |||||||||||||||||
Unrecognized tax benefits that, if recognized, would favorably impact the effective rate | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Interest and penalties recognized in the Consolidated Statements of Operations | $ | $ | $ |
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Interest and penalties recognized in liabilities in the Consolidated Statements of Financial Position | $ | $ |
Major Tax Jurisdiction | Open Tax Years | |||||||
United States | 2014-2022 | |||||||
Japan | Fiscal years ended March 31, 2018-2022 | |||||||
Korea | 2017-2020 |
2022 | 2021 | ||||||||||
($ in millions) | |||||||||||
Commercial paper: | |||||||||||
Prudential Financial | $ | $ | |||||||||
Prudential Funding, LLC | |||||||||||
Subtotal commercial paper | |||||||||||
Current portion of long-term debt: | |||||||||||
Senior Notes | |||||||||||
Mortgage Debt | |||||||||||
Surplus Notes subject to set-off arrangements(1) | |||||||||||
Subtotal Current portion of long-term debt | |||||||||||
Other(2) | |||||||||||
Subtotal | |||||||||||
Less: Assets under set-off arrangements(1) | |||||||||||
Total short-term debt(3) | $ | $ | |||||||||
Supplemental short-term debt information: | |||||||||||
Portion of commercial paper borrowings due overnight | $ | $ | |||||||||
Daily average commercial paper outstanding for the quarter ended | $ | $ | |||||||||
Weighted average maturity of outstanding commercial paper, in days | |||||||||||
Weighted average interest rate on outstanding commercial paper | % | % |
Borrower | Original Term | Expiration Date | Capacity | Amount Outstanding | |||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Prudential Financial and Prudential Funding | Jul 2026 | $ | $ | ||||||||||||||||||||
Prudential Holdings of Japan, Inc. | Sep 2024 | ¥ | ¥ |
Maturity Dates | Rate(1) | December 31, | |||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||
Fixed-rate notes: | |||||||||||||||||||||||
Surplus notes | 2025 | $ | $ | ||||||||||||||||||||
Surplus notes subject to set-off arrangements | 2024-2038 | ||||||||||||||||||||||
Senior notes | 2026-2051 | ||||||||||||||||||||||
Mortgage debt | 2027 | ||||||||||||||||||||||
Floating-rate notes: | |||||||||||||||||||||||
Line of Credit | 2025 | ||||||||||||||||||||||
Surplus notes subject to set-off arrangements | 2024-2037 | ||||||||||||||||||||||
Mortgage debt(2) | 2029 | ||||||||||||||||||||||
Junior subordinated notes(3) | 2043-2062 | ||||||||||||||||||||||
Subtotal | |||||||||||||||||||||||
Less: assets under set-off arrangements(4) | |||||||||||||||||||||||
Total long-term debt(5) | $ | $ |
Calendar Year | |||||||||||||||||||||||||||||||||||
2024 | 2025 | 2026 | 2027 | 2028 and thereafter | Total | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Long-term debt | $ | $ | $ | $ | $ | $ |
Facility Name | Maturity Date Range | 2022 Amount Outstanding | 2021 Amount Outstanding | |||||||||||||||||
($ in millions) | ||||||||||||||||||||
Medium-Term Notes | 2023-2051 | $ | $ | |||||||||||||||||
Senior Notes | 2047-2049 | |||||||||||||||||||
InterNotes® Retail Notes | 2029-2045 | |||||||||||||||||||
Mortgage Debt(1) | 2023-2029 | |||||||||||||||||||
Total | $ | $ | ||||||||||||||||||
Agreement Start Date | Maturity Years | Maximum Borrowing Capacity | 2022 Amount Outstanding | 2021 Amount Outstanding | ||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||||
Regulation XXX | ||||||||||||||||||||||||||
2013-2021(1)(2) | 2023-2036 | $ | $ | $ | ||||||||||||||||||||||
2014-2017 | 2024-2037 | |||||||||||||||||||||||||
2018 | 2038 | |||||||||||||||||||||||||
Guideline AXXX | ||||||||||||||||||||||||||
2013(3) | 2033 | |||||||||||||||||||||||||
2017 | 2037 | |||||||||||||||||||||||||
2020 | 2032 | |||||||||||||||||||||||||
Other Notes | ||||||||||||||||||||||||||
2019 | 2029 | |||||||||||||||||||||||||
Total | $ | $ | $ |
Issue Date | Principal Amount | Initial Interest Rate | Investor Type | Optional Redemption Date | Interest Rate Subsequent to Optional Redemption Date | Maturity Date | |||||||||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||||||||||||||
Nov-12 | $ | % | Institutional | 6/15/2023 | LIBOR + | 6/15/2043 | |||||||||||||||||||||||||||||
Mar-13 | $ | % | Institutional | 3/15/2024 | LIBOR + | 3/15/2044 | |||||||||||||||||||||||||||||
May-15 | $ | % | Institutional | 5/15/2025 | LIBOR + | 5/15/2045 | |||||||||||||||||||||||||||||
Sep-17 | $ | % | Institutional | 9/15/2027 | LIBOR + | 9/15/2047 | |||||||||||||||||||||||||||||
Aug-18 | $ | % | Retail | 8/15/2023 | 8/13/2058 | ||||||||||||||||||||||||||||||
Sep-18 | $ | % | Institutional | 9/15/2028 | LIBOR + | 9/15/2048 | |||||||||||||||||||||||||||||
Aug-20 | $ | % | Retail | 9/1/2025 | 9/1/2060 | ||||||||||||||||||||||||||||||
Aug-20 | $ | % | Institutional | 10/1/2030 | US Treasury + | 10/1/2050 | |||||||||||||||||||||||||||||
Feb-22 | $ | % | Institutional | 2/28/2032 | US Treasury + | 3/1/2052 | |||||||||||||||||||||||||||||
Aug-22 | $ | % | Institutional | 9/1/2032 | US Treasury + | 9/1/2052 | |||||||||||||||||||||||||||||
Aug-22 | $ | % | Retail | 9/1/2027 | 9/1/2062 |
Pension Benefits | Other Postretirement Benefits | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Change in benefit obligation | ||||||||||||||||||||||||||
Benefit obligation at the beginning of period | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Service cost | ( | ( | ( | ( | ||||||||||||||||||||||
Interest cost | ( | ( | ( | ( | ||||||||||||||||||||||
Plan participants’ contributions | ( | ( | ||||||||||||||||||||||||
Medicare Part D subsidy receipts | ( | ( | ||||||||||||||||||||||||
Amendments | ( | |||||||||||||||||||||||||
Curtailments | ||||||||||||||||||||||||||
Actuarial gains (losses), net(1) | ||||||||||||||||||||||||||
Settlements | ||||||||||||||||||||||||||
Special termination benefits | ( | ( | ( | |||||||||||||||||||||||
Benefits paid | ||||||||||||||||||||||||||
Acquisition/Divestiture | ||||||||||||||||||||||||||
Foreign currency changes and other | ||||||||||||||||||||||||||
Benefit obligation at end of period | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Change in plan assets | ||||||||||||||||||||||||||
Plan assets at beginning of period | $ | $ | $ | $ | ||||||||||||||||||||||
Actual return on plan assets | ( | ( | ||||||||||||||||||||||||
Employer contributions | ||||||||||||||||||||||||||
Plan participants’ contributions | ||||||||||||||||||||||||||
Disbursement for settlements | ( | ( | ||||||||||||||||||||||||
Benefits paid | ( | ( | ( | ( | ||||||||||||||||||||||
Acquisition/Divestiture | ( | |||||||||||||||||||||||||
Foreign currency changes and other | ( | ( | ||||||||||||||||||||||||
Plan assets at end of period | $ | $ | $ | $ | ||||||||||||||||||||||
Funded status at end of period | $ | $ | $ | ( | $ | ( | ||||||||||||||||||||
Amounts recognized in the Statements of Financial Position | ||||||||||||||||||||||||||
Prepaid benefit cost | $ | $ | $ | $ | ||||||||||||||||||||||
Accrued benefit liability | ( | ( | ( | ( | ||||||||||||||||||||||
Net amount recognized | $ | $ | $ | ( | $ | ( | ||||||||||||||||||||
Items recorded in “Accumulated other comprehensive income (loss)” not yet recognized as a component of net periodic (benefit) cost: | ||||||||||||||||||||||||||
Prior service cost | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
Net actuarial loss | ||||||||||||||||||||||||||
Net amount not recognized | $ | $ | $ | $ | ||||||||||||||||||||||
Accumulated benefit obligation | $ | ( | $ | ( | $ | ( | $ | ( |
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Projected benefit obligation | $ | $ | ||||||||||||
Fair value of plan assets | $ | $ |
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Accumulated benefit obligation | $ | $ | ||||||||||||
Fair value of plan assets | $ | $ |
Pension Benefits | Other Postretirement Benefits | |||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2020 | 2022 | 2021 | 2020 | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Service cost | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Interest cost | ||||||||||||||||||||||||||||||||||||||
Expected return on plan assets | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||
Amortization of prior service cost | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Amortization of actuarial (gain) loss, net | ||||||||||||||||||||||||||||||||||||||
Settlements | ||||||||||||||||||||||||||||||||||||||
Curtailments(1) | ( | |||||||||||||||||||||||||||||||||||||
Special termination benefits(2)(3) | ||||||||||||||||||||||||||||||||||||||
Net periodic (benefit) cost | $ | $ | $ | $ | ( | $ | ( | $ |
Pension Benefits | Other Postretirement Benefits | |||||||||||||||||||||||||
Prior Service Cost | Net Actuarial (Gain) Loss | Prior Service Cost | Net Actuarial (Gain) Loss | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Balance, December 31, 2019 | $ | ( | $ | $ | $ | |||||||||||||||||||||
Amortization for the period | ( | ( | ( | |||||||||||||||||||||||
Deferrals for the period(1) | ||||||||||||||||||||||||||
Impact of foreign currency changes and other | ( | ( | ||||||||||||||||||||||||
Balance, December 31, 2020 | ( | |||||||||||||||||||||||||
Amortization for the period | ( | ( | ( | |||||||||||||||||||||||
Deferrals for the period(2) | ( | ( | ( | |||||||||||||||||||||||
Impact of foreign currency changes and other | ( | ( | ||||||||||||||||||||||||
Balance, December 31, 2021 | ( | ( | ||||||||||||||||||||||||
Amortization for the period | ( | ( | ||||||||||||||||||||||||
Deferrals for the period(3) | ( | |||||||||||||||||||||||||
Impact of foreign currency changes and other | ( | ( | ||||||||||||||||||||||||
Balance, December 31, 2022 | $ | ( | $ | $ | ( | $ |
Pension Benefits | Other Postretirement Benefits | |||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2020 | 2022 | 2021 | 2020 | |||||||||||||||||||||||||||||||||
Weighted average assumptions | ||||||||||||||||||||||||||||||||||||||
Discount rate (beginning of period) | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||
Discount rate (end of period) | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||
Rate of increase in compensation levels (beginning of period) | % | % | % | N/A | N/A | N/A | ||||||||||||||||||||||||||||||||
Rate of increase in compensation levels (end of period) | % | % | % | N/A | N/A | N/A | ||||||||||||||||||||||||||||||||
Expected return on plan assets (beginning of period) | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||
Interest crediting rate (beginning of period) | % | % | % | N/A | N/A | N/A | ||||||||||||||||||||||||||||||||
Interest crediting rate (end of period) | % | % | % | N/A | N/A | N/A | ||||||||||||||||||||||||||||||||
Health care cost trend rates (beginning of period) | N/A | N/A | N/A | % | % | % | ||||||||||||||||||||||||||||||||
Health care cost trend rates (end of period) | N/A | N/A | N/A | % | % | % | ||||||||||||||||||||||||||||||||
For 2022, 2021 and 2020, the ultimate health care cost trend rate after gradual decrease until: 2028, 2028, 2028, (beginning of period) | N/A | N/A | N/A | % | % | % | ||||||||||||||||||||||||||||||||
For 2022, 2021 and 2020, the ultimate health care cost trend rate after gradual decrease until: 2030, 2028, 2028 (end of period) | N/A | N/A | N/A | % | % | % |
Pension | Postretirement | |||||||||||||||||||||||||
Minimum | Maximum | Minimum | Maximum | |||||||||||||||||||||||
Asset Category | ||||||||||||||||||||||||||
U.S. Equities | % | % | % | % | ||||||||||||||||||||||
International Equities | % | % | % | % | ||||||||||||||||||||||
Fixed Maturities | % | % | % | % | ||||||||||||||||||||||
Short-term Investments | % | % | % | % | ||||||||||||||||||||||
Real Estate | % | % | % | % | ||||||||||||||||||||||
Other | % | % | % | % |
As of December 31, 2022 | As of December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. government securities (federal) | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
U.S. government securities (state & other) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Non-U.S. government securities | ||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate Debt: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate bonds | ||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Collateralized mortgage obligations | ||||||||||||||||||||||||||||||||||||||||||||||||||
Collateralized loan obligations | ||||||||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps(1) | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Registered investment companies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other(2) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal fixed maturities | ||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Partnerships | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Partnerships | ||||||||||||||||||||||||||||||||||||||||||||||||||
Hedge funds | ||||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal other | ||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets in the fair value hierarchy | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Investments Measured at Net Asset Value, as a Practical Expedient(3): | ||||||||||||||||||||||||||||||||||||||||||||||||||
Pooled separate accounts | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||
Common/collective trusts | ||||||||||||||||||||||||||||||||||||||||||||||||||
United Kingdom insurance pooled funds | ||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets at fair value | $ | $ |
Fixed Maturities | Real Estate | Other | ||||||||||||||||||||||||
Other | Partnerships | Partnerships | Hedge Fund | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Fair Value, January 1, 2021 | $ | $ | $ | $ | ||||||||||||||||||||||
Actual Return on Assets: | ||||||||||||||||||||||||||
Relating to assets still held at the reporting date | ||||||||||||||||||||||||||
Relating to assets sold during the period | ||||||||||||||||||||||||||
Purchases, sales and settlements | ( | ( | ||||||||||||||||||||||||
Transfers in and/or out of Level 3 | ||||||||||||||||||||||||||
Fair Value, December 31, 2021 | $ | $ | $ | $ | ||||||||||||||||||||||
Actual Return on Assets: | ||||||||||||||||||||||||||
Relating to assets still held at the reporting date | ( | |||||||||||||||||||||||||
Relating to assets sold during the period | ||||||||||||||||||||||||||
Purchases, sales and settlements | ( | |||||||||||||||||||||||||
Transfers in and/or out of Level 3 | ||||||||||||||||||||||||||
Fair Value, December 31, 2022 | $ | $ | $ | $ |
As of December 31, 2022 | As of December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3(3) | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Equities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. equities(1) | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
International equities | ||||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal equities | ||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Equities(1) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Subtotal fixed maturities | ||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term Investments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Registered investment companies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets in the fair value hierarchy | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Investments Measured at Net Asset Value, as a Practical Expedient(2): | ||||||||||||||||||||||||||||||||||||||||||||||||||
Common/collective trusts | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||
Net assets at fair value | ||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Life Insurance Policies at contract value | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total net assets | $ | $ |
Pension Benefit Payments | Other Postretirement Benefit Payments | |||||||||||||
(in millions) | ||||||||||||||
2023 | $ | $ | ||||||||||||
2024 | ||||||||||||||
2025 | ||||||||||||||
2026 | ||||||||||||||
2027 | ||||||||||||||
2028-2032 | ||||||||||||||
Total | $ | $ |
Common Stock | ||||||||||||||||||||
Issued | Held In Treasury | Outstanding | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Balance, December 31, 2019 | ||||||||||||||||||||
Common Stock issued | ||||||||||||||||||||
Common Stock acquired | ( | |||||||||||||||||||
Stock-based compensation programs(1) | ( | |||||||||||||||||||
Balance, December 31, 2020 | ||||||||||||||||||||
Common Stock issued | ||||||||||||||||||||
Common Stock acquired | ( | |||||||||||||||||||
Stock-based compensation programs(1) | ( | |||||||||||||||||||
Balance, December 31, 2021 | ||||||||||||||||||||
Common Stock issued | ||||||||||||||||||||
Common Stock acquired | ( | |||||||||||||||||||
Stock-based compensation programs(1) | ( | |||||||||||||||||||
Balance, December 31, 2022 |
January 1, 2023 - December 31, 2023 | January 1, 2022 - December 31, 2022 | January 1, 2021 - December 31, 2021 | January 1, 2020 - December 31, 2020(1) | |||||||||||||||||||||||
Total Board authorized share repurchase amount ($ in billions) | $ | $ | $ | $ | ||||||||||||||||||||||
Total number of shares repurchased under this authorization as of the period end (in millions) | N/A* |
Accumulated Other Comprehensive Income (Loss) Attributable to Prudential Financial, Inc. | |||||||||||||||||||||||
Foreign Currency Translation Adjustment | Net Unrealized Investment Gains (Losses)(1) | Pension and Postretirement Unrecognized Net Periodic Benefit (Cost) | Total Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Balance, December 31, 2019 | $ | ( | $ | $ | ( | $ | |||||||||||||||||
Change in OCI before reclassifications | ( | ||||||||||||||||||||||
Amounts reclassified from AOCI | ( | ( | |||||||||||||||||||||
Income tax benefit (expense) | ( | ( | ( | ||||||||||||||||||||
Balance, December 31, 2020 | ( | ||||||||||||||||||||||
Change in OCI before reclassifications | ( | ( | ( | ||||||||||||||||||||
Amounts reclassified from AOCI | ( | ( | ( | ||||||||||||||||||||
Income tax benefit (expense) | ( | ( | |||||||||||||||||||||
Balance, December 31, 2021 | ( | ( | |||||||||||||||||||||
Change in OCI before reclassifications | ( | ( | ( | ||||||||||||||||||||
Amounts reclassified from AOCI | |||||||||||||||||||||||
Income tax benefit (expense) | ( | ( | |||||||||||||||||||||
Balance, December 31, 2022 | $ | ( | $ | ( | $ | ( | $ | ( |
Years Ended December 31, | Affected line item in Consolidated Statements of Operations | ||||||||||||||||||||||
2022 | 2021 | 2020 | |||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Amounts reclassified from AOCI(1)(2): | |||||||||||||||||||||||
Foreign currency translation adjustment: | |||||||||||||||||||||||
Foreign currency translation adjustment | $ | ( | $ | $ | Realized investment gains (losses), net | ||||||||||||||||||
Foreign currency translation adjustment | ( | Other income (loss) | |||||||||||||||||||||
Total foreign currency translation adjustment | ( | ( | |||||||||||||||||||||
Net unrealized investment gains (losses): | |||||||||||||||||||||||
Cash flow hedges—Interest Rate | ( | (3) | |||||||||||||||||||||
Cash flow hedges—Currency | ( | (3) | |||||||||||||||||||||
Cash flow hedges—Currency/Interest rate | (3) | ||||||||||||||||||||||
Fair value hedges—Currency | ( | ( | ( | (3) | |||||||||||||||||||
Net unrealized investment gains (losses) on available-for-sale securities | ( | Realized investment gains (losses), net | |||||||||||||||||||||
Total net unrealized investment gains (losses) | ( | (4) | |||||||||||||||||||||
Amortization of defined benefit items: | |||||||||||||||||||||||
Prior service cost | ( | ( | (5) | ||||||||||||||||||||
( | ( | ( | (5) | ||||||||||||||||||||
Total amortization of defined benefit items | ( | ( | ( | ||||||||||||||||||||
Total reclassifications for the period | $ | ( | $ | $ |
Net Unrealized Gains (Losses) on Available-for-Sale Fixed Maturity Securities on which an OTTI Loss has been Recognized | Net Unrealized Gains (Losses) on Available-for-Sale Fixed Maturity Securities on which an Allowance for Credit Losses has been Recorded | Net Unrealized Gains (Losses) on All Other Investments(1) | DAC, DSI, VOBA and Reinsurance Recoverables | Future Policy Benefits, Policyholders’ Account Balances and Reinsurance Payables | Policyholders’ Dividends | Income Tax Benefit (Expense) | Accumulated Other Comprehensive Income (Loss) Related to Net Unrealized Investment Gains (Losses) | ||||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2019 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||||
Reclassification to all other due to implementation of ASU 2016-13(2) | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Net investment gains (losses) on investments arising during the period | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Reclassification adjustment for (gains) losses included in net income | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Reclassification adjustment for OTTI losses excluded from net income | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Impact of net unrealized investment (gains) losses | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2020 | $ | $ | ( | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||||
Net investment gains (losses) on investments arising during the period | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Reclassification adjustment for (gains) losses included in net income | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
Reclassification due to allowance for credit losses recorded during the period | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Impact of net unrealized investment (gains) losses | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2021 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||||
Net investment gains (losses) on investments arising during the period | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Reclassification adjustment for (gains) losses included in net income | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Reclassification due to allowance for credit losses recorded during the period | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Impact of net unrealized investment (gains) losses | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2022 | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | ( |
PICA | ||||||||||||||||||||
In millions and presented as of or for the year ended | December 31, 2022 | December 31, 2021 | December 31, 2020 | |||||||||||||||||
Statutory net income (loss)(1) | $ | $ | $ | |||||||||||||||||
Statutory capital and surplus(1) | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income | Weighted Average Shares | Per Share Amount | Income | Weighted Average Shares | Per Share Amount | Income | Weighted Average Shares | Per Share Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
(in millions, except per share amounts) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic earnings per share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Less: Income (loss) attributable to noncontrolling interests | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $ | ( | $ | ( | $ | $ | $ | ( | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Effect of dilutive securities and compensation programs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred and long-term compensation programs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted earnings per share(1) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Prudential Financial available to holders of Common Stock | $ | ( | $ | ( | $ | $ | $ | ( | $ | ( |
2022 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||
Shares | Exercise Price Per Share | Shares | Exercise Price Per Share | Shares | Exercise Price Per Share | |||||||||||||||||||||||||||||||||
(in millions, except per share amounts, based on weighted average) | ||||||||||||||||||||||||||||||||||||||
Antidilutive stock options based on application of the treasury stock method | $ | $ | $ | |||||||||||||||||||||||||||||||||||
Antidilutive stock options due to net loss available to holders of Common Stock | ||||||||||||||||||||||||||||||||||||||
Antidilutive shares based on application of the treasury stock method | ||||||||||||||||||||||||||||||||||||||
Antidilutive shares due to net loss available to holders of Common Stock | ||||||||||||||||||||||||||||||||||||||
Total antidilutive stock options and shares |
2022 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||
Omnibus Incentive Plan: | Total Compensation Cost Recognized (1) | Income Tax Benefit | Total Compensation Cost Recognized (1) | Income Tax Benefit | Total Compensation Cost Recognized (1) | Income Tax Benefit | ||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Employee stock options | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Employee restricted stock units | ||||||||||||||||||||||||||||||||||||||
Employee performance shares and performance units | ||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||
Assurance IQ Acquisition: | Total Compensation Cost Recognized | Income Tax Benefit | Total Compensation Cost Recognized | Income Tax Benefit | Total Compensation Cost Recognized | Income Tax Benefit | ||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||
Employee stock options | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Employee restricted stock units | ||||||||||||||||||||||||||||||||||||||
Employee performance shares | ||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
Employee Stock Options | ||||||||||||||||||||||||||
Omnibus Incentive Plan | Assurance IQ Acquisition | |||||||||||||||||||||||||
Shares | Weighted Average Exercise Price | Shares | Weighted Average Exercise Price | |||||||||||||||||||||||
Outstanding at December 31, 2021 | $ | $ | ||||||||||||||||||||||||
Granted | ||||||||||||||||||||||||||
Exercised | ( | ( | ||||||||||||||||||||||||
Forfeited | ( | ( | ||||||||||||||||||||||||
Expired | ( | ( | ||||||||||||||||||||||||
Outstanding at December 31, 2022 | $ | $ | ||||||||||||||||||||||||
Exercisable at December 31, 2022 | $ | $ |
Employee Stock Options | ||||||||||||||||||||||||||
Omnibus Incentive Plan | Assurance IQ Acquisition | |||||||||||||||||||||||||
Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | |||||||||||||||||||||||
(in years) | (in millions) | (in years) | (in millions) | |||||||||||||||||||||||
Outstanding | $ | $ | ||||||||||||||||||||||||
Exercisable | $ | $ |
Restricted Stock Units | Weighted Average Grant Date Fair Value | Performance Share and Performance Unit Awards(1) | Weighted Average Grant Date Fair Value | |||||||||||||||||||||||
Restricted at December 31, 2021 | $ | $ | ||||||||||||||||||||||||
Granted | ||||||||||||||||||||||||||
Forfeited | ( | ( | ||||||||||||||||||||||||
Performance adjustment (2) | ( | |||||||||||||||||||||||||
Released | ( | ( | ||||||||||||||||||||||||
Restricted at December 31, 2022 | $ | $ |
Restricted Stock Units | Weighted Average Grant Date Fair Value | Performance Share Awards(1) | Weighted Average Grant Date Fair Value | |||||||||||||||||||||||
Restricted at December 31, 2021 | $ | $ | ||||||||||||||||||||||||
Granted | ||||||||||||||||||||||||||
Forfeited | ( | ( | ||||||||||||||||||||||||
Performance adjustment(2) | ( | |||||||||||||||||||||||||
Released | ( | |||||||||||||||||||||||||
Restricted at December 31, 2022 | $ | $ |
Year Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Net gains (losses) from(1): | ||||||||||||||||||||
Terminated hedges of foreign currency earnings | $ | $ | $ | |||||||||||||||||
Current period yield adjustments | $ | $ | $ | |||||||||||||||||
Principal source of earnings | $ | $ | $ |
Year Ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Net gains (losses) from: | ||||||||||||||||||||
Investments carried at fair value through net income | $ | ( | $ | ( | $ | |||||||||||||||
Foreign currency exchange movements | $ | $ | $ | ( | ||||||||||||||||
Other activities | $ | ( | $ | ( | $ | ( |
Year ended December 31, | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Adjusted operating income before income taxes by segment: | ||||||||||||||||||||
PGIM | $ | $ | $ | |||||||||||||||||
U.S. Businesses: | ||||||||||||||||||||
Institutional Retirement Strategies | ||||||||||||||||||||
Individual Retirement Strategies | ||||||||||||||||||||
Retirement Strategies(1) | ||||||||||||||||||||
Group Insurance | ( | ( | ( | |||||||||||||||||
Individual Life | ( | ( | ||||||||||||||||||
Assurance IQ | ( | ( | ( | |||||||||||||||||
Total U.S. Businesses | ||||||||||||||||||||
International Businesses | ||||||||||||||||||||
Corporate and Other | ( | ( | ( | |||||||||||||||||
Total segment adjusted operating income before income taxes | ||||||||||||||||||||
Reconciling Items: | ||||||||||||||||||||
Realized investment gains (losses), net, and related adjustments | ( | ( | ||||||||||||||||||
Charges related to realized investment gains (losses), net | ( | ( | ( | |||||||||||||||||
Market experience updates | ( | |||||||||||||||||||
Divested and Run-off Businesses: | ||||||||||||||||||||
Closed Block division | ( | ( | ||||||||||||||||||
Other Divested and Run-off Businesses | ( | |||||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | ( | ( | ||||||||||||||||||
Other adjustments(2) | ( | ( | ||||||||||||||||||
Consolidated income (loss) before income taxes and equity in earnings of operating joint ventures | $ | ( | $ | $ | ( |
As of December 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
(in millions) | ||||||||||||||
Assets by segment: | ||||||||||||||
PGIM | $ | $ | ||||||||||||
U.S. Businesses: | ||||||||||||||
Institutional Retirement Strategies | ||||||||||||||
Individual Retirement Strategies | ||||||||||||||
Retirement Strategies(1) | ||||||||||||||
Group Insurance | ||||||||||||||
Individual Life | ||||||||||||||
Assurance IQ | ||||||||||||||
Total U.S. Businesses | ||||||||||||||
International Businesses | ||||||||||||||
Corporate and Other(1) | ||||||||||||||
Closed Block division | ||||||||||||||
Total assets per Consolidated Statements of Financial Position | $ | $ |
Year Ended December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues, and benefits and expenses on an adjusted operating income basis by segment | Total Revenues | Net Investment Income | Total Benefits and Expenses | Policyholders’ Benefits | Interest Credited to Policyholders’ Account Balances | Dividends to Policyholders | Interest Expense | Amortization of DAC | ||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
PGIM | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
U.S. Businesses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Retirement Strategies | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Strategies | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Group Insurance | ||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Life | ||||||||||||||||||||||||||||||||||||||||||||||||||
Assurance IQ | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total U.S. Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
International Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate and Other | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Total revenues, and benefits and expenses on an adjusted operating income basis | ||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciling items: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Realized investment gains (losses), net, and related adjustments | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Charges related to realized investment gains (losses), net | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Market experience updates | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Divested and Run-off Businesses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block division | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other Divested and Run-off Businesses | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Other adjustments | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total revenue, and benefits and expenses per Consolidated Statements of Operations | $ | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues, and benefits and expenses on an adjusted operating income basis by segment | Total Revenues | Net Investment Income | Total Benefits and Expenses | Policyholders’ Benefits | Interest Credited to Policyholders’ Account Balances | Dividends to Policyholders | Interest Expense | Amortization of DAC | ||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
PGIM | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
U.S. Businesses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Group Insurance | ||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Life | ||||||||||||||||||||||||||||||||||||||||||||||||||
Assurance IQ | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total U.S. Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
International Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate and Other | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
Total revenues, and benefits and expenses on an adjusted operating income basis | ||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciling items: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Realized investment gains (losses), net, and related adjustments | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Charges related to realized investment gains (losses), net | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Market experience updates | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
Divested and Run-off Businesses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block division | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other Divested and Run-off Businesses | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Other adjustments | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total revenue, and benefits and expenses per Consolidated Statements of Operations | $ | $ | $ | $ | $ | $ | $ | $ |
Year Ended December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues, and benefits and expenses on an adjusted operating income basis by segment | Total Revenues | Net Investment Income | Total Benefits and Expenses | Policyholders’ Benefits | Interest Credited to Policyholders’ Account Balances | Dividends to Policyholders | Interest Expense | Amortization of DAC | ||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
PGIM | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
U.S. Businesses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Strategies | ||||||||||||||||||||||||||||||||||||||||||||||||||
Group Insurance | ||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Life | ||||||||||||||||||||||||||||||||||||||||||||||||||
Assurance IQ | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total U.S. Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
International Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate and Other | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Total revenues, and benefits and expenses on an adjusted operating income basis | ||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciling items: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Realized investment gains (losses), net, and related adjustments | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Charges related to realized investment gains (losses), net | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
Market experience updates | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Divested and Run-off Businesses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block division | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other Divested and Run-off Businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||
Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Other adjustments | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total revenue, and benefits and expenses per Consolidated Statements of Operations | $ | $ | $ | $ | $ | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
United States | $ | $ | $ | |||||||||||||||||
Japan | ||||||||||||||||||||
Other countries | ||||||||||||||||||||
Total PFI consolidated revenue | $ | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
PGIM segment intersegment revenues | $ | $ | $ |
2022 | 2021 | 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
Asset-based management fees | $ | $ | $ | ||||||||||||||
Performance-based incentive fees | |||||||||||||||||
Other fees | |||||||||||||||||
Total asset management and service fees | $ | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Total outstanding mortgage loan commitments(1) | $ | $ | |||||||||
Portion of commitment where prearrangement to sell to investor exists | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Expected to be funded from the general account and other operations outside the separate accounts(1) | $ | $ | |||||||||
Expected to be funded from separate accounts | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Indemnification provided to certain clients for securities lending and securities repurchase transactions(1) | $ | $ | |||||||||
Fair value of related collateral associated with above indemnifications(2) | $ | $ | |||||||||
Accrued liability associated with guarantee | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Guaranteed value of third parties’ assets | $ | $ | |||||||||
Fair value of collateral supporting these assets | $ | $ | |||||||||
Asset (liability) associated with guarantee, carried at fair value | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Maximum exposure under indemnification agreements for mortgage loans serviced by the Company | $ | $ | |||||||||
First-loss exposure portion of above | $ | $ | |||||||||
Accrued liability associated with guarantees(1) | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Other guarantees where amount can be determined | $ | $ | |||||||||
Accrued liability for other guarantees and indemnifications | $ | $ |
December 31, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Other assets: | |||||||||||
Premium tax offset for future undiscounted assessments | $ | $ | |||||||||
Premium tax offset currently available for paid assessments | |||||||||||
Total | $ | $ | |||||||||
Other liabilities: | |||||||||||
Insolvency assessments | $ | $ |
(a) | (b) | (c) | |||||||||||||||||||||
Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted-average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in (a)) | |||||||||||||||||||||
Equity compensation plans approved by security holders—Omnibus Plan | 10,486,543 | (1) | $ | 90.50 | (2) | 14,546,451 | |||||||||||||||||
Equity compensation plans approved by security holders—Director Plan | 236,703 | ||||||||||||||||||||||
Equity compensation plans approved by security holders—PSPP(3) | 6,101,110 | ||||||||||||||||||||||
Total equity compensation plans approved by security holders | 10,723,246 | 20,647,561 | |||||||||||||||||||||
Equity compensation plans not approved by security holders | |||||||||||||||||||||||
Grand Total | 10,723,246 | 20,647,561 |
Page | ||||||||
1. | ||||||||
2. | Financial Statement Schedules: | |||||||
Any remaining schedules provided for in the applicable SEC regulations are omitted because they are either inapplicable or the relevant information is provided elsewhere within this Form 10-K. |
Type of Investment | Amortized Cost or Cost(1) | Fair Value | Amount Shown in the Balance Sheet | |||||||||||||||||
Fixed maturities, available-for-sale: | ||||||||||||||||||||
Bonds: | ||||||||||||||||||||
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | $ | $ | |||||||||||||||||
Obligations of U.S. states and their political subdivisions | ||||||||||||||||||||
Foreign governments | ||||||||||||||||||||
Asset-backed securities | ||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||
Public utilities | ||||||||||||||||||||
All other corporate bonds | ||||||||||||||||||||
Redeemable preferred stock | ||||||||||||||||||||
Total fixed maturities, available-for-sale | $ | $ | $ | |||||||||||||||||
Fixed maturities, held-to-maturity: | ||||||||||||||||||||
Bonds: | ||||||||||||||||||||
Foreign governments | $ | $ | $ | |||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||
All other corporate bonds | ||||||||||||||||||||
Total fixed maturities, held-to-maturity | $ | $ | $ | |||||||||||||||||
Equity securities: | ||||||||||||||||||||
Common stocks: | ||||||||||||||||||||
Other common stocks | $ | $ | $ | |||||||||||||||||
Mutual funds | ||||||||||||||||||||
Nonredeemable preferred stocks | ||||||||||||||||||||
Perpetual preferred stocks | ||||||||||||||||||||
Total equity securities, at fair value | $ | $ | $ | |||||||||||||||||
Fixed maturities, trading | $ | $ | $ | |||||||||||||||||
Assets supporting experience-rated contractholder liabilities | ||||||||||||||||||||
Commercial mortgage and other loans(2) | ||||||||||||||||||||
Policy loans | ||||||||||||||||||||
Short-term investments | ||||||||||||||||||||
Other invested assets | ||||||||||||||||||||
Total investments | $ | $ |
2022 | 2021 | |||||||||||||
ASSETS | ||||||||||||||
Investment contracts from subsidiaries | $ | $ | ||||||||||||
Fixed maturities, available for sale, at fair value (amortized cost: 2022- $ | ||||||||||||||
Equity securities, at fair value (cost: 2022- $ | ||||||||||||||
Other invested assets | ||||||||||||||
Total investments | ||||||||||||||
Cash and cash equivalents | ||||||||||||||
Due from subsidiaries | ||||||||||||||
Loans receivable from subsidiaries | ||||||||||||||
Investment in subsidiaries | ||||||||||||||
Property, plant and equipment | ||||||||||||||
Income taxes receivable | ||||||||||||||
Other assets | ||||||||||||||
TOTAL ASSETS | $ | $ | ||||||||||||
LIABILITIES AND EQUITY | ||||||||||||||
LIABILITIES | ||||||||||||||
Due to subsidiaries | $ | $ | ||||||||||||
Loans payable to subsidiaries | ||||||||||||||
Short-term debt | ||||||||||||||
Long-term debt | ||||||||||||||
Income taxes payable | ||||||||||||||
Other liabilities | ||||||||||||||
Total liabilities | ||||||||||||||
EQUITY | ||||||||||||||
Preferred Stock ($ | ||||||||||||||
Common Stock ($ | ||||||||||||||
Additional paid-in capital | ||||||||||||||
Common Stock held in treasury, at cost ( | ( | ( | ||||||||||||
Accumulated other comprehensive income (loss) | ( | |||||||||||||
Retained earnings | ||||||||||||||
Total equity | ||||||||||||||
TOTAL LIABILITIES AND EQUITY | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
REVENUES | ||||||||||||||||||||
Net investment income | $ | $ | $ | |||||||||||||||||
Realized investment gains (losses), net | ( | |||||||||||||||||||
Affiliated interest revenue | ||||||||||||||||||||
Other income (loss) | ||||||||||||||||||||
Total revenues | ||||||||||||||||||||
EXPENSES | ||||||||||||||||||||
General and administrative expenses | ||||||||||||||||||||
Interest expense | ||||||||||||||||||||
Total expenses | ||||||||||||||||||||
INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF SUBSIDIARIES | ( | ( | ( | |||||||||||||||||
Total income tax expense (benefit) | ( | ( | ( | |||||||||||||||||
INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF SUBSIDIARIES | ( | ( | ( | |||||||||||||||||
Equity in earnings of subsidiaries | ( | |||||||||||||||||||
NET INCOME (LOSS) | $ | ( | $ | $ | ( | |||||||||||||||
Other Comprehensive Income (loss) | ( | ( | ||||||||||||||||||
TOTAL COMPREHENSIVE INCOME (LOSS) | $ | ( | $ | ( | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||||||
Net income (loss) | $ | ( | $ | $ | ( | |||||||||||||||
Adjustments to reconcile net income to cash provided by operating activities: | ||||||||||||||||||||
Equity in earnings of subsidiaries | ( | ( | ||||||||||||||||||
Realized investment (gains) losses, net | ( | ( | ||||||||||||||||||
Dividends received from subsidiaries | ||||||||||||||||||||
Property, plant and equipment | ( | ( | ( | |||||||||||||||||
Change in: | ||||||||||||||||||||
Due to/from subsidiaries, net | ( | |||||||||||||||||||
Other, operating | ||||||||||||||||||||
Cash flows from (used in) operating activities | ||||||||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||||||||||
Proceeds from the sale/maturity of: | ||||||||||||||||||||
Fixed maturities, available-for-sale | ||||||||||||||||||||
Short-term investments | ||||||||||||||||||||
Payments for the purchase of: | ||||||||||||||||||||
Fixed maturities, available for sale | ( | ( | ( | |||||||||||||||||
Short-term investments | ( | ( | ( | |||||||||||||||||
Capital contributions to subsidiaries | ( | ( | ( | |||||||||||||||||
Returns of capital contributions from subsidiaries | ||||||||||||||||||||
Loans to subsidiaries, net of maturities | ( | ( | ||||||||||||||||||
Other, investing | ||||||||||||||||||||
Cash flows from (used in) investing activities | ( | ( | ||||||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||||||
Cash dividends paid on Common Stock | ( | ( | ( | |||||||||||||||||
Common Stock acquired | ( | ( | ( | |||||||||||||||||
Common Stock reissued for exercise of stock options | ||||||||||||||||||||
Proceeds from the issuance of debt (maturities longer than 90 days) | ||||||||||||||||||||
Repayments of debt (maturities longer than 90 days) | ( | ( | ( | |||||||||||||||||
Repayments of loans from subsidiaries | ( | ( | ||||||||||||||||||
Proceeds from loans payable to subsidiaries | ||||||||||||||||||||
Net change in financing arrangements (maturities of 90 days or less) | ( | |||||||||||||||||||
Other, financing | ( | ( | ( | |||||||||||||||||
Cash flows from (used in) financing activities | ( | ( | ( | |||||||||||||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ( | |||||||||||||||||||
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | ||||||||||||||||||||
CASH AND CASH EQUIVALENTS, END OF YEAR | $ | $ | $ | |||||||||||||||||
SUPPLEMENTAL CASH FLOW INFORMATION | ||||||||||||||||||||
Cash paid during the period for interest | $ | $ | $ | |||||||||||||||||
Cash paid (refunds received) during the period for taxes | $ | ( | $ | ( | $ | ( | ||||||||||||||
NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||
Non-cash capital contributions to subsidiaries | $ | ( | $ | ( | $ | ( | ||||||||||||||
Non-cash dividends/returns of capital from subsidiaries | $ | $ | $ | |||||||||||||||||
Treasury Stock shares issued for stock-based compensation programs | $ | $ | $ | |||||||||||||||||
December 31, | |||||||||||||||||||||||
Maturity Dates | Rate(1) | 2022 | 2021 | ||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||
Short-term debt: | |||||||||||||||||||||||
Commercial paper(2) | $ | $ | |||||||||||||||||||||
Current portion of long-term debt | |||||||||||||||||||||||
Total short-term debt | $ | $ | |||||||||||||||||||||
Long-term debt: | |||||||||||||||||||||||
Fixed rate senior notes | 2026-2051 | $ | $ | ||||||||||||||||||||
Junior subordinated notes | 2043-2062 | ||||||||||||||||||||||
Total long-term debt | $ | $ |
Calendar Year | |||||||||||||||||||||||||||||||||||
2024 | 2025 | 2026 | 2027 | 2028 and thereafter | Total | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Long-term debt | $ | $ | $ | $ | $ | $ |
2022 | 2021 | 2020 | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Prudential Annuities Holding Company | $ | $ | $ | |||||||||||||||||
International Insurance and Investments Holding Companies(1)(2) | ||||||||||||||||||||
The Prudential Insurance Company of America(3) | ||||||||||||||||||||
PGIM Holding Company(2) | ||||||||||||||||||||
Prudential Annuities Life Assurance Corporation(3) | ||||||||||||||||||||
Other Holding Companies | ||||||||||||||||||||
Total | $ | $ | $ |
Segment | Deferred Policy Acquisition Costs | Future Policy Benefits, Losses, Claims Expenses | Unearned Premiums | Other Policy Claims and Benefits Payable | Premiums, Policy Charges and Fee Income | Net Investment Income | Benefits, Claims, Losses and Settlement Expenses | Amortization of DAC | Other Operating Expenses | ||||||||||||||||||||||||||||||||||||||||||||
PGIM | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
U.S. Businesses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Group Insurance | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Life | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Assurance IQ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total U.S. Businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
International Businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate and Other | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total PFI excluding Closed Block division | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block division | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Segment | Deferred Policy Acquisition Costs | Future Policy Benefits, Losses, Claims Expenses | Unearned Premiums | Other Policy Claims and Benefits Payable | Premiums, Policy Charges and Fee Income | Net Investment Income | Benefits, Claims, Losses and Settlement Expenses | Amortization of DAC | Other Operating Expenses | ||||||||||||||||||||||||||||||||||||||||||||
PGIM | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
U.S. Businesses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Retirement Strategies(1) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Group Insurance | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Life | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Assurance IQ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total U.S. Businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
International Businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate and Other(2) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total PFI excluding Closed Block division | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block division | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Segment | Deferred Policy Acquisition Costs | Future Policy Benefits, Losses, Claims Expenses | Unearned Premiums | Other Policy Claims and Benefits Payable | Premiums, Policy Charges and Fee Income | Net Investment Income | Benefits, Claims, Losses and Settlement Expenses | Amortization of DAC | Other Operating Expenses | ||||||||||||||||||||||||||||||||||||||||||||
PGIM | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
U.S. Businesses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Institutional Retirement Strategies(3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Strategies | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Group Insurance | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Individual Life | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Assurance IQ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total U.S. Businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
International Businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate and Other(3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total PFI excluding Closed Block division | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block division | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | $ |
Gross Amount | Ceded to Other Companies | Assumed from Other Companies | Net Amount | Percentage of Amount Assumed to Net | ||||||||||||||||||||||||||||
2022 | ||||||||||||||||||||||||||||||||
Life Insurance Face Amount In Force | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
Premiums: | ||||||||||||||||||||||||||||||||
Life Insurance | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
Accident and Health Insurance | ||||||||||||||||||||||||||||||||
Total Premiums | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
2021 | ||||||||||||||||||||||||||||||||
Life Insurance Face Amount In Force | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
Premiums: | ||||||||||||||||||||||||||||||||
Life Insurance | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
Accident and Health Insurance | ||||||||||||||||||||||||||||||||
Total Premiums | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
2020 | ||||||||||||||||||||||||||||||||
Life Insurance Face Amount In Force | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
Premiums: | ||||||||||||||||||||||||||||||||
Life Insurance | $ | $ | $ | $ | % | |||||||||||||||||||||||||||
Accident and Health Insurance | ||||||||||||||||||||||||||||||||
Total Premiums | $ | $ | $ | $ | % |
Prudential Entities | ||||||||||||||
Assurance IQ | Assurance IQ, LLC | POK | The Prudential Life Insurance Company of Korea, Ltd. | |||||||||||
Company | Prudential Financial, Inc. and its subsidiaries | POT | The Prudential Life Insurance Company of Taiwan Inc. | |||||||||||
PALAC | Prudential Annuities Life Assurance Corporation | PRIAC | Prudential Retirement Insurance and Annuity Company | |||||||||||
PFI | Prudential Financial, Inc. and its subsidiaries | Pruco Life | Pruco Life Insurance Company | |||||||||||
PGFL | Prudential Gibraltar Financial Life Insurance Co., Ltd. | Prudential | Prudential Financial, Inc. and its subsidiaries | |||||||||||
PIIH | Prudential International Insurance Holdings, Ltd. | Prudential Financial | Prudential Financial, Inc. | |||||||||||
PHJ | Prudential Holdings of Japan, Inc. | Prudential Funding | Prudential Funding, LLC | |||||||||||
PLIC | Prudential Legacy Insurance Company of New Jersey | Prudential Insurance/PICA | The Prudential Insurance Company of America | |||||||||||
PLNJ | Pruco Life Insurance Company of New Jersey | Prudential of Japan | The Prudential Life Insurance Company Ltd. | |||||||||||
POA | Prudential of Argentina | Registrant | Prudential Financial, Inc. | |||||||||||
POB | Prudential of Brazil |
Defined Terms | ||||||||||||||
AFS Debt Securities | Fixed maturities, available for sale, at fair value | Guideline AXXX | The Application of the Valuation of Life Insurance Policies Model Regulation | |||||||||||
AIG | American International Group | Hartford Financial | Hartford Financial Services Group, Inc. | |||||||||||
Allstate | The Allstate Corporation | Hartford Life Business | The Hartford Financial Services Group's individual life insurance business acquired by Prudential Financial | |||||||||||
A.M. Best | A.M. Best Company | Holistic Framework | Holistic Framework for Systemic Risk in the Insurance Sector | |||||||||||
Board | Prudential Financial's Board of Directors | HTM Debt Securities | Fixed maturities, held-to-maturity, at amortized cost | |||||||||||
CIO Organization | Chief Investment Officer Organization | IB | Dynamic Income Benefit | |||||||||||
Closed Block | Certain in-force participating insurance and annuity products, along with corresponding assets used for the payment of benefits and policyholders' dividends on these products | ICS | The IAIS’s Risk-based Global Insurance Capital Standard | |||||||||||
ComFrame | The Common Framework for the Supervision of Internationally Active Insurance Groups | Moody's | Moody's Investor Service, Inc. | |||||||||||
Council | Financial Stability Oversight Council | Morningstar | Morningstar, Inc. | |||||||||||
Credit-Linked Note Structures | Agreements with external counterparties providing for the issuance of surplus notes by our captive reinsurers in return for the receipt of credit-linked notes | Other Postretirement Benefits | Certain health care and life insurance benefits provided by the Company for its retired employees, their beneficiaries and covered dependents | |||||||||||
DAI | The Prudential Fixed Annuity with Daily Advantage Income Benefit® | PBR | Principle-based reserving approach for life insurance products | |||||||||||
Designated Financial Companies | Non-bank financial companies that are subject to stricter standards and supervision | Pension Benefits | Funded and non-funded non-contributory defined benefit pension plans which cover substantially all of the Company’s employees | |||||||||||
Dodd-Frank | Dodd-Frank Wall Street Reform and Consumer Protection Act | PGIM | The global investment management businesses of Prudential Financial, Inc. | |||||||||||
Exchange Act | The Securities Exchange Act of 1934 | Regulation XXX | Valuation of Life Insurance Policies Model Regulation | |||||||||||
Fitch | Fitch Ratings Inc. | S&P | Standard & Poor's Rating Services | |||||||||||
Fortitude | Fortitude Group Holdings, LLC | Star and Edison Businesses | AIG Star Life Insurance Co., Ltd, AIG Edison Life Insurance Company, AIG Financial Assurance Japan K.K. and AIG Edison Service Co., Ltd., collectively | |||||||||||
FRB | Board of Governors of the Federal Reserve System | Tax Act of 2017 | The United States Tax Cuts and Jobs Act of 2017 | |||||||||||
GDPR | The European Union’s General Data Protection Regulation | Union Hamilton | Union Hamilton Reinsurance, Ltd. | |||||||||||
Great-West | Great-West Life & Annuity Insurance Company | U.S. GAAP | Accounting principles generally accepted in the United States of America | |||||||||||
Generator | Economic Scenario Generator |
Acronyms | ||||||||||||||
ABA | Activities-Based Approach | IAIS | International Association of Insurance Supervisors | |||||||||||
ACL | Allowance for Credit Losses | IRA | Individual Retirement Account | |||||||||||
ALM | Asset Liability Management | IRS | Internal Revenue Service | |||||||||||
AOCI | Accumulated Other Comprehensive Income (Loss) | LIBOR | London Inter-Bank Offered Rate | |||||||||||
ASC | Accounting Standards Codification | LPs/LLCs | Limited Partnerships and Limited Liability Companies | |||||||||||
ASU | Accounting Standards Updates | MD&A | Management's Discussion and Analysis of Financial Condition and Results of Operations | |||||||||||
AUD | Australian Dollar | MEC | Modified Endowment Contract | |||||||||||
BEAT | Base Erosion and Anti-Abuse Tax | MVA | Market Value Adjusted Investment Options | |||||||||||
bps | Basis Points | MRB | Market Risk Benefit | |||||||||||
CAA | The Consolidated Appropriations Act of 2021 | NAIC | National Association of Insurance Commissioners | |||||||||||
CARES Act | Coronavirus Aid, Relief, and Economic Security Act | NAV | Net Asset Value | |||||||||||
CECL | Current Expected Credit Loss | NFA | National Futures Association | |||||||||||
CFC | Capital and Finance Committee | NJDOBI | New Jersey Department of Banking and Insurance | |||||||||||
CFTC | Commodity Futures Trading Commission | NOLs | Net Operating Losses | |||||||||||
CLO | Collateralized Loan Obligation | NPR | Non-Performance Risk | |||||||||||
COSO | Committee of Sponsoring Organizations of the Treadway Commission | NY DFS | New York State Department of Financial Services | |||||||||||
COVID-19 | 2019 Novel Coronavirus | OCI | Other Comprehensive Income (Loss) | |||||||||||
DAC | Deferred Policy Acquisition Costs | OECD | Organization of Economic Cooperation and Development | |||||||||||
DOL | U.S. Department of Labor | OTC | Over-The-Counter | |||||||||||
DRD | Dividend Received Deduction | OTTI | Other-Than-Temporary Impairments | |||||||||||
DSI | Deferred Sales Inducements | PCAOB | Public Company Accounting Oversight Board | |||||||||||
EBITDA | Earnings Before Interest, Taxes, Depreciation and Amortization | PDI | Prudential Defined IncomeSM | |||||||||||
ERC | Enterprise Risk Committee | PFL | Profits Followed by Losses | |||||||||||
ERISA | Employee Retirement Income Security Act | PIIA | The Prudential Immediate Income Annuity | |||||||||||
ERM | Enterprise Risk Management | PPACA | The Patient Protection and Affordable Care Act | |||||||||||
ESG | Environmental, Social and Governance | PPC | Japan Policyholders Protection Corporation | |||||||||||
ETFs | Exchange-traded Funds | PPI | Prudential Premier® Investment Variable Annuity | |||||||||||
E.U. | The European Union | QPAMs | Qualified Professional Asset Managers | |||||||||||
FANIP | Funding Agreement Notes Issuance Program | RAF | Risk Appetite Framework | |||||||||||
FASB | Financial Accounting Standards Board | RBC | Risk-Based Capital | |||||||||||
FHLBB | Federal Home Loan Bank of Boston | RICO | Racketeer Influenced and Corrupt Organizations Act | |||||||||||
FHLBNY | Federal Home Loan Bank of New York | RILA | Registered Index Linked Annuities | |||||||||||
FINRA | Financial Industry Regulatory Authority | ROP | Return of Purchase Payment | |||||||||||
FIO | Federal Insurance Office | SEC | Securities and Exchange Commission | |||||||||||
FLIAC | Fortitude Life Insurance and Annuity Company | SECURE | Setting Every Community up for Retirement Enhancement Act | |||||||||||
FSA | Financial Services Agency | SMR | Solvency Margin Ratio framework | |||||||||||
FSB | Financial Stability Board | SOFR | Secured Overnight Funding Rate | |||||||||||
GICs | Guaranteed Investment Contracts | SVO | Securities Valuation Office | |||||||||||
GILTI | Global Intangible Low-Taxed Income | TBA | To Be Announced | |||||||||||
GMAB | Guaranteed Minimum Accumulation Benefits | TDR | Troubled Debt Restructuring | |||||||||||
GMDB | Guaranteed Minimum Death Benefits | UCITS | Undertakings for the Collective Investment in Transferable Securities | |||||||||||
GMIB | Guaranteed Minimum Income Benefits | U.K. | The United Kingdom | |||||||||||
GMIWB | Guaranteed Minimum Income and Withdrawal Benefits | URR | Unearned Revenue Reserve | |||||||||||
GMWB | Guaranteed Minimum Withdrawal Benefits | U.S. | The United States of America | |||||||||||
GSE | Government Sponsored Entities | USD | United States Dollar | |||||||||||
G-SII | Global Systemically Important Insurer | VIEs | Variable Interest Entities | |||||||||||
HDI | Highest Daily Lifetime Income | VOBA | Value of Business Acquired | |||||||||||
IMO | Independent Marketing Organizations | |||||||||||||
IAIG | Internationally Active Insurance Groups |
4.1 | Upon the request of the Securities and Exchange Commission, the Registrant will furnish copies of all instruments defining the rights of holders of long-term debt of the Registrant. | |||||||
101.INS—XBRL | Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
101.SCH—XBRL | Taxonomy Extension Schema Document. | |||||||
101.CAL—XBRL | Taxonomy Extension Calculation Linkbase Document. | |||||||
101.LAB—XBRL | Taxonomy Extension Label Linkbase Document. | |||||||
101.PRE—XBRL | Taxonomy Extension Presentation Linkbase Document. | |||||||
101.DEF—XBRL | Taxonomy Extension Definition Linkbase Document. | |||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
Prudential Financial, Inc. | ||||||||
By: | /S/ Kenneth Y. Tanji | |||||||
Name: | Kenneth Y. Tanji | |||||||
Title: | Executive Vice President and Chief Financial Officer (Authorized signatory and principal financial officer) |
Name | Title | |||||||
/S/ CHARLES F. LOWREY | Chief Executive Officer, President and Director | |||||||
Charles F. Lowrey | (Principal Executive Officer) | |||||||
/S/ KENNETH Y. TANJI | Executive Vice President and Chief Financial Officer | |||||||
Kenneth Y. Tanji | (Principal Financial Officer) | |||||||
/S/ ROBERT D. AXEL | Senior Vice President and Controller | |||||||
Robert D. Axel | (Principal Accounting Officer) | |||||||
THOMAS J. BALTIMORE, JR.* | Director | |||||||
Thomas J. Baltimore, Jr. | ||||||||
GILBERT F. CASELLAS* | Director | |||||||
Gilbert F. Casellas | ||||||||
ROBERT M. FALZON* | Director | |||||||
Robert M. Falzon | ||||||||
MARTINA HUND-MEJEAN* | Director | |||||||
Martina Hund-Mejean | ||||||||
WENDY E. JONES* | Director | |||||||
Wendy E. Jones | ||||||||
KARL J. KRAPEK* | Director | |||||||
Karl J. Krapek | ||||||||
PETER R. LIGHTE* | Director | |||||||
Peter R. Lighte | ||||||||
SANDRA PIANALTO* | Director | |||||||
Sandra Pianalto | ||||||||
CHRISTINE A. POON* | Director | |||||||
Christine A. Poon | ||||||||
DOUGLAS A. SCOVANNER* | Director | |||||||
Douglas A. Scovanner | ||||||||
MICHAEL A. TODMAN* | Director | |||||||
Michael A. Todman | ||||||||
By:* | /S/ KENNETH Y. TANJI | |||||||
Attorney-in-fact |